Synthetic and metabolic studies on [bēta],[gamma]-unsaturated  [alpha]-amino acids by Hallinan, Keith Oliver
 warwick.ac.uk/lib-publications  
 
 
 
 
 
 
A Thesis Submitted for the Degree of PhD at the University of Warwick 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/110385 
 
Copyright and reuse:                     
This thesis is made available online and is protected by original copyright.  
Please scroll down to view the document itself.  
Please refer to the repository record for this item for information to help you to cite it. 
Our policy information is available from the repository home page.  
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Synthetic and metabolic studies 
on
P.y-unsaturated a-amino acids.
By
K. O. Hallinan.
Submitted for the degree o f 
Doctor of Philosophy.
The University of Warwick.
Department o f Chemistry.
January 1992.
CONTENTS.
List of figures. ' v
List of tables. ' v
Acknowledgements. v
Declaration. v '
Summary. v **
Abbreviations. VH1
Chapter One.
Isopenicillin N cyclisation catalysed by isopcnicillin N synthase.
1.1 Historical background. 1
1.2 Biosynthetic pathway. 1
1.3 Isopenicillin N synthase. 2
1.4 Enzyme requirements. 3
1.5 Enzymatic synthesis of isopenicillin N. 4
1.6 Stereochemistry and requirements of fi-lactam ring closure. 4
1.7 Stereochemistry and requirements of
thiazolidine ring closure. 10
1.8 Substrate specificity of 1PNS. 13
1.9 Competing mechanisms of IPNS. 25
1.10 Summary. 34
C hapter Two.
Vinylglycine, its preparation and the Neber rearrangement.
2.1 Biological uses of vinylglycine. 35
2.2 Mechanism of inhibition of
i
pyridoxal-phosphatc dependent enzymes. 35
2.3 Synthetic preparations of vinylglycine. 37
2.4 Historical background to the Neber rearrangement. 50
2.5 Mechanism of the rearrangement. 50
C hapter Three.
Investigations into the stereochemistry of the isopenicillin N synthase 
catalysed cyclisation of an unnatural specifically labelled precursor.
3.1 Background. 57
3.2 Project objective. 58
3.3 General strategy. 59
3.4 Synthesis of o-benzyl N -bcnzyloxycarbonyl-
L-a-aminoadipate. 61
3.5 Preparation of benzyl-protected aminoadipyl cysteine. 64
3.6 Preparation of benzyl D-vinylglycine
p-tolucncsulphonic acid salt. 65
3.7 Preparation of benzyl protected
aminoadipylcysteinylvinylglycine. 68
3.8 Preparation of specifically labelled vinylglycine. 69
3.9 Summary. 77
C hapter Four.
Preparation of vinylglycinc and other p.y-unsaluratcd a-amino acids by 
the Neber rearrangement.
4.1 Project objective. 78
4.2. General strategy. 78
4.3 Synthesis of analogues of vinylglycine. 83
ii
4.4 Resolution of the unsaturated amino acid Boc derivatives. 93
4.5 Synthesis of vinylglycine epoxide. 94
4.6 Synthesis of ethyl AM -butyloxycarbonyl
-4-hydroxylhrconine. 96
4.7 Synthesis of ethyl W -f-butyloxycarbonyl
cyclopropylglycine. 99
4.8 Synthesis of ethyl AM -butyloxycarbonyl
-2-amino-but-2-cnoatc. 99
4.9 Summary. 101
C hapter Five.
The development of a reagent for the determination of enantiomeric 
excess of chiral carboxylic acids by nmr.
5.1 Introduction. 102
5.2 Project objective. 103
5.3 Preparation of chiral analysis reagent. 105
5.4 Preparation of diastercomcrs of methyl \ -p -m e th o x y
phenyl (2R)-(2-2H i Iglycinatc with chiral acids. I l l
5.4 Summary. 117
C hapter Six.
Experimental details.
6.1 Introduction. 118
6.2 Experimental details for chapter three. 119
6.3 Experimental details for chapter four. 128
6.4 Experimental details for chapter five. 146
ill
B ib lio g ra p h y . 152
L is t o f F ig u re s .
Figure 1 l H nmr of 5.5'-dimelhyl-2-methoxy-
1-pyrrol idinium hydrochloride (180). 92
Figure 2 X-ray structure of (2S.J/?)-AM -butyloxycarbonyl
-4-hydroxy threonate (183). 98
Figure 3 250 MHz proton nmr of methyl
/V-(4-mclhoxyphenyl)-/V '-(0-acetyl-m andelate)
glycinate (196). 113
L ist o f  ta b le s .
Table 1.1 Km and VmM values of substrates for IPNS. 17
Table 1.2 3° residue side chain v isomeric ratio of penams. 24
Table 3.1 Randomisation of deuterium labelling in
the terminal position of vinylglycine. 76
Table 4.1 Optical rotations of the resolved amino acids. 94
Table 5.1 Isotopic composition of chiral reagent 187. 111
Table 5.2 Chemical shift and J values of
diastercomcrs 195-199. 114
Table 5.3 Chemical shift of C-2 protons of amide 200. 115
iv
ACKNOW LEDGEM ENTS.
I wish lo express my gratitude to Professor D. H. G. Crout for the 
advice, guidance, and encouragement which he extended during the 
course of this research at Warwick.
I would like to thank the academic staff for helpful suggestions 
offered and express my gratitude to the technical staff for running nmr 
and MS spectra.
I would also like to thank Alice Parton for her help in preparing 
this thesis and finally all my co-workers for making my time at Warwick 
most enjoyable.
The financial assistance of the Science and Engineering Research 
Council is gratefully acknowledged.
DECLARATION.
The work described in this thesis is the original of the author, except 
where acknowledgement has been made to results and ideas previously 
published. It was carried out at the Department of Chemistry. University 
of Warwick between January 1988 and July 1991 and has not been 
submitted previously for a degree at any institution.
vi
SUMMARY.
(1) Chapter three describes the attempted investigation of the 
mechanism of ccpham formation catalysed by the enzyme isopenicillin 
N synthase of Acremonium cephalosporium. The stereochemistry of this 
cyclisation was to be investigated with a specifically labelled butyrate 
residue in the unnatural substrate. 8 - (a - a m in o )a d ip o y l- c y s te in y l -  
a-aminobutyric acid. The chiral methyl and methylene groups were to 
be synthesised by the tritiation of specifically deuterated vinylglycine. 
This, in turn, was to be prepared from phenyl (2-lrimcthylsilylethynyl) 
sulphone. Scrambling of the deuterium labelling occurred in this 
synthesis of vinylglycine and so forced the abandonment of the 
experiment without concluding the investigation.
(2) Chapter four describes the preparation of vinylglycine in a simple,
inexpensive, three step synthesis. The synthetic pathway involved a 
Pinner reaction, sodium hypochlorite treatment and an aqueous Neber 
rearrangement. The overall yield was 52% from the vinylcyanide. This 
method was applied to the production of other p.y-unsaturated a -a m in o  
acids with mixed success. The resolution of the r -b u ty lo x y c a rb o n y I  
derivatives of the amino acids so prepared was investigated with the 
thiol protease, papain. Ethyl L -W -f-b u ty lo x y c a rb o n y lv in y lg ly c in e  
prepared in th is  m anner was transform ed by epoxidation ,
dihydroxylation and cyclopropylation. An attempt to prepare a 
fluorothreonine derivative from the epoxide gave only the 
2.3-dehydrohomoserine analogue.
(3) Chapter five describes the development of methyl ( /? ) -(2 -2 H )-  
N -4-mcthoxyphcnylglycinatc (I) as a potential reagent for determining 
enantiomeric excess in chiral acids. The diastcrcomcrs formed differ 
only in isotopic stereochem istry, thus the possibility o f kinetic 
resolution is reduced to a minimum. The ec is measured by the proton 
nmr spectrum of the diastcrcomcrs. In coupling (I) to a range of racemic 
chiral carboxylic acids the expected 1:1 ratio was observed. However 
during one of the steps in the preparation of (I) raccmisation of the 
proton label occurred thus a single diastcrcomcr has yet to be prepared.
vii
A bbreviations.
tic Thin layer chromatography.
HPLC High pressure liquid chromatography.
CLC Gas liquid chromatography.
MS Mass spectroscopy.
IR Infra red spectroscopy.
n m r nuclear magnetic resonance.
ppm parts per million.
TMS
J
T etram elhylsilane. 
Coupling constant.
Hz Hertz.
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cys cysteinyl.
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CHAPTER 1.
ISOPENICILLIN N CYCLISATION CATALYSED BY 
ISOPENICILUN N SYNTHASE.
1.1 : Historical background.
Alexander Fleming first observed antibiosis between moulds in 
1929. Considering the ingenuity of nature, the discovery that 
microorganisms wage chemical warfare to destroy competition should 
not be surprising. This activity has been seen in several different 
species o f microbes. Man has since used these weapons in his own fight 
against pathological microorganisms. However the development of 
resistance to the original antibiotics has created the need for more 
active antibiotics.
The original and one of the most important of these groups are the 
penicillins. Penicillin N has been chemically synthesized but the 
chemical route cannot compete commercially with the efficiency of the 
producer microorganisms. There is thus a need to fully understand the 
biosynthetic pathway in order to exploit it.
1.2 : Biosynthetic pathway.
In Cephalosporium  acrem onium  the biosynthetic pathway to 
penicillin N (and finally to cephalosporin C) has been elucidated 
(Scheme I . !)*•*.
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Scheme 1.1
1.3 : Isopenicillin N synthase.
The crucial siep in lhe biosynihesii ia lhe cyclisation of the intact
2
(Arnstcin) tripcpiidc (1) into isopenicillin N (2)3-4 . Isopenicillin N 
d iffers from penicillin N by having the L- rather than the
D-configuration in the amino adipoyl side chain. The enzyme 
responsible for this cyclisation (isopcnicillin N synthase, IPNS) has 
been cloned5 and highly purified6' 7 and found to be stable for at least 
two months at -20°C. IPNS is a non-heme iron oxidase en..yme with a 
m olecular weight of 38kDa8 and pi 5.05°. Though an X-ray crystal 
structure has not yet been obtained, the first SO N-terminal amino acid 
sequence has been established9.
IPNS has been found to exist in two states, an oxidized state (with a 
disulphide bridge) and an active reduced state (with free thiol groups), 
which can be interconvcrtcd and isolated8 . These cysteinyl residues arc 
not involved in the catalytic activity. When they were replaced with 
serine residues, by site-directed mutagenesis, the optical or EPR spectra 
for the similar IPNS-ACV-NO complex remained unchanged10.
1.4 : Enzym e requirements.
There is a fundamental requirement for iron. The active site of 
IPNS contains one iron ion in the high (II) spin slate. The use of 
different spectral techniques has demonstrated the capacity of IPNS to 
coordinate the ACV substrate and the co-substrate molecular oxygen to 
the iron simultaneously. The ACV appears to be bound to the iron by a 
single sulphydryl bond. This causes the iron to gain some Fc(III) 
c h a ra c te r10. lOpM Fe(ll) is sufficient for maximum activity. Removal of 
this Fe(ll) by complexation with EDTA slopped cyclisation6 . Enzymatic 
activity was also strongly inhibited by thiol blocking agents. Molecular 
oxygen consumption has a 1:1 stoichiom etry with tripeptide
3
cyclisation11, terminating as two molecules of water.
1.5 : Enzymatic synthesis of isopenicillin N.
Isopenicillin N (2) has a bicyclic structure with fused f)-lactarn 
and thiazolidine rings. The overall reaction is dcsaturative with four 
protons lost and two new bonds (C-N, C-S) formed, with retention of 
stereochemistry. Several intermediates originally proposed have been 
eliminated as being unstable in the reaction medium12 or not being 
accepted as substrates or inhibitors (ie  recovered unchanged)13. No 
evidence of any enzyme-free intermediates has been detected by nmr14.
Incubating either unnatural and/or labelled substrates with IPNS 
has revealed a great deal about this complicated enzymic mechanism. 
These experiments have indicated the sequential cyclisation of the 
f)-lactam and thiazolidinc rings.
1.6 : Stereochemistry and requirements of (1-lactam ring closure.
Direct evidence o f the initial f)-lactam ring closure has been 
gained with incubation o f the specifically dcuterated precursors (3a, b, 
c) (Scheme 1.2)*3-*®.
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R - " W
Scheme 1.2
Incubation of a 1:1 mixture of (3a) and (3b) with IPNS resulted in 
the preferential formation of the unlabclled isopenicillin N (4a) in 
competition with ( 4 b ) * T h i s  preference is a consequence of isotopic 
discrimination whereby the carbon-proton bond is more easily broken 
than the carbon-deuterium bond. No such discriminative cyclisation is 
seen in the incubation of a 1:1 mixture of precursors (3a) and (3c). both 
substrates are consumed at equal rates to give a single product (4a).
Isotopic discrimination in such a competitive mixed label 
incubation is a Vm ax /K m effect and is observed only up to the first 
irreversible step18. This effect is present only with tripeptide 3b and not 
3c. It therefore implies that the cleavage of the cysteinyl 3-H bond is the 
first such irreversible step. Accordingly this is indicative of the initial 
formation of an enzymatically bound monocyclic fl-lactam intermediate 
(Scheme 1.3).
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Scheme 1 . 3
Suicide substrates are compounds which mimic an enzyme's 
natural substrate and while being accepted as such result in the 
inactivation of the enzyme in the course or the transformation. The 
glycine analogue (5a) is such a suicide inhibitor19. Whilst it could form 
the proposed 0 -lactam ring intermediate, it is structurally incapable of 
forming the thiazolidine ring. The attempted cyclisation of (Sa) by IPNS 
has thus been used to give information on the initial bond formation.
Incubation of the glycine containing tripeptide (5b) led to the 
release of tritium oxide in proportion to the inactivation of the enzyme 
(Scheme 1.4). The addition of dithiolhreitol to the reaction medium 
resulted in the breakdown of the proposed enzyme substrate complex (6) 
to liberate the monocyclic 0-lactam (7). The 0-lactam ring then opened to 
give the thioaldchyde (8). Labelling can be introduced exclusively to the
6
C-3 cysteinyl position by reduction of thioaldehyde (8) by sodium 
borotritiide. Labelled tripeptide (5b) can thus be recovered from the 
incubation of unlabellcd (5a).
n  on
mhJ î  ^ Rl
À —  NH 2
0 1
COjH
(5) a : R* = R2 *'H 
b : R ' - 3H. R2* *H
(5)
COjH
IH\ f  T > ~
0  I
S — Enz
HOT
COaH
hiothreitol j
RNHJ r  v SH
(7 ,
HOaC.
' t ------Ï*
n h 2 o
Scheme 1.4
Further evidence for the initial formation of the P-lactam ring 
was seen with the incubation of specifically labelled tripcptide (9) with 
IP N S 20. Study of the enzymatic cyclisation with nmr revealed the
presence of two peaks at approximately 8 - 8 9  ppm. In addition to the
7
expected penam (1). a 'shunt metabolite' was also present. This shunt 
metabolite production was a result of the deutcration at the valinyl C-3 
position. The primary isotope effect of this labelling decreased the 
efficiency at which the enzyme processed the presum ed bound 
monocyclic intermediate (10). This resulted in the leakage of a 
metabolite identified as the geminal diol (aldehyde hydrate) (14) 
(Scheme 1.5).
The accumulation of this unexpected product was rationalised as 
follows. The cyclisation of the thiazolidine ring in the natural product 
required a carbon-hydrogen bond to be broken. In the dcuterated 
precursor (9) this was slowed by the increased energy required to break 
the C-D bond of the valinyl residue. Consequently the alternative 
pathway b became significant. The intermediate (10) collapsed to the 
iminium ion (11) and atomic sulphur. Oxide attack on the ¡minium ion 
( II )  gave the unstable hydroxy f)-lactam (12). Hydrolysis o f  this entity 
yielded the aldehyde (13) which in the aqueous reaction medium was 
observed in the hydrated diol form (14). Indeed the efficiency of the 
IPNS was so decreased by the presence of this carbon-deuterium bond 
that the shunt metabolite (14) and isopcnicillin N were formed in equal 
amounts.
8
9
The cyclisation o r the f)-lactam ring is very siereospecific. 
Incubation of tripeptides stcreospccifically labelled at the C-3 position of 
the cysteinyl residue (13a and 13b) with IPNS led to the complete loss of 
the 3-pro-S hydrogen and the complete retention of the 3-pro-R
This was seen in tripeptide (13b) even though greater energy is 
required to break the carbon-tritium bond of the pro-S position relative 
to the carbon-proton bond of the pro-R position (Scheme 1.6).
1.7 : Stereochemistry and requirements of thiazolidine ring closure.
The closure of the thiazolidinc ring by IPNS. at first, appeared to 
be equally stereospccific. Only the C-3 proton of the valinyl residue 
appeared to be abstracted22. The incubation of the didehydrovaline 
derivative (17) did not give isopcnicillin N2 3 . This suggested that 
formation of a dehydrovalinyl intermediate during cyclisation did not 
occur.
hydrogen of the cystcinyl residue in the penam (I6)21. (Scheme 1.6).
COjHCOzH
(13) a : Hr = 'H. Hs 
b : Hr » 3H. Hs
(16)
NHa O
Scheme 1.6
10
ho2c
Incubation of natural substrates with specifically labelled valinyl 
residues (18a and 18b) cyclised with retention of the C-2 and C-3 
configuration to give the appropriate penam (Scheme 1.7)24.
b : R1 ■ ,3CHj 
r  =
NH, 0
Scheme 1.7
A surprising result, however, was observed on incubation of the 
unnatural substrate containing an aminobutyrate residue (20a) with 
IP N S 25. In addition to the expected penam product, a cepham (22) was 
also isolated. Furthermore incubation o f  the diastereomers (20a) and 
(20b), with a chiral C-3 centre, resulted in the formation of a single 
demethyl penam product with a (J-mcthyl configuration (21b)26. There 
was no evidence of the presence of the a-epim er (21a) (Scheme 1.8).
(18) a : R1 -  C2H3
COjH
(19)
tt . ix — j, = ri
b : R1 -  2H. R2 « CHj
Scheme 1.8
These anomalous results are in accordance with a free radical 
mechanism. Deprotonation at the C-3 position, with the breaking of the 
weaker C-H (over the stronger C-D bond) of both precursors (20b) and 
(20c) gave secondary radicals. These species were then sufficiently long 
lived to adopt the most favourable conformation with regard to the active 
site of the enzyme. In this case the f)-conform er was formed 
(Schem e 1.9).
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(20c)
c o 2h
(20b)
co2h
CO ^
(21c)
r  = H°2c V j X V ^ V |p i ;  
nh2 o
Scheme 1 . 9
This suggested mechanism was also in agreement with the 
formation of the ccpham (22). There is no report of a cepham formed 
with the natural substrate. This was probably because the tertiary free 
radical that would be generated in the natural substrate is much more 
stable than the primary free radical that would form on the C-4 position. 
However in the tripeptide (20) the difference in energy between the C-3 
secondary free radical and the C-4 primary free radical is apparently 
insufficient to  favour its  exclusive formation. Consequently, both 
cepham and penam products arc formed. Ccphams were also produced 
when isoleucine and norvalinc containing tripeplidcs were incubated 
with IPNS27.
13
A lest for the free radical hypothesis would be to incubate a 
radical probe to trap the proposed intermediate if generated. Cyclopropyl 
carbinyl radicals arc known to rearrange to but-3-enyl systems 
extremely fast, with a rate constant of 108 see'* (Scheme 1.10)28.
t > ~  ---------------  l / =
Scheme 1 . 10
Tripeplides containing this cyclopropyl moiety (23) and (24) were 
incubated with IPNS (Scheme 1.11).
Scheme 1 .1 1
Incubation of (23) resulted in the isolation of two products, a 
penam (23) and a ccpham analogue (26), in the ratio of 1:3. Incubation of
14
(24) yielded a single product, a homocepham (27). The formation of both
(26) and (27) is consistent with the free radical postulation. The free 
radicals of tripeptides (28) and (29) generated at the C-3 and C-4 positions 
respectively rearranged to give the open chain primary radicals (30) 
and (31). These then closed to the isolated ccphams (26) and homocepham
(27) with 6 and 7 mcmbered rings respectively (Scheme 1.12).
1.8 : Substrate specificity of IPNS.
Systematic alteration of the specific residues has given an insight 
into the requirements and tolerances of IPNS. It has also indicated the 
range of possible enzymic products.
Enz
(26)
(27)
NHj O
Scheme 1 . 12
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1.8.1 : Alteration of the aminoadipoyl residue.
The a-aminoadipoyl residue, while present, is not incorporated 
into the bicyclic structure. Its function, it appears, is to anchor the 
tripeptide to the enzyme and position it into the active site. A wide 
variety of tripeptides with differing residues in the primary position 
have been p repared  and incubated w ith IPNS (Schem e 
1 13) 29.30.31 .32,33
R -  L-Cys-D-Val
Scheme I . 13
Tripeptides (34) (35) (36) and (39) were not transformed as they 
had low Vmax values. The D-aminoadipoyl containing tripeptide (33) was
16
accepted for cyclisation. but at a lower rate. Analogues (37) and (40) 
were satisfactory substrates. These results signified that not only was the 
terminal L configuration not a requirement for cyclisation but that the 
terminal amino group did not even have to be present. It also indicated 
that to perform as an efficient substrate the 1° residue must be of a 
length equivalent to a 6 carbon chain and terminate in a carboxylic acid 
group. The rigid transoid conformation of the m -ca rb o x y p h cn y lace ty I 
tripeptide (41) satisfied these requirements and in accordance with the 
above observations acted as an excellent substrate with a Vm a x 
comparable with that of the native tripeptide (Table 1.1).
Table 1.1 : Km and Vmax values of substrates 1. 34 and 37 for IPNS.
Substrate Km Vmax
(mMI (um ol/m in)
(1) 0.16 1.64
(33) 0.9 2 .5 .1 0 ’
(41) 0.8 0.8
By the use of isotopically labelled precursors it was established 
that none of the oxygen atoms of the aminoadipoyl residue were 
exchanged during the cyclisation34. This suggested that the carboxylic 
group is bound by electrostatic interaction to a basic residue in the IPNS 
peptide chain such as lysine or arginine. We can thus conceive the 
binding site to be a basic residue separated from the active site by a 
distance equivalent to the 6 carbon chain.
17
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1.8.2 : Alteration of the cysteinyl residue.
As previously stated the p-lactam ring formation proceeded with 
the total loss of the cysteinyl 3-pro-S hydrogen atom and the total 
retention of the 3-pro-R hydrogen atom. The presence of this 3-pro-S 
hydrogen atom and the terminal thiol group was found to be an 
essential requirem ent for enzymatic activity . Provided these 
requirements were satisfied then the enzyme was tolerant to increases 
in the stcric bulk of the 2° residue-*5.
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(42) > : R1 .  R3 -  H. R3 * CHj (43) a : R1 -  H, R3 -  CHj
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Scheme 1.14
Incubation of tripeptide (42a). with a methyl group in the
cysteinyl C-3 pro-R position of the natural substrate, resulted in the 
formation of the corresponding methyl penicillin (43a). However 
substituted tripeptide (42b). which lacked a C-3 (S) hydrogen, was not 
transfo rm ed35. Substrates (42c) and (42d) with a-methyl and a -m elhoxy  
cysteinyl residues respectively were both cyclised successfully into the 
corresponding penams (43b) and (43c) (Scheme 1.I4)3®.
Incubation of homocystcinyl tripeptides (44) resulted in the
exclusive formation of the monocyclic shunt metabolite (45)
(Scheme 1.15)37.
RNH j — SH
—  X  V 0”
COjH ho2c^  \
(44) (45)
r .  h°2c y n ^ ;
nh2 0
Scheme 1.15
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The oxygen atom of the hydroxy group of (45) originated, in part 
at least, from the co-substrate, molecular oxygen. The proposed 
biosynthesis of the y-lactam is as follows (Scheme 1.16).
(44)
NH2 O
Scheme 1.16
Intermediate (47) was formed presumably because the substrate- 
enzyme complex (46) collapsed faster than the closure of the thiazolidine 
ring, with the release of atomic sulphur. This iminium ion was then 
attacked by the oxide of the iron-oxo centre to release the monocyclic 
Y-lactam (45).
To prepare an bicyclic rather than a monocyclic y-lactam a
20
nucleophile was included in the side chain o f the tertiary residue. 
Substrates containing serine, allylglycine or aminobutyrate side chains 
yielded only the analogous monocyclic y-lactam products. However the 
incubation of the tertiary cysteinyl residue (48) resulted in a single 
bicyclic disulphide y-lactam product (50). There was no indication of any 
monocyclic y-lactam or 5.5 bicyclic y-lactam (Scheme 1.17)3®.
NH2 O
Scheme 1.17
The enzyme bound monocyclic intermediate (49) is proposed as 
having a sulphydryl bond between the homocystcinyl residue and the 
electron-withdrawing iron-oxo centre. Nucleophilic attack on the 
sulphur by the 3° cystcinyl thiol group breaks this Fe-S bond resulting 
in the exclusive generation of the bicyclic y-lactam (SO) (Scheme 1.17).
21
Scheme 1.18
Recently the difluoro analogue (51) was incubated with IPNS
(Scheme 1.I8)39. It was hoped that the electron-withdrawing fluorine 
atoms would inhibit the formation of positively charged iminium 
intermediate. The substrate-enzyme intermediate (52) would thus be 
sufficiently stabilised to enable a thiazolidine containing y-lactam to 
form. However the only products isolated were the carboxylic acids (53a)
and (S3b). Product (53a) was seen to give (53b) at the pH of the
incubation (the other oxygen coming from the co-substrate) indicating 
that (33a) is the only enzymatic carboxylate product. No cyclic products 
were detected. Thus the fluorine atoms do indeed appear to stabilise an
enzyme-bound monocyclic intermediate (52). but instead of any cyclic
22
structure forming it is oxidised to the thiocarboxylic acid (53a) 
exclusively. This pathway is absent in the incubation o f the 
unfluorinated analogue (48).
1.8.3 : Alteration of the valinyl residue.
A complicated relationship was observed between the alteration of 
the 3° residue and the products recovered. In the natural substrate of the 
enzyme the thiazolidine ring closure proceeds with retention of
c o n fig u ra tio n 24. This appears to be totally a consequence of the active 
site topology which restricts rotation. Thus the isoleucine and 
alloisoleucine tripeptides also cyclise with retention4 0 . When the side 
chains were sufficiently small to allow rotation, saturated groups tended 
to adopt the P configuration whilst the unsaturated groups adopted the 
a  configuration. Thus both specifically dcuterated aminobutyrate and 
the D-norvaline tripeptides had predominantly the ^ -c o n f ig u ra tio n  
while the allenyl glycine and propargyl glycine tripeptides 
predominantly adopt the a-configuration. Ally I glycine tripeptide
occupies an intermediate position. This observation possibly reflects the 
composition of the active site with saturated and unsaturated residues 
making up the f) and a  sites respectively. Cyanoglycine tripeptide gave a 
1:1 ratio of a -  and f)-conformers indicating that the highly polar cyano 
group was unaffected by such influences (Table 1.2)27*41.
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Table 1.2 :3 °  residue side chain v isomeric ratio of penams.
D-valine substitute R group a :p
D -norvalinc e th y l >10:1
D -a-am ino butyrate m eth vl 7:1
D -allvIsI veine v in y l 4:1
D -propargyIk 1veine e th v n v l >1:15
D-cvanoKlvcinc evano 1:1
1PNS catalysed the cyclisation of a tripeptide containing a D-(f)- 
m cthy  I ) -a l lo  threonine residue (54) to the expected penam (56); 
surprisingly however the D*(0-methyl)threonine containing tripeptide 
(55) was not accepted as a substrate for cyclisation (Scheme 1.19)42-43.
r,
nh2 o
Scheme 1.19
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The stereochemistry of the C-3 position of the 3° residue is the 
only difference between the substrates (54) and (55). The steric bulk of 
the methoxy group is comparable to the ethyl group of the successfully 
cyclised isoleucine analogue. Therefore this discrimination by the 
enzyme must be a result of substrate interference. Thus it must be the 
orientation adopted by the oxygen of the threonine precursor (55)
within the active site that prohibits cyclisation. This docs not occur with 
the similar o/Zothreonine tripeptide (54). This observation reflects the 
sensitivity of the enzyme to the location of polar groups within the 
active pocket.
1.9 : Competing mechanisms of IPN S.
IPNS is curious in that it is an oxygenase enzyme that docs not 
insert oxygen into its natural substrate. However incubation of 
substrates containing an unsaturated 3° residue displayed two
mechanisms in competition. Alongside the normal desaturative (-4H) 
mechanism, a competing monooxygenase activity is seen with a 
hydroxylative (-2H+10) mechanism. The oxygen originated as the 
co-substrate molecular oxygen4 4 . The balance between the two rival 
mechanisms depended on the position of the unsaturated bond in the 
tertiary residue of the substrate4^.
COjH
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«P-A lkcncs gave neither pathway as the products would 
presumably be too unstable. If the double bond was located between the 
Py or the yS bonds but not the 5e bonds then the hydroxylative 
mechanism could occur in competition to the desaturative pathway. Thus 
the products of the enzymic cyclisation of the isodehydrovaline 
containing tripeptide (18) results from both mechanisms (Scheme 
1. 20 ) 4 6 .
26
RNH SH
] '  I 2 : R '- R j - ' h 
f — NH.  „ 2  b : R1 - JH. RJ » 'H  
°  Y  T  c :R '- 'H .R » - > H
( I K )  r n . u  q 1
X
Enz
\
Enz
1
Fe= 0
RNH .S  R’y - R 2XX
co2h
I
F e= 0
1
RNH
X y V -
COaH Rl
1
I 'e n e '
Enz
X -r
HOsC
I
2x ♦ 2x
RNhV  ^  /EnzXx?
COjH
1I
RNH e  olXX'
COjH
1
RNH. _
HOaC M
(58)
r .
(59)
NHa O
Scheme 1.20
The observed stereochemistry of products (38) and (39) is in 
accordance with the 'ene' reaction and a 'syn ' (2 x + 2 x | cycloaddition
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reaction respectively. This was then followed by reductive elimination 
with retention of configuration. This result suggested again that the 
proposed Fe-O centre is in close proximity to the second and third 
residues during cyclisation.
Tripeptides containing an allene side chain (60a) and (60b) 
resulted in products solely by a desaturalive mechanism47. The absence 
of hydroxylative mechanism is possibly due to differences in electron 
density between the allene and the isolated double bond; the lower 
electron density of the allene is insufficient to enable electrophilic 
attack by the oxygen of the Fe-O centre.
In contrast, the alkcnc derivative LLD-AC allylglycine (61) gave 
products by both routes. The enzymatic cyclisation results in the 
formation of different penam, homoccpham. homoceph-3-em and 
hydroxyhomoccpham products (Scheme 1.21)48.
H
a : R1 » H. R2 > CH=C=CH2 
b : R1 » CH=C=CHj. R2 » H
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(64)
> R = nh2 o
COaH
(62) (63) (64) (65) (6 6 )
10 4 1 5 2
Scheme 1 .21
Incubation of specifically labelled allylglycinc tripeptides (6 la-d) 
has indicated that more than two mechanisms were operating49.
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ho2c (61): R1 R2 R3 R4
a : 'H >H 'H ‘H
b : 2H •h ' h  ‘h
c : ! H 2h 2h  ‘h
d : 2H ■h ' h  2h
Nation of the analogue
in of the allyl glycine
residue, with the enzyme gave products by the hydroxylative mechanism
almost exclusively (Scheme 1.22).
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(61b)
R =
nh2 o
Ratio : (62b) (6 8 )
trace 1
COjH
(6 6 b)
(65b) (6 6 b)
20 8
Scheme 1.22
Investigation of the formation of the hydroxyhomocepham (6 8 ) 
using derivatives (61c) and (61d) (specifically dcutcratcd at the C-4 and 
C-5 positions) showed that inversion of configuration had occurred at 
the C-5 in relation to C-4.
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(6 1 b )
(6 8 c)
(6 1 d )
r  s
nh2 o
(68d )
Scheme 1.23
The inversion of the deuterium labelling of these products could 
be explained if epoxide formation or equivalent mechanism was 
o p e ra tin g 4 9  (Scheme 1.24). The cyclisation resulted in the opening of 
the epoxide ring of the enzyme bound intermediate (70) with inversion 
of the C-5 stereochemistry of the 3° residue (Scheme 1.24). This 
observation is in contrast to the retention of configuration that is seen 
with the 'ene' reaction that results in the formation in (62).
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Scheme 1.24
The competing mechanisms that are proposed to occur in the 
incubation of the ally 1 tripeptide can be identified as the following:
MECHANISM PRODUCT.
1 : Hydrogen abstraction /  recombination (63X64).
2 : Oxo-ene reaction (62).
3 : |2it+2it| cycloaddilion / reduction (65X66).
4 : Epoxide formation /  inversion (6 8 ).
Mechanisms 1 and 2 are desaturative whilst 3 and 4 are 
monooxygenalive. The ratio between the competing mechanisms is 
probably a consequence o f the geometry between the bound 
intermediate and the iron-oxene centre within the active site. The high 
energy of such a system giving rise to the complex pathways which then 
ensue.
1.10 : Summary.
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1.10 : Summary.
The isopenicillin N synthase is a monooxidase enzyme that does 
not insert oxygen into its natural substrate. It is seen to exhibit very 
tight stereochemical control in the P-lactam ring formation while being 
tolerant of changes in steric bulk. The thiazolidine ring closure is seen 
to be much more loosely controlled with a variety  of mechanisms 
expressed depending on the substrate.
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CHAPTER 2
VINYLGLYCINE. ITS METHODS OF PREPARATION AND 
THE NEBER REARRANGEMENT.
2.1 : Biological uses of vinylglycine.
Vinylglycine (71), (he simplest of the fLy-unsaturated a - a m i  no 
acid series, has been isolated from mushrooms50. As with other non- 
protcinogcnic amino acids it is the possible biological applications that 
provoked interest in vinyl glycine. As a consequence it has been shown 
to be a specific inhibitor of photorespiration5 1 and a plant growth 
r e g u l a to r 5 2 . It has also displays anti-bacterial properties against 
B acillus subtilis  and Escherichia colfi*.
2.2 : Mechanism of inhibition of pyridoxal-phosphate dependent enzymes.
However it is the inhibition of a wide range of pyridoxal-5- 
phosphate (PLP) (72) dependent enzymes that provokes greatest interest. 
These enzymes include aspartate am inotransferase5 4 , alanine 
rac e m ase 55, serine:glyoxylatc aminotransferase56, heart a -k e to g lu ta ra te  
dehydrogenase5 7  and other PLP dependent enzymes5®. PLP is an enzyme 
co-factor which in the absence of the substrate forms a Schiff-base with 
a e -N H 2  of a specific lysine residue within the active site of the enzyme 
(73). The a-amino substituent of the substrate displaces the lysine of the 
enzyme prior to the biotransformation. The covalent Schiff base PLP- 
substrate intermediate (74) is bound by non-covalent forces of attraction 
within the active site (Scheme 2.1). After the biotransformalion the 
Schiff base is hydrolysed releasing the product. PLP also stabilises 
negatively charged intermediates59.
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o
(71)
Scheme 2.1
Rando has given a possible mechanism for the inhibition of 
aspartate aminotransferase60. The enzyme deprotonates the a-hydrogen  
of the PLP bound vinylglycine intermediate (75) resulting in 
isomerisation of the double bond to give the conjugated intermediate
(76). The active site lysine then reacts with a Michael addition to give an 
alkylated lysine residue which destroys the catalytic activity of the 
enzyme (77) (Scheme 2.2).
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(77)
Scheme 2.2
2.3 : Synthetic preparations of vinylglycine.
Synthetic vinylglycine was first prepared by Larsen el al in  
197461. In this report vinylglycine was prepared in extremely low (1%) 
yield by two methods; the amination and saponification of ethyl-2 - 
bromo-3-butenoate and by a Strecker reaction from acrolein. Over the 
last 1 0  years improved methods for the preparation of both 
enantiomerically pure and racemic vinylglycine have been published. A 
brief synopsis of these procedures is presented in the following pages. 
The method of Sawada et a /6 2  for the preparation of specifically 
deuterium labelled racemic vinylglycine is discussed in the Chapter 3 
and will not be examined here.
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In 1984 Greenlee also used the Strecker reaction for his
preparation of racemic vinylglycine using trim ethylsilyl cyanide 
instead of potassium cyanide. A slightly better yield of 7% was achieved 
from acrolein. The application of this method to prepare other analogues 
of vinylglycine was more successful with yields ranging from IS to 
6 8 % « .
2.3.1 : Oxidative and thermal degradation of amino acids.
Oxidative degradation of amino acid derivatives has been employed 
in several preparations of vinylglycinc. It has the advantage in that the 
stereochemistry of the original amino acid can be preserved in the key 
step. Afzali-Ardakani and Rapaport used this approach in their synthesis 
of L-vinylglycine from L-methionine with 54% yield in five steps 
(Scheme 2.3)64. The thermolysis of the methionine sulphoxide derivative
(78) gave the protected vinylglycine (79).
The temperature and pressure of the thermolysis used in the 
sulphoxide had a significant effect on the yield of product and the 
degree of isomerisation to the a,f)-unsalurated isomer (80 and 81). The
NHRNHR NHR
(78)
(79) (80)
O
NHR
(81)
Scheme 2.3
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optimum conditions gave 90% yield with S% isomerisation to give the cis  
conjugated by-product (80). This result gives an indication of one of the 
problems associated with the synthesis of the vinylglycine; namely that 
of the isomerism of the double bond due to the labile a -pro ton .
In 1989 Mcffre el al also used thermolysis of the sulphoxide (78) 
for the preparation of the corresponding vinyl glycine derivative6*. In 
this method l ,2 dichloro benzene was used to dissolve the sulphoxide at 
I6 0 °C  for 3.S hours. Again temperature was found to be critical to limit 
the degree of isomerisation. The yield also depended on the amount of the 
sulphenic trapping agent calcium carbonate used. However the
elimination reaction is relatively inefficient with nearly half the 
starting sulphoxide recovered from the reaction mixture, giving an 
overall yield of only 2 0 % of the vinylglycine derivative in three steps.
Belokon et al report the production of optically enhanced 
vinylglycine (38% ee) in 43% yield from racemic methionine66. The 
chiral complex of (S)-o-(Af*(Af-benzylprolyl)amino| benzophenone and 
nickel (II) enantioselccted only the L-isomers to form an optically pure 
Schiffs base. Oxidation and thermal elimination at I80°C  of the 
diastereomerically pure nickel (II) methionine complex gave a mixture 
containing the nickel (II) vinylglycine complex which acid treatment 
gave the vinylglycine derivative. The mechanism is assumed to be 
sim ilar to the Rapoport mechanism. The poor optical purity was 
attributed to the reaction workup rather than the racemisation of the 
complex.
Hanessian and Sahoo used the decarboxylative elimination of 
L-glutamate derivatives, facilitated by lead tetraacetate and cupric ion, to
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prepare optically pure vinylglycine (Scheme 2.4)6?. Two routes were 
devised with overall yields of 45% from L-benzyloxycarbonylglutamic 
acid.
Scheme 2.4
In method A the a-carboxylic acid is neatly protected as the 
readily prepared formaldehyde adduct (83) and treated with the lead 
tetraacetate to effect the decarboxylation to the vinylglycine (84). The 
yield for this step is stated as approximately 50% however when 
repeating the step in this laboratory an almost quantitative yield was 
achieved. Thus this convenient and practical method can have a much
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higher overall yield than that reported. Method B merely involves 
treating the formaldehyde adduct (84) with methoxide to produce the 
a-methyl ester of N -benzyloxycarbonyl-glutamate (85) prior to the 
decarboxylation step. Deprotection by acid hydrolysis gave the
vinylglycine hydrochloride (71).
2.3.2 : Use of selenium chemistry in the synthesis of vinylglycine.
The relatively high temperatures required by the above methods 
are inconvenient for large scale synthesis. Selenoxides readily undergo 
a syn  elimination at or around room temperature. Barton et al developed 
two routes involving selenoxides in the formation of L-vinylglycine
from protected glutamic acid68.
Method A in the preparation of vinylglycine consisted of three 
steps with 45% overall yield. The glutamic selenohydroxamic ester (87) 
was prepared from selenohydroxamic acid and rapidly rearranged to
give the alkylselenide (8 8 ) with the loss of carbon dioxide. Ozonolysis of 
this compound and in situ elimination gave the vinylglycine (83). 
Method B involved four steps with 52% overall yield. In this instance the 
use of selenohydroxamic acid was avoided by the preparation of the 
phenyl selenide (8 8 ) via the bromide (89). (Scheme 2.5).
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Scheme 2.5
Similarly Pellicciari et al prepared optically pure vinylglycine 
from the in situ oxidation and elim ination o f the 2 -nitrophenyl* 
selenocyanate adduct of protected homoserine i90) in three steps with 
49% yield69.
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cx< H H
O COjiPr
(90)
2.3.3 : synthesis via heterocyclic compounds.
S cho llkopf et al used heterocyclic chem istry to prepare 
enantiomerically pure vinylglycine (Scheme 2.6)7®. Heterocycle (91) 
was prepared from a chiral auxiliary (methyl L-valinate) and glycine 
methyl ester. Dcprotonation of the acidic C-H by butyl lithium formed a 
rigid and planar anion (92). The asymmetric electrophilic attack by
2 -|dimethyl t-butyl silyl) ethanal (a masked ethenyl group) on the 
planar anion results in a single diastereomer (93). Acid hydrolysis of 
this product cleaved the imino ether linkages to give the isolatable free 
hydroxy silyl (94). Acid and ion exchange treatment gave vinylglycine 
(71) in 25% overall yield. This method can also be used for the 
preparation of other p.y-unsaluratcd amino icids7® ^ 1.
43
(71)
Scheme 2.6
Shea el al also used selenium chemistry in their preparation of 
racemic vinylglycine in a four step synthesis (Scheme 2.7)7 2 . The 
y-bromination and phenylselenide displacement of methyl 2 -butenoate 
(95) gave the selenide (96). The key stage of the synthesis was the 
\-chlorosucinimide treatment o f this intermediate to the selenide (9 7 ) 
which underwent a [2,3) sigmatropic rearrangement to the vinylglycine
(98). Acid treatment gave the protected vinyl glycine (99) with overall 
yield of 18% .
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'S^ Y ° V ---------- -
(95) (96) 0
NHC02C(CH3)3
(99)
Scheme 2.7
2.3.4 : Use of glycine equivalents.
The use of electrophilic glycine equivalents for the synthesis of 
vinyl glycine has been investigated by several groups73*74»75 . All 
involved the initial preparation of chloro or bromo glycine derivatives
(100) followed by reaction with a vinyl Grignard reagent. The derivative 
(100) can be considered as the carbocation equivalent (101). This method 
gives good yields of a wide range of racemic p.y-unsaturated amino acids.
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2.3.5 : Sigmatropic rearrangements to vinylglycine.
Vyas et al made use of the sigmatropic rearrangement in their 
vinyl glycine preparation from the inexpensive (Z)-2*butene-1,4-diol 
(102) (Scheme 2.8)?6 . Imidates (103), (104) and (103) were prepared 
under a variety  of conditions. The thermal (3.3) sigmatropic 
rearrangement of these intermediates at I80°C gave the alcohol (107). 
The Jones oxidation and acid hydrolysis of the compound (107) gave 
vinyl glycine hydrochloride (71). The poor yield from the hydrolysis 
step, only 44%. caused the overall yield from butenediol to be only 26%. 
This could presumably be increased when the efficiency of hydrolysis is 
im proved.
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NHCOCCI3
(107)I\K.
NHCOCCI3
(108)t
^ C 0 2h 
nh2 hci 
(71)
Scheme 2.8
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2.3.6 : Use of Wittig reagents.
The most recently published synthesis involves the use of a Wittig 
reaction with the aldehyde (110) followed by oxidation (Scheme 2.9)77. 
In this manner optically pure vinylglycine can be prepared in a five 
step synthesis starling from serine of the opposite configuration. The 
overall synthesis however proceeds with a low overall yield.
Scheme 2.9
2.3.7 : Use of D-mannitol.
Mulzer et al used D-mannitol as an chiral educt in the synthesis of 
D-vinylglycine (97% ec) in six steps (Scheme 2.10)7*. Erylhro-selective 
addition of organomctal reagents to the starting materials gave the vinyl 
alcohols (114a and b). The diastereomeric phthalates (115a and b). 
prepared by Milsunobu inversion, were separable by crystallisation. 
Deprotection to the diol (116) followed by a Jones oxidation and further
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deprotection, by refluxing with hydrazine, gave vinylglycine ii 
overall yield.
Scheme 2.10
10%
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2.4 : Historical Background of the Neber rearrangement.
The 'Neber rearrangement' is the general name given to the 
reaction observed when oxime arylsulphonates are treated with a base. 
The nitrogen is seen to undergo a 1,2 migration, with the loss of the 
tosylate ion, to yield an a-amino ketal. It can thus be an effective method 
for the preparation of a-amino ketones. The reaction was first observed 
in 1929 by F.W. Neber and A. von Freidolheim when investigating the 
Beckm ann rea rran g em en t7 9 . Their alkoxide treatment of phenyl
propanone oxime tosylate (119) gave 1-phenyl-l-amino-propanone 
(120). This original example is demonstrative of a typical migration.
(119) (120)
Over the following years they extended this reaction to the 
preparation of both straight chain8 0  and cyclic amino ketones81 . The 
mechanism originally proposed by Neber is generally that quoted 
today8 2  (Scheme 2.11).
2.5 : Mechanism of the Neber rearrangement.
In the Neber mechanism8 2  the alkoxide removed the acidic proton 
from the a-methylene of the oxime (121) (Scheme 2.11). The anion then 
closed to form an azacyclopropene (azirine) ring intermediate ( 1 2 2 ) with 
concomitant loss of the tosylate group. Solvolysis o f the azirine ring 
resulted in the ketal (123). The amino ketone (124) is recovered after acid
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treatm ent. The lack of isomeric amino ketones indicated that
tautomerisation was absent in the azirine ring of intermediate (122).
n ' OT*
(121)
„OT«
___R
(122)
1
R \
0
.  X  . _
I
ElO JOB»’sX .,
NHZ
T *
nh2
(124) (123)
R 1 ■ Aryl. RJ ■ aryl, alkyl, etc.
Scheme 2.11
The presence of the azirine ring is remarkable. This three
membcred unsaluratcd ring is a highly strained and therefore unstable 
entity. Nebcr cited the base treatment of 1 -(2,4-dinitrophenyl) 
propanone oxime tosylate (125) as evidence of its participation in the 
mechanism. There were two consequences of the presence of these 
electron withdrawing nitro groups which make this oxime exceptional. 
Firstly the acidity of the methylene protons was increased such that 
pyridine was sufficiently basic to initiate the reaction. Secondly, and 
more importantly, the stability of the azirine intermediate was enhanced 
due to the increased resonance structures provided by the nitro groups. 
Thus the otherwise fleeting azirine intermediate was isolated as the 
hydrochloride of a pyridine-water complex ( 126)®°.
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Pyridine. HCI . H2O
(125) (126)
2.5.1 : Hatch and Cram  proposals.
Other mechanisms have been proposed to explain the migration.
Hatch and Cram confirmed the Neber findings twenty five years after 
the original reports®3. Lithium aluminium hydride reduction of the
intermediate (126) gave the corresponding aziridine. However they
suggested that the stability of the azirine moiety of intermediate (126) 
was an extreme case and might not be representative. They studied 
examples thought to be more typical of the normal oximes. They isolated 
intermediate (128) from the alkoxide treatment of desoxybenzoin oxime 
tosylate (127). From this they reasoned that the strained azirine need not 
be present. Instead it was suggested that the reaction was a base 
catalysed 1.3 elimination superimposed on a 1.2 addition reaction. This
pathway would give their isolated alkoxy ethylenimine (128)®4 .
(127) (128)
To make their findings compatible with the isolation of 
intermediate (126) they proposed that the pyridine-water complex was a
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resonance form of the structure (129) similar to the structure that they 
had suggested.
(126) (129)
Products from stereospecific Beckmann rearrangem ent side 
reactions indicated that the equilibration of the oxime bond did not occur 
under the reaction conditions. Surprisingly in the Neber rearrangement 
the configuration of the oxime bond did not appear to influence the 
direction of nitrogen migration. Thus both cis  and irons oximes gave the 
same amino ketone85. When two differing a-methylenes were available 
the reaction proceeded in a irons  direction84. The single exception is 
1 -(2 -n iiro p h cn y  l)propanonc-f)-oxim c tosylatc. This anomaly possibly 
results from some interaction between the nitrogen of the oxime and the 
ortho-nilro group that prevent the normal steric course.
This observation is very unexpected. A strong and unfavourable 
steric interference would be expected between the attacking anion and 
the cis  tosylate group which should markedly influence the reaction. 
This suggests two further mechanistic possibilities; ie saturated and 
unsaturated nitrene intermediates.
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2 .5 .2  : Presence of nitrenes?
In addition to the above observation, nitrenes would explain the 
lack of stereospecificity of the Neber rearrangement in contrast to that 
seen in the Beckmann rearrangement. These could also account for the 
fact that rearrangements involving substituted nitrogens have not been 
reported. A saturated nitrene intermediate (130) could arise from a direct 
base attack on the carbon-nitrogen double bond. Then, after the 
elimination of the negatively charged losylate group, a singly bonded 
neutral nitrogen would result (Scheme 2.12).
O O
NHZ NH2
R 1 ■ aryl, alkyl, etc. 
R 2 * aryl, alkyl, etc.
Scheme 2.12
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This species (130). in common with other nitrenes and carbenes, 
should display little  selectivity in the insertion reaction with the 
adjacent carbon-hydrogen bonds. Where two discernible carbon-proton 
bonds are present the electrophilic nature of the nitrene should favour 
attack at the centre with higher electron density.
l-(4-m ethoxyphenyl)-3-(4-nilrophcnyl)propanone oxime tosylate 
(131) possesses such distinguishable methylenes. The C -l methylene 
with the attached methoxy substituted phenyl ring is electron rich. In 
contrast the nitro phenyl substituted C-3 methylene is relatively 
electron deficient with acidic protons. Only the acidic protons of the C-3 
methylene are seen to be removed. Alkoxide treatment of oxime tosylate 
(131) results in the rearrangement to a single amino ketone (133) with a 
complete absence o f  the isomeric product (132)®5 . This finding 
eliminates the possibility of a saturated nitrene being present as an 
intermediate during the nitrogen migration (Scheme 2.13).
(132) 0 3 3 )
Scheme 2.13
The presence o f  an unsaturated nitrene is however a possibility86. 
The base deprotonation and the loss of the tosylate could lead to the
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formation of the unsaturated nitrene intermediate which could then
close to the azirine ring (Scheme 2.14). There is an example of such 
intermediates giving rise to an azirine ring8 7 . The presence of an 
unsaturated nitrene could also explain why the configuration of the 
oxime has no influence on the product form ed and the
non-stereospecific nature of the rearrangement.
Although the mechanism has not been conclusively established 
yet the Neber rearrangements have been used over the years where 
conventional methods have failed. In addition to the tosyl group other 
leaving groups have also been employed successfully. These include the 
use of chloride etc88,89,9^.
H
R = aryl, alkyl, etc. 
R2 * aryl, alkyl, etc.
Scheme 2.14
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CHAPTER THREE.
INVESTIGATIONS INTO TH E  STEREOCHEMISTRY O F 
T H E  ISOPENICILLIN N SYNTHASE CATALYSED CYCLISATION OF AN 
UNNATURAL SPECIFICALLY LABELLED PRECURSOR
3.1 : Background.
The mechanism by which the enzymatic thiazolidine ring closure 
occurs during penicillin biosynthesis is still not completely understood. 
As stated in the introduction the proposed mechanism involves a rotation 
restricted free radical intermediate. As a consequence the natural 
substrate ( 1) undergoes cyclisation with retention of stereochemistry to 
the penam (2 ).
In the cyclisation of the aminobutyrate tripcptidcs (20a and 20b) 
the smaller size of the radical intermediate means that it is able to rotate 
before cyclisation occurs. This results in the isolation of a single 
P-dem ethyl isopenicillin N (21b) product from both precursors 
(Schem e 3 .1)25.
(20) a : R1 = CH3> R2 « 2H 
b : R1 « 2H. R2 » CH3
( 21 ) ( 22 )
NH2 o
Scheme 3.1
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However when the proton is abstracted from the C-4 position of 
the unnatural substrates (2 1 a and 2 1 b) an additional product, a ccpham 
(2 2 ) was also recovered.
3.2 : Project objective.
The objective of this project was to examine the stereochemistry 
of the enzymatic formation of ccphams. This involved the preparation of 
the stereospecifically labelled tripeptides (134a) and (134b) and 
incubating them with 1PNS. Cepham (135 and 136) formation would be 
favoured over penam formation, as breaking the relatively weak 
carbon-proton bond of the C-4 position would be preferred to breaking 
the carbon-deuterium and carbon-tritium bonds (Scheme 3.2).
Scheme 3.2
Tritium nmr could have been used to examine the stereochemistry 
of the cyclisation. The spectra of the ccpham producl(s) would have been
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simple and would have shown only two signals corresponding to the two 
tritium atoms in the product. Examination of the chemical shifts and the 
coupling constants in the spectra could then have been used to see if the 
cyclisation had proceeded with retention or inversion (yielding a single 
cepham 135 or 136), or loss of stereochemistry (yielding a mixture of 135 
and 136).
In one case (retention), the substrate 134a would give a product 
with a c/i-arrangem ent of tritium atoms whereas in the other case 
(inversion), a trans-arrangem ent would result. The complementary 
result would be obtained with the substrate 134b. These possibilities 
would be distinguishable on the basis of the different coupling constants 
for the cis and trans isotopomers.
3.3 : General strategy.
The proposed pathway for the preparation of the specifically 
labelled substrates was a five step synthesis involving specifically 
deuterated vinylglycine and benzyl protecting groups (Scheme 3.3). All 
benzyl protecting groups could have been removed in a single step with 
sodium in liquid ammonia91. Tritiation of the specifically deuterated 
vinylglycine derivatives in the penultimate step of the pathway would 
have given the product in high radiopurity at a late stage of the 
syn thesis.
59
Scheme 3.3
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3.4 : Synthesis of benzyl N-benzyloxycarbonyl-L-a-aminoadipate (139).
The preparation of the N -b en z y lo x y c a rb o n y l-L -a -am in o ad ip ic  
acid (138) was a straight forward reaction with benzyl chloroformate 
and L-a-aminoadipic acid in a biphasic mixture of toluene and water at 
0°C and was accomplished in high yield (85%) (Scheme 3.4)92.
Conditions : Benzyl chloroformate, toluene, acetone, water, 
sodium hydroxide, 0°C, 2hr.
Scheme 3.4 
O
O
(139)
The preparation of a -b e n z y l N  - b e n z y I o x y c a r b o n y I - 
L-a-aminoadipatc (139) is more complicated due to the presence of two 
carboxylic acid groups. The a-benzyl ester (139) is a key intermediate in 
the synthesis o f a wide range of unnatural substrates for IPNS. There 
have been many efforts to synthesize this from a-aminoadipic acid and 
other amino acids92.93.94 fj,e  usua| method of preparing it from the 
parent amino acid is by the Williamson synthesis. This involves 
preparing the mono caesium salt of the a-carboxylic acid group of
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N -bcn/.y loxycarbonyl-L -a-am inoadip ic acid and reacting with benzyl 
bromide to give the desired product. When we attempted to prepare the 
product by this method it was round to be unreliable and readily formed 
dibenzyl ester instead. Attempts to specifically remove the « -ca rb o x y lic  
acid benzyl group by a range of enzymes were not successful.
This method was clearly not a reliable one for the repeated 
preparation of this intermediate in high yields. Ideally we require a 
method that could only give the a-benzyl mono ester as the sole product.
Enzymes are well known for being both stereo and regioselective 
in their reactions. Thus, in principle, an enzymatic method would be 
ideal to protect specifically the a-carboxylic acid group of the amino acid 
a-aminoadipate. Papain is an inexpensive thiol protease derived from 
the papaya plant. It has an active site thiol residue and the catalysis 
proceeds through a thioester intermediate9 5 . It has a wide substrate 
range and is stereospecific for the L-isomer of amino acid substrates. It 
has previously been used by Cantacuzene et al to resolve amino acids into 
the L-ester and the D-free acid9 6 . Papain was therefore an ideal 
candidate for the preparation of the mono ester (139).
The esterification of the substrate by papain, like all enzymatic 
esterifications, is a reversible equilibrium reaction; which increases 
both the forward and reverse rates of hydrolysis equally. In an aqueous 
medium the presence of approximately 55 molar water results in an 
unfavourable equilibrium with respect to ester formation. However, 
biphasic systems have been used to overcome this limitation96. If the 
ester product of the reaction is preferentially partitioned into the 
organic phase relative to the substrate then the equilibrium is shifted
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towards ester formation. The equilibrium constant for such a reaction, 
K biphatic 'n a two P^asc system, is related to the equilibrium constant in 
water, the partition coefficients and the volume of the phases as 
follows^7.
Kbiphrtc = [B]/[A| = K,
+ Pb V o,s
____ V.
+ P a Vot,
V.
(A) and [B] represent the concentrations of the reactant and the 
product respectively, Kw is the equilibrium constant of the reaction in 
the aqueous phase. Pa and Pb arc the partition coefficients of the 
reactant and the product respectively between the two phases and V the 
volume of the phase.
F or the  p a p a in -c a ta ly s e d  a  - e s t e r i f i c i t i o n  o f  
AT-benzyloxycarbonyl-L-a-aminoadipic acid (138), a biphasic mixture of 
dichloromethane and 0.1 M citrate /  phosphate buffer (pH 4.2) was used. 
Cysteine and ethylene diaminotetraacetic acid tetra sodium salt were 
added to the reaction medium in order to protect the thiol residue within 
the active site of the papain and to complex out any heavy metal ions 
present in the solution (Scheme 3.5).
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HOjC
*COaH
B zO ^.N H
Y
0  (138)
BzO'
BzO,
O (139)
Conditions : papain, dichloromethane, benzyl alcohol.
citrate /  phosphate buffer, pH 4.2, 37°C, 2 days.
Scheme 3.5
The mixture was stirred at 37°C for two days until the starting 
material had disappeared (tic). The product was extracted with ethyl 
acetate and the combined organic layers were worked up to give an oily 
residue of product and excess benzyl alcohol, which were separated by 
flash chromatography. Initial elution with a petroleum ether /  ethyl 
acetate 20 : I mixture removed the benzyl alcohol. The product was then 
obtained by elution with petroleum ether /  ethyl acetate 3 : 1 mixture in 
6 6 % yield. The product was rccrystalliscd from ethyl acetate /  petroleum 
ether to give the pure monobenzyl ester (139).
3.5  : Preparation of benzyl-protected am lnoadipyl cysteine (140).
The dipeptide (140) was prepared by the addition of isobutyl 
chloroformate to a stirred solution of the protected aminoadipate to form 
the mixed anhydride98. Addition of the S-benzyl cysteine resulted in the 
formation of the dipeptidc which was isolated by extraction in 54% yield 
and used without further purification (Scheme 3.6). The light sensitive 
nature of the dipeptide, which resulted in the loss of the S-benzyl group, 
necessitated its storage in a cold and dark environment.
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o
BzO
BzO
Conditions : isobutyl chloroformate, THF,
5-benzyl-cysteine, triethylamine, 0°C
Scheme 3.6
3.6 : Preparation of benzyl D-vinylglycinate p-toluenesulphonic acid salt 
(142).
The delicate nature of the vinylglycine precluded application of 
the normal method for preparing benzyl esters of amino acids by 
refluxing in benzene with benzyl alcohol and p-toluene sulphonic acid. 
Thus a gentle method of preparing the benzyl ester p - to lu e n esu lp h o n ic  
salt of vinylglycinc (142) was required.
The tf-f-butyloxycarbonyl (Boc) vinylglycine (143) derivative was 
prepared by the addition of 1 .2  equivalents of di-f-butyl-dicarbonate to a 
solution of vinylglycine in 1,4-dioxanc / 5% aqueous sodium bicarbonate 
/  water 2 : 1 : I in high yield (93% )".
As the D-isomer only is required in the tripeptide (134), the 
enzymatic removal o f  the L-isomcr at this stage was planned, as this 
would avoid w asting half the valuable dipeptide and ease the 
chromatographic separation of the LLL-tripeptide from the LLD-
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tripeptide. Esterification was achieved by incubation of the racemic 
Boc-vinylglycine, D,L-(143), with papain in a biphasic medium. In this 
instance, as the starting material was much less soluble in the buffer 
than was the aminoadipate derivative, the ratio of organic phase to 
aqueous phase was altered from 30 : 1.3 to 3 : 15 . The alcohol chosen was 
ethanol which could be easily removed under reduced pressure thereby 
avoiding rigorous purification. The desired Boc-D-vinylglycine. D-(143). 
was thus simply extracted and recovered from the organic phase by 
washing with sodium bicarbonate and recovered by re-extraction 
(Scheme 3.7).
(144)
Conditions : Papain. L-cysteine, EDTA Na4 ,
citrate /  phosphate buffer. pH 4.2, 
dichloromcthanc, ethanol, 37°C. 2 days.
Scheme 3.7
The benzyl ester of the Boc-D-vinylglycine (145) was prepared in 
high yield (80% ) by reaction with phenyl diazom ethane 
(Schem e 3 .8 )100. In contrast to the extreme reactivity of diazomethane, 
in this instance prolonged stirring and heating to reflux failed to induce 
the reaction but addition of a small portion of ethereal hydrogen 
chloride caused the reaction to go immediately to completion. The
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product was purified by flash chromatography with ethyl acetate /  
petroleum ether 40-60° I : 10.
(143) (145)
Conditions : Phenyldiazomethane, diethyl ether, 
cat. hydrogen chloride, RT.
Scheme 3.8
The e x tre m e ly  s e n s i t iv e  b e n z y l v in y lg ly c in a te  
p-tolucnesulphonic acid salt (142) was prepared by stirring with exactly 
one equivalent of p-tolucnesulphonic acid in diethyl ether for 4 hours at 
room tem perature1 . The product was recovered by evaporation under 
reduced pressure and used without further purification (Scheme 3.9). 
The proton nmr of the product showed a complete absence of the 
prominent r-butyl signal normally at 1.4 ppm.
Conditions : p-toluenesuphonic acid, diethyl ether. 4hr, RT.
Scheme 3.9
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3 .7  : P rep a ra tio n  of benzy l-p ro tec ted  am in o ad ip y lcy ste in y l 
vinylglycine (141).
The fully protected tripeptide was prepared by the EEDQ (2-ethoxy- 
1 -ethoxycarbonyl-1 ,2 -dihydroquinoline) m ediated coupling of the 
dipeptide (140) and the vinylglycine derivative (142). The yield of the 
reaction was only 1 0 % because the conditions had to be sufficiently basic 
to keep the amino group available for the coupling. However the basicity 
also resulted in the double bond migrating into conjugation with the 
ester group with consequent loss of yield. The product was purified by 
reverse phase HPLC (Scheme 3.10).
Conditions : EEDQ, THF, trielhylamine, RT, 8 hr.
Scheme 3.10
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Increasing the amount of vinylglycine derivative (142) relative to 
the dipeptide (140), and the use of the alternative coupling reagent
dicyclohexylcarbodiimide failed to increase the amount of tripeptide 
(141) recovered. The attempted coupling of the free D-vinylglycine with
isobutyl chloroformate also failed to give any tripeptide.
3.8 : Preparation of specifically labelled vinylglycine.
A convenient method for the preparation o f such labelled
vinylglycines was published by Hill et a /6 2  starting from diethyl
acctamidomalonate (Scheme 3.11).
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( i)D
H3CCOND— I— C02CH2CH3
c o 2c h 2c h 3
(146)
COaCHaCHa
(147) (■) ■ *H
(b) -  2H cis
(c) ■ 2H trans
( H )
Ra
O
(71)» : R* ■ R2 ■ R3 ■ *H 
b :R '-R 3- 2H. R2- ' h 
c :R '-R 2- 2H. R3- ' h
HjCCOND— l—  C02CH2CH3
c o 2c h 2c h 3
(148) • : R , - R 2 - R , - ,H
b : R* * R3 * 2H, R2- ' h 
c : r ‘ -R 2- 2H. R3- ' h
Conditions : (i) Phenyl 2 -(trimethylsilyl)cthynyl sulphone. THF. D2 0 .
(ii) Hg /  alumium amalgam, dioxane. 10°C.
(iii) methanol /  6  M HCI. reflux. 4hr.
Scheme 3.11
Several problems were encountered whilst attempting to repeat 
this apparently straight forward procedure.
3.8.1 : Preparation of diethyl acetamido [2-(pheny!sulphonyl)-vinyl] 
malonate (147).
The Z and E- specifically deuterated vinyl sulphones (147b and c) 
were prepared by the following method. The labile protons of diethyl
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acetamidomalonate (146) were exchanged by iwice dissolving the 
malonate in a mixture of dj-methanol / deuterium oxide /  dry pyridine 
and evaporating. The malonate (146) so treated showed no signals for the 
methine or amido protons in the proton nmr spectrum. The d2 m alonate 
(146) and 0.15 equivalents of freshly sublimed potassium r-butoxide were 
stirred at -10°C  in THF before the addition o f the phenyl 
(2-trimethylsilylcthynyl)sulphone. The silyl intermediate (149) resulted 
from the Michael addition of the malonate to the elhynylsulphone. The
timing of the addition of the deuterium oxide fixed the ratio of cis /  trans 
products formed on removal of the trimelhylsilyl group. The kinetic
ratio of 3:1 cis sulphone (147b) to the trans sulphone (147c) resulted
when the D2 O was added after 1 hour, whereas if it was added after 24
hours the trans sulphonc (147c) was recovered almost exclusively as the 
thermodynamic product (Scheme 3.12). The products were both purified 
and separated by flash chromatography. Examination of the proton nmr 
spectra of the individual products showed <5% residual proton.
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•  : R '* R 2 « ' h . 
cif b : Rl -  R2 -  2H. 
Iran, c : R1 -  R2 -  2H.
a
Z J Z *
H3CCOND — I— c o 2c h 2c h 3 
c o 2c h 2c h 3
Conditions : phenyl 2-(trimethylsilyl)ethynyl sulphone. 
potassium r-butoxide. THF, D2O.
Scheme 3.12
In practice, and contrary to the published procedure, it was found 
that the time period before addition of the ethynyl sulphone had to be 
decreased from one hour to thirty minutes to reduce the formation of an 
unwanted by-product which dramatically affected the yield of the 
desired products. The by-product was identified as the unsaturated amino 
acid derivative (150). This compound was possibly formed by a Krapcho- 
lype decarbethoxylation (Scheme 3.13).
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3.8.2 : Synthesis of diethyl acetaminovinylmalonate (148).
The de-phenylsulphonation was carried out by stirring the 
separated trans and c is  isomers of the phenylsulphone (147a and 147b) 
with aluminium amalgam in 1,4-dioxane for 2 days. At the stated 
temperature of 5-10°C the yield of product (148a and 148b) was very low 
(<10%). To increase the yield in the de-phcnylsulphonation the 
temperature of the reaction was increased to room temperature which 
increased the yield o f product to 80% after vacuum distillation 
(Schem e 3.14).
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HjCC< HjCHj H3CCOI HjCHj
COjCh^CHj
(147) a : R1 » R2 -  'H. 
clj b : R1 -  R2 -  2 H. 
Irani c : R1 -  R! -  2 H.
( 148) i : R ' - R ! - R 3 - ' h .
b : R1 ■ R3 ■ 2H. R ^ H .  
c :R 3 - R 2 - 2H. R3 « ' h .
Conditions : Hg /  alumium amalgam, dioxane, RT.
Scheme 3.14
Examination of the proton nmr spectra of the purified products 
showed the expected signal integrating for a single proton.
3.8.3 : Synthesis of deuterated vinylglycine.
The literature method of deprotection of the vinyl malonatcs (148) 
was given as boiling under reflux in equal portions of 6  M hydrochloric 
acid and methanol for four hours. However when this was attempted, 
little product was recovered. The desired products were recovered in 
very high yield by boiling the m alonates under reflux in 
6  M hydrochloric acid for 60 minutes. The solution was then passed 
down a Dowex 50-8X (H+) column and the vinylglycine eluted with 4% 
aqueous pyridine (Scheme 3.15).
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(1 4 8 )«  : R 1 -  Rl  -  RJ »  'H  (7 1 )  « : R 1 .  R1 -  R! -  ' h
b : R1 • R3 . 2H. RJ -  ‘h  b : R1 -  R* -  JH. RJ -  ' h
c : R ' - R J - JH. r ’ . ' h c : R ' - R J « : H, r ’ . ' h
Conditions : 6  M HCI. reflux , lhr.
Scheme 3.15
3.8.4 : Labelled D-f-butyloxycarbonyl-vinylglycine.
The Boc-vinylglycine derivative was prepared as before in high 
yield. As for the unlabellcd vinylglycine, racemic Boc-vinylglycine was
incubated with papain in a biphasic medium to remove the unwanted 
L-isomer.
The published procedure states that the method is suitable for the 
preparation of specifically  labelled c is  and t r a n s  isomers of 
| 3 ,4 -2 H 2 lvinylglycine. However, no indication was given of the degree of 
scrambling of the deuterium in the terminal position. The proton nmr 
spectrum of the labelled Boc-vinylglycine (143) was such that the
signals corresponding to both terminal vinylic protons were well
resolved as broad singlets. The integrals of these signals permitted the
estimation of the % residual proton at both C-4 terminal positions 
(Table 3 .1).
75
T a b le  3 .1  : R a n d o m is a tio n  o f  d e u te r iu m  la b e llin g  In  t h e  te rm in a l  p o s i t io n  of 
v lny lg lyclne.
143 b : R1.  Rj » ’ h . R! » ' h 
c : * ' •  R! •  JH. R1-  'H
Boc vinvlslvcine R 2 R3
143b 2 . 6 1 .0
143c 1 .0 2 .0
This result showed that randomisation of the deuterium had 
occurred during the synthesis of the Boc-vinylglycine. The scrambling 
of the deuterium presumably occurred during the reductive removal of 
the sulphone substituent. The de-phenylsulphonation of alkenes with 
sodium amalgam is reported as involving a free radical mechanism 
which can lead to the scrambling of any labelling102- 103. This 
presumably also happens with aluminium amalgam.
The success of the project depended on the specific labelling of 
the deuterium in the vinylglycine residue. The extent of the
randomisation of the label was so great such that the aim of the project 
could not be fulfilled using labelled iripeptide precursor prepared by the 
Sawada method.
A final attempt to de-protect the vinylsulphonc was made using a 
biphasic method of Julia et a /104. This employed sodium dithionatc and a
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phase transfer catalyst in the dc-phenylsuphonation. This is reported to 
proceed through an anion rather than the free radical. However no 
product was recovered from the reaction mixture corresponding to the 
starting material, product, or vinylglycine itself.
3 .9  : Summary.
(1) As a result of unforeseen scrambling of the labelling in the 
preparation of the specifically labelled precursor the project could not 
be completed as planned.
(2) A convenient enzymatic method for the preparation of 
1 -benzyl a-(A T -ben zy lo x y carb o n y l)am in o ad ip a te , an im portan t 
intermediate in the synthesis of a wide range of suitable unnatural 
substrates for IPNS, using papain has been developed.
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C H A P T E R  F O U R
PREPARATION O F VINYLGLYCINE 
AND O T H E R  p.y-UNSATTJRATED a-A M IN O  A CID S 
BY T H E  N EB ER  REARRANGEMENT.
4.1 : Project objective.
It was the need for vinylglycine in the preparation of the 
unsaturated tripeptidc for the experiment on IPNS that prompted our 
interest in a quick, cheap and efficient synthesis. As indicated in the 
introduction most o f the published methods are relatively long and time 
consuming with low overall yield. The purchasing of the material from 
commercial suppliers is prohibitive due to the extremely high cost (£7.40 
/ mg racemate, £10.10 /  mg L-isomer; the D-isomer is not available)105. 
Thus if an inexpensive route to the preparation of vinylglycine could be 
devised it would allow freer investigation into its uses as an enzyme 
inhibitor and as a springboard to the preparation of a wide range of 
other unnatural amino acids by exploitation of the double bond.
4.2 : General strategy.
The use o f the Ncbcr rearrangement in the preparation of amino 
acids has long been established107. In 1977 Friis et al reported the 
formation of vinylglycine (71) upon simple aqueous base treatment of 
the natural product potassium allylglucosinolate (sinigrin) ( 151 ) 1 06 . 
This was reported as resulting from a Neber type rearrangement 
(Scheme 4.1).
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(71)
Scheme 4.1
It was thus recognised that a synthesis of vinylglycine could be 
achieved starting from the readily available vinylcyanide. The following 
pathway was proposed for the preparation (Scheme 4.2). The key step of 
the synthesis involves a Neber rearrangement of an /V-chloroimidate to 
the unsaturated amino acid.
Conditions : (i) Methanol, hydrogen chloride. 0°C , 1 hr.
(ii) Sodium hypochlorite solution, 0°C. I hr.
(iii) Sodium hydroxide. 4°C. 8  hr.
Scheme 4.2
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4.2.1 : Synthesis of imidate hydrochloride (153).
The preparation of the imidate hydrochloride (153) involved a 
Pinner acid methanolysis of the nitrile group of vinylcyanide (152) 
(Scheme 4.3).
(152) (153)
Conditions : Methanol. Hydrogen chloride. 0°C. Ihr.
Scheme 4.3
Hydrogen chloride was passed through a methanolic solution of 
vinylcyanide for 1 hour at 0 ° C 107. The protonation of the nitrile is 
followed by attack of the methanol. The product of the reaction was a 
white solid precipitated by the addition of cold, dry diethyl ether. The 
hygroscopicity of the product disappeared once all traces of the 
hydrogen chloride were removed. The yield of the reaction was 
quantitative provided it was carried out at the stated temperature. Control 
of the temperature during the reaction was essential to prevent the 
formation of ammonium chloride (if ammonium chloride was formed it 
would be converted in the next step (sodium hypochlorite treatment) 
into explosive nitrogen trichloride).
4.2.2 : Synthesis of N-chloroimidate (154).
The addition of the sodium hypochlorite solution to an aqueous 
solution of the imidate hydrochloride (153) typically gave low yields of 
around 15%. This was a result of hydrolysis of the imidate hydrochloride
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to the corresponding amide108-*09. This hydrolysis was easily followed 
by observing the proton nmr spectrum in D2 O. After SO minutes the 
imidate hydrochloride was completely decomposed. However the addition 
of solid imidate hydrochloride directly to the hypochlorite solution did 
not allow time for this hydrolysis and results in the quantitative 
formation of the volatile, colourless and water insoluble oil which was 
extracted with petroleum ether (Scheme 4.4).
(133) (154)
Conditions : 12-14% Sodium hypochlorite. 0°C. Ihr.
Scheme 4.4
The Af-chloro imidate (154) prepared in this manner was highly 
pure and was used in the next stage without further purification.
4.2.3 : Synthesis of vinylglycine (71).
As stated in the introduction the Neber rearrangement is 
normally brought about using an alkoxide as a base. However, as with 
sinigrin, the acidity o f the a-proton of the N -chloroimidate is again 
increased by the allylic double bond to the extent that It is eliminated by 
aqueous alkali (Scheme 4.5), , °.
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lo the corresponding amide*08-*09. This hydrolysis was easily followed 
by observing the proton nmr spectrum in D2 O. After 50 minutes the 
imidate hydrochloride was completely decomposed. However the addition 
of solid imidate hydrochloride directly to the hypochlorite solution did 
not allow time for this hydrolysis and results in the quantitative 
formation of the volatile, colourless and water insoluble oil which was 
extracted with petroleum ether (Scheme 4.4).
(153) (134)
Conditions : 12-14% Sodium hypochlorite, 0°C. lhr.
Scheme 4.4
The A(-chloro imidate (154) prepared in this manner was highly 
pure and was used in the next stage without further purification.
4.2.3 : Synthesis of vinylglycine (71).
As stated in the introduction the Neber rearrangement is 
normally brought about using an alkoxide as a base. However, as with 
sinigrin, the acidity of the a-proton o f the \-ch loro im idate  is again 
increased by the allylic double bond to the extent that it is eliminated by 
aqueous alkali (Scheme 4.5)* *°.
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o( 1 5 4 )  ( 7 1 )
Conditions : 3 eq. sodium hydroxide. 0°C, overnight.
Scheme 4.5
Thus simple base treatment of the oily Af-chloroimidate with three 
equivalents of sodium hydroxide overnight at 4°C caused the 1.2 nitrogen 
migration to occur. The product was isolated by passing the reaction 
mixture directly over a Dowex 50W 8 X (H+) ion exchange column and 
eluting with 4% aqueous pyridine.
Examination o f the crude product before the ion exchange 
treatment showed no trace of impurities. However the yield o f isolated 
product after ion exchange was, at best, only 52%. If the column was 
allowed to stand for a short period of time before continuing the elution 
a yellow polymeric gum formed. This by-product would appear to result 
from some polymerisation of the product in the reaction solution on the 
column. This side reaction was not seen when vinylglycine, from other 
sources, was passed down the column the recovery was quantitative.
4.2.4 : Synthesis of AJ-f-butyloxycarbonylvinylglycine (143).
It was considered that protection of the amino group would make 
it possible to isolate the protected vinylglycine through extraction. The 
need for the ion exchange procedure with its attendant side reaction 
would thus be avoided. Therefore an equal volume of 1.4-dioxane and 
1 .2  equivalents o f di-f-butyldicarbonate were added d irectly  to the
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o(154) (71)
Conditions : 3 cq. sodium hydroxide, 0°C, overnight.
Scheme 4.5
Thus simple base treatment of the oily Af-chloroimidate with three 
equivalents of sodium hydroxide overnight at 4°C caused the 1,2 nitrogen 
migration to occur. The product was isolated by passing the reaction 
mixture directly over a Dowcx 50W 8 X (H+) ion exchange column and 
eluting with 4% aqueous pyridine.
Examination of the crude product before the ion exchange 
treatment showed no trace of impurities. However the yield of isolated 
product after ion exchange was, at best, only 52%. If the column was 
allowed to stand for a short period o f time before continuing the elution 
a yellow polymeric gum formed. This by-product would appear to result 
from some polymerisation of the product in the reaction solution on the 
column. This side reaction was not seen when vinylglycine, from other 
sources, was passed down the column the recovery was quantitative.
4.2.4 : Synthesis of A/-f-butyloxycarbonylvinylglycine (143).
It was considered that protection of the amino group would make 
it possible to isolate the protected vinylglycine through extraction. The 
need for the ion exchange procedure with its attendant side reaction 
would thus be avoided. Therefore an equal volume of 1,4-dioxane and 
1 .2  equivalents o f di-t-butyldicarbonate were added directly to the
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reaction medium at 0°C  and the mixture was allowed to stir overnight to 
prepare Af-f-butyloxycarbonylvinylglycine (143). Careful extraction of 
the product with ice-cold 1 M potassium hydrogen sulphate increased the 
yield of the vinylglycine to 67%. Care was required to prevent the 
de-protection of the acid sensitive AM-butyloxycarbonyl group.
4.3 : Synthesis of analogues of vinylglycine.
Having thus established a new method for the preparation of 
vinylglycine we then examined the feasibility of the method for the 
preparation of other p.y-unsalurated amino acids.
4.3.1 : Synthesis of 2-amino-pent-3-enoic acid (158).
Distilled trans pent-3-enenitrile (135). a commercially available 
material, was subjected to the Pinner reaction and subsequent sodium 
hypochlorite treatment as above. The yields for these steps was 87% and 
94% respectively.
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Conditions : (¡) Methanol, hydrogen chloride, 0°C, I hr.
(ii) Sodium hypochlorite solution, 0 C, I hr.
(iii) Sodium hydroxide. 4 C. 8 hr.
Scheme 4.6
The Neber rearrangem ent in aqueous medium gave a
disappointing yield of only 14% p.y-unsaturated amino acid after ion 
exchange treatment. The use of the more typical Neber base such as 
allcoxide had previously been used by Crout el a l in the preparation of 
2-amino-3-methyl-but-3-enoic acid. However use of allcoxide as base 
gave a similar yield of 12%. The product was not sensitive to the basicity 
of the solution. A solution of 2-amino pent-3-enoic acid in 0.63 M NaOD 
solution and heated to 30°C overnight showed no decomposition by 
proton nmr. Again when the Boc-derivative (139) was prepared, 
obviating the need for an ion exchange column, as with vinylglycine, 
an increase in the yield to 29% was observed.
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4 . 3 . 2  : S y n t h e s i s  o f  2 - a m i n o - 3 - m e t h y l - p e n t - 3 - e n o i c  a c i d  ( 1 6 7 ) .
The required nitrile (164), not available commercially, was 
prepared from methyl tiglate in the following manner.
Conditions : (i) Lithium aluminium hydride, diethyl ether, 0°C, 2 hr.
Lithium aluminium hydride treatment of an ethereal solution of 
methyl tiglate at 0°C  afforded the corresponding alcohol (162) in 89% 
yield. Addition of phosphorous tribromide to an ethereal solution of the 
2-methyl-but-2-ene-l-ol at 0°C followed by stirring for 8 hours gave the 
corresponding bromide (163) in 76% yield. The addition of 
l-bromo-2-methyl-but-2-ene to a DMSO solution of sodium cyanide at 
50°C  followed by stirring for 2 hours gave the nitrile (164) in 67% yield 
(Scheme 4.7).
(161) O (162)
(164) (163)
(ii) Phosphorous tribromide, diethyl ether, 0°C, 8 hr.
(iii) Sodium cyanide. DMSO. 50°C. 2 hr.
Scheme 4.7
8 5
Conditions : (i) Methanol, hydrogen chloride. 0°C. 1 hr.
(ii) Sodium hypochlorite solution. 0°C, 1 hr.
(iii) Sodium methoxide. 4°C. 8 hr.
(iv) Sodium methoxide. methanol, di-r-butyl-di-carbonate
Scheme 4.8
Both the Pinner reaction and the bleach treatment proceeded in 
quantitative yields. The Nebcr reaction with ethoxide as the base gave a 
yield of 58% after passing down a ion exchange column. However if the 
ethoxide solution was quenched into water and reacted with di-r- bu ty l - 
dicarbonate, a yield of 50% of \ - l - b u ty lo x y c a r b o n y l- 2 - a m in o - 3 -  
methylpent-3-enoic acid (168) was obtained (Scheme 4.8).
8 6
3-Methylbut-3-enenilrile (171) was prepared by the slow addition 
of methallyl chloride to a solution of cuprous cyanide in nitrobenzene 
heated at 125°C for 2 hours. The product was isolated by fractional 
distillation in 77% yield1 * *.
Jk^cl ~ J^CN
(170) <I 7 I >
Conditions : Sodium cyanide, nitrobenzene, DMSO, 125°C, 2 hr.
Scheme 4.9
The usual synthesis by reacting the halide with sodium cyanide in 
dimethylsulphoxide resulted in the isomerisation of the double bond to 
give the conjugated 3-methyl-2-butenenitrile as the only product.
The Pinner reaction and subsequent sodium hypochlorite 
treatment of the nitrile (171) gave yields of 100 and 87% respectively. 
The use of aqueous base for the Ncbcr rearrangement of Af-chloroimidatc 
(173) gave a yield of 19% of recovered amino acid (174). The Neber 
rearrangement gave a yield of 76% with elhoxide as the base107. The 
Boc-derivative was prepared in high yield (100%) with di-r*buty l- 
dicarbonatc (Scheme 4.10).
4 . 3 . 3  : S y n t h e s i s  o f  2 - a m i n o - 3 - m e t h y l - b u t - 3 - e n o i c  a c i d  ( 1 7 3 ) .
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Conditions : (i) Methanol, hydrogen chloride, 0°C, 1 hr.
(ii) Sodium hypochlorite solution, 0°C. I hr.
(iii) Sodium ethoxide, 4°C, 8 hr.
(iv ) Di-f-butyl-dicarbonatc, 1.4-dioxane. water, 
sodium bicarbonate. 0°C, 8 hr.
Scheme 4.10
4.3.4 : Pinner reaction of 4-methyl pent-3-enenitrile (176).
4-Methylpent-3-enenitrilc (178) is not available commercially 
and was prepared from the inexpensive 3-methylbut-3-en-l-ol (176) 
(Scheme 4.11).
8 8
(176) (177) (178)
Conditions : (i) Phosphorous tribromide, diethyl ether, C°C, 8 hr.
(ii) Sodium cyanide. DMSO, 50°C, 2 hr.
Scheme 4.11
The corresponding bromide (177) was prepared by adding the 
alcohol to an ethereal solution of 0.33 equivalents of phosphorous 
tribromidc at 0°C in 83% yield. The nitrile (178) was then prepared in 
74% yield by stirring the bromide (177) in a solution of 1.2 equivalents 
of sodium cyanide in DMSO at room temperature overnight.
The Pinner reaction of 4-methylpent-3-cnenitrile (178) did not 
give the expected imidate hydrochloride product (179). The proton nmr 
gave none of the expected signals. There was a complete absence of the 
signal due to vinylic protons expected at 5.5-6.S ppm (Scheme 4.12).
(179) (180)
Conditions : methanol, hydrogen chloride 0°C, Ihr.
Scheme 4.12
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The analytical data suggested that the structure of the product is 
the hydrochloride o f  5,5’-dimethyl-2-methoxy-l -pyrrolidine (180). The 
proton nmr spectrum (Figure 1, p92) contains two singlets at 3.64 and 
1.52 ppm corresponding to the methoxy and the two methyl protons
respectively. The methylene protons displayed a typical A2 B 2  splitting
pattern. The splitting pattern of the two signals arc identical and 
symmetrical as the difference of the chemical shifts is large compared to 
the coupling constants.
The mass spectra and nmr also agree with the proposed
structure. This compound would not normally be expected to form under
the acidic conditions of the Pinner reaction. A possible mechanism for
the formation of the pyrrolidine ring results from the protonation o f the 
double bond of the imidate hydrochloride (179) to give a relatively 
stable tertiary carbocation (Scheme 4.13). Although the reaction medium 
is extremely acidic, an equilibrium must exist between protonated and
unprotonated imidate species. The lone pair of the neutral unprotonated 
nitrogen instigates a nucleophilic attack at the carbocation forming an 
energetically favourable five membered ring (Scheme 4.13). This cyclic 
structure (180) is of interest for its potential in the preparation o f y- 
amino acids.
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(180)
Scheme 4.13
4-Phenyl-but-3-enenilrile and 1.4-but-2-ene dicyanide were 
subjected to the Pinner reaction and sodium hypochorite treatment 
successfully but failed  to give any product from the Neber 
rea rran g em en t.
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Figure 1 :
*H nmr of J.J'-dimethyl^-methoiiy-l-pyrrolidiniuin hydrochloride
4.4 : Resolution of the unsaturated amino acids Boc derivatives.
Having prepared Af-r-butyloxycarbonyl-amino acids an altem pl 
was made to resolve them into their optical isomers. The simplest way to 
do this is by enzymic resolution (Scheme 4.14).
Conditions : papain. L-cysteine, EDTA Naa,
citrate /  phosphate buffer. pH 4.2, 
dichloromethanc, ethanol. 37°C. 2 days.
Scheme 4.14
Papain had previously been used Cantacuzene et al in the 
resolution of benzyloxycarbonyl-amino acid derivatives96 and by us in 
the selective a-benzylation of A f-benzyloxycarbonyl-2-am inoadipic ac id  
(Chapter 2). Papain is enantiospecific for the the L-isomer of amino 
acids so this method readily lent itself to the inexpensive resolution of 
the Af-r-butyloxycarbonyl-amino acids. The conditions of the enzymatic 
resolution of the amino acids is the same as that given in chapter two. 
The L-ester (144) was purified by flash chromatography with ethyl 
acetate / petroleum ether 10 : 1.
A single incubation with papain was not sufficient for the 
complete resolution of racemic Boc-vinylglycine. To complete the 
resolution therefore a second incubation with papain of the recovered
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impure D-acid was carried out. The optical purity was checked by 
comparison of the optical rotation of the free amino acids which 
obtained after the acid hydrolysis and ion exchange treatment.
By this method vinylglycine and 2-aminopent-3-enoic acid were 
resolved into their L- and D-isomcrs. The resolution of 2-amino- 
3-mcthylpcnt-3-cnoic acid was still incomplete after two incubations. 
The Boc derivative of 2-amino-3-methylbut-3-enoic acid (173) failed 
completely to act as a substrate for papain. The unsuitability of 2-amino- 
3-methyl-but-3-enoic acid to act as a substrate is consistent with the 
results of Cantacuzcne et who had observed that the structurally
similar Boc-L-valine failed as a substrate. This indicates possibly that an 
isopropyl side chain on the amino acid substrate cannot be 
accommodated in the active site of the papain, whereas n -propyl and 
isobutyl chains are accepted, although in the latter case only poorly. The 
results are summarised in Table 4.1.
Table 4.1: Optical rotations of the resolved amino acids.
Amino acid L-isom er D-isomer
(71) +95° -96°
(158) ♦ 112° -114°
_________t a n ________ +65.4°
4.5 : Synthesis of vinylglycine epoxide (181).
The p resen ce  of the d o u b le  bond in e th y l-  
L - N -f-butyloxycarbony l-vinylglycinatc (144) could be used to provide
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access to a wide range of unnatural L-a-amino acids. Epoxidation of the 
double bond and subsequent nucleophilic ring opening is a versatile 
method by which a wide range of derivatives can be readily 
sy n th es ised 112. The epoxide of vinylglycine was prepared in good yield 
with m-chloroperbenzoic acid in 1.2-fold excess (Scheme 4.14)11^.
(144) 0 * 0
Conditions : m-chloropcrbenzoic acid, carbon tetrachloride. RT 
Scheme 4.14
The epoxidation by m-chloroperbenzoic acid is by syn addition114. 
The chiral centre of the vinylglycine adjacent to the double bond led to 
asymmetric epoxidation in the ratio of 1 : 4 in chloroform. The signal 
corresponding to the r-butyl protons in the proton nmr indicated the 
diastereomeric ratio of the product (181). Altering the polarity of the 
solvent was seen to affect this diastereomeric ratio. Repeating the 
reaction in carbon tetrachloride increased the diastereomeric ratio to 
1 : 6 .
The major product was identified as having the 2 S . 3 R  
configuration as follows. The Raney nickel catalysed hydrogenolysis of 
the epoxide product gave the corresponding alcohols (182) (Scheme 
4 .1 5 )115. The tic of the free amino acids, obtained by acid hydrolysis, 
against threonine and a/Zolhrconinc, in the solvent system n-butanol /
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2-butanonc /  cone, ammonia / water 1 5 : 9 : 4 : 2 ,  identified the major 
diastereomer as threonine.
The nucleophilic ring opening of the epoxide can be used to 
prepare a large range of unnatural amino acids. Recently Mcffre et  
a/116 published a report in which they describe the preparation of a 
range of ß-hydroxy a-am ino acids by this route.
(181) (182)
Conditions : Ethanol. Raney nickel. 10 atm. H2 . 100°C. 8 hr. 
Scheme 4.15
4.6 : Synthesis of ethyl N-f-butyloxycarbonyl-4-hydroxythreonine (183).
Hydroxythreonine is an intermediate in several biochemical 
p a th w a y s117. The protected hydroxythreonine (183) was prepared in 
good yield from ethyl L-AM-butyloxycarbonylvinylglycinate (144) using 
osmium tetraoxide (Scheme 4.16)118. The vinylglycine (144) was stirred 
overnight with osmium tetraoxide at room temperature in an 8 : 1 
mixture of r-butanol /  water to give a diasteromeric mixture of the 
product diols (183). 4-Mcthylmorpholine N -oxide was used to recycle the 
osmium letraoxide (Scheme 4.16)119.
9 6
OH
(144) 0 8 3 )
Conditions : N -methyl morpholine N-oxide.
osmium tetraoxide. /-butanol, RT
Scheme 4.16
By careful flash chromatography, eluting with 2 : 1 ethyl acetate / 
petroleum ether, the diaslcrcomcrs could be separated in a ratio of 2 : 1. 
The minor component solidified and was recrystallised from ethyl 
acetate / petroleum ether. Its structure was established by an X-ray 
diffraction by Doctor W. Errington (Warwick) and it was found to have 
the 25, 3R configuration. As before the hydrolysis of the protected 
diastereomers in 6 M hydrochloric acid gave the free hydroxythreonine 
isomers.
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Figure 2 :
X-ray structure of ethyl (2 S .3 Ä )-A f- l-b u ty lo x y c a rb o n y l-4 -h y d ro x y  
threonate (183)
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(11)0/
4.7 : Synthesis of ethyl A/-l-butyloxycarbonylcyclopropylglycine (184).
The most common method for the cyclopropanation of double 
bonds is the Simmons-Smith method involving diiodomclhane and zinc. 
The use of these reagents under a variety of conditions, including 
heating and sonication120> 121. failed to give any product. However the 
palladium (II) acetate-catalysed reaction with diazomethanc proceeded 
smoothly to give a product that was purified by flash chromatography 
with ether / ethyl acetate 10 : 1 as eluent, followed by bulb to bulb
distillation to give a colourless oil (184) in 80% yield (Scheme 
4 .1 7 ) 121 •*22. The biologically active free amino acid123 (185) was 
obtained by hydrolysis with 6 M hydrochloric acid under reflux and ion 
exchange treatment in 66% yield.
Conditions : diazomethanc. palladium (II) acetate, diethyl ether, RT
4.8 : Synthesis of ethyl N-f-butyloxycarbonyl-2-amino-but-2-enoate (186).
4-Fluorothreonine is a potential enzyme inhibitor. Nucleophilic 
attack on the epoxide (181) by the fluoride ion could be a simple way to 
prepare this compound. Stirring potassium fluoride in DMSO or methanol 
with the epoxide resulted, not in the formation of the desired product.
(144)
Scheme 4.17
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but in the unsaturatcd homoserine derivative (186) in 75% yield 
(Schem e 4.18).
Conditions : potassium fluoride, methanol, RT 
Scheme 4.18
This dchydrohomoscrinc derivative (186) presumably results from 
the a-deprotonation and elimination (Scheme 4.19).
No trace of the fluorothrconinc derivative was detected under 
these conditions or when the epoxide was stirred with hydrogen fluoride 
in pyridine124.
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4.9 : Summary.
(1) Vinylglycine and analogues were prepared from an 
inexpensive starting material in a potentially viable com m ercial 
process. The route involves three step synthesis using Pinner reaction, 
bleach treatment and Neber rearrangement.
(2) The enzyme papain was used to resolve, completely or 
partially, the Boc-derivatives into their optical isomers.
(3) A range of vinylglycine derivatives were prepared through 
the reaction o f the double bond. These included epoxidation , 
dihydroxylation and cyclopropanation.
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CHAPTER FIVE
T H E  DEVELO PM EN T O F  A  R EA G E N T  FO R T H E  DETERM INATION OF 
ENANTIOM ERIC E X C ESS O F C H IR A L CARBOXYLIC A CIDS BY NMR.
5.1 : Introduction.
The determination of enantiom eric excess (ee) of chiral 
compounds is of growing importance in all areas of chemistry. Several 
methods have been developed to determine the enaliomeric excess. The 
use of chromatographic techniques such as chiral HPLC125 and GLC1 26 
has found widespread application. These rely on the different 
interactions between the optical isomers with the chiral stationary 
phases, which result in different retention times, thereby permitting 
determination of the enantiomeric excess.
The use of nmr is another major technique in the determination 
of ee. Two general approaches have been used. The first relies on the 
addition o f shift reagents to a solution of the chiral compound. The 
interaction between the shift reagent and the two enantiomers result in 
the formation of diastercoisomeric complexes with different chemical 
shifts of the pmr signals, the integrals of which relate directly to the ee 
of the mixture. Examples of these shift reagents include (S )-(+ )-2 ,2 .2 - 
t r i f lu o ro -1 -(9 -an th ry l) ethanol * 2 7 , a -m  e t hy I am i ne 1 28 and chiral 
lan th a n id e 129 reagents.
The second approach involves the chemical synthesis of covalent 
diastereom ers of the chiral compound with enantiomerically pure 
reagents. The resultant pair of diastereomers have two sets of signals in 
the proton nmr the intensities o f which are directly related to the
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amounts of the enantiomers present in the original sample (Scheme 5.1). 
Acetylmandelic ac id 131 and a -m e th o x y -a - ( t r i f lu o ro m c th y l)p h c n y l  
acetic acid (Mosher's acid)132 are examples of compounds whose pure 
enantiomers have found use as such reagents.
B
(♦)-A -----------------► OO-A.B
B
(-)-A  -----------------► (-)-A.B
Scheme 5.1
A problem arises in the use of these compounds; namely that the 
chemical synthesis of the diastereomers must be quantitative. As the 
products of the reaction are diastereomers. incomplete reaction could 
lead to a kinetic resolution whereby one diastereom er might be 
preferentially formed with a rate faster than the other. The purification 
by crystallisation or chromatography of the diastereomers could also 
result in the preferential loss of a single diastereomer. If either of these 
possibilities were to occur then they would give an incorrect estimation 
of the ee of the chiral compound.
5.2 : Project objective.
The examination of the proton nmr spectra of diastereomers is 
nevertheless an excellent method for determining ee. The formation of 
diastereomers with the above reagents always involves the stated risks. 
The objective of this project was the develop a reagent for the 
determination of ee where the possibilities for the above kinetic 
resolution would he reduced to a minimum.
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For example, a compound with a prochiral centre, made chiral by 
isotopic substitution in the attached enantiotopic groups, would give 
diastereoisotopomeric products when coupled to a racemic or partly
racemic compound.
H D
R*X X
Z « chiral entity
Scheme 5.2
Since the diastereotopicity of the product is due only to the 
isotopic substitution, there would be no risk o f  significant kinetic 
resolution in the coupling step. For the m ethod to work the 
diastereotopic substituents in the product would have to be
distinguishable by nmr. A suitable system for testing this approach 
would be one based on glycine because the C-2 methylene protons of 
glycine arc cnantiotopic. Reacting the glycine with a chiral reagent 
would result in the formation of diastereotopic methylene protons. The 
proton nmr spectra of such compounds often demonstrate an AB quartet 
for the C-2 methylene protons (Scheme 5.3).
1 2 3 4 5
Scheme 5.3
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5.3 : Preparation of chiral analysis reagent.
To test the above ideas methyl AF-p-methoxyphenylglycinate (187) 
was prepared by reacting p -an isid ine  with methyl brom oacetate 
(Schem e S.4).
(187)
Conditions : Triethylamine, THF, reflux, 2hr.
Scheme 3.4
The p-methoxy substituent was necessary to activate the nitrogen 
of the amine (187) to enable it to react with a range of carboxylic acids. 
The diastereotopic methylene protons in the product amides would give 
an AB quartet in the pmr. The intensities of the signals of the doublets 
would be first order.
Stereospecifically replacing one of the protons by a deuteron in 
the amine (187) would result in the formation of diastereomers when 
coupled with a chiral acid. This would result in the formation of a pair of 
diastereomers in which the signals corresponding to the C-2 proton 
would be widely separated, as they are in different environments. The 
signal for the glycinate proton would be expected to appear as a poorly 
resolved triplet resulting from geminal proton-deuterium coupling 
(normally in the order of 0-2Hz). The intensity of the signals due to the
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glycinate protons of the two diastereomers could therefore be used as a 
direct measure of the ee of the optically active acid. As the only 
difference between the two diastereomers is isotopic, kinetic resolution 
would be reduced to a minimum and would be expected to be 
insignificant, as noted above. The chiral reagent (187) was prepared as 
outlined in Scheme S.S.
5.3.1 : Preparation of (2 S )-(2 -2H i]glycine (188b).
There are many published methods for the preparation of 
specifically deuterated glyc¡ne,32•,33•*34•,35•,36•,37•,38•,3 9 • However, 
m ost of the methods involve extrem ely long synthetic or 
chemoen/.ymatic routes. The simplest method, involving the use of 
glutamic pyruvic transaminase, has been used by Oani et a /139 a n d  
Arigoni and Besmer140' 141 in their preparation of specifically labelled 
g ly cin e .
n O O
H D
(190)(187) (189)
Scheme 5.5
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D
D— J—CO,H
© O C H , ,
t t oh
V L HH,N ^ C O jH (192)
V ' X  Y * '
HV
© “ H’vJ y OH
L+JL
H
11+JL^N^CH,
H
(I9 I>  S ^ H2°  
DV > H | T N V i  /V
XOaH
0»j—CQjH 
H y N
© O C H ^t r^ n^ ch3
(194)
Scheme 5.6
Transaminases catalyse the stereospecific interconversion of 
L-amino acids and a-ketoacids. In the absence of an a -ke toacid  the 
reaction with glycine can only proceed as far as the Schifrs base. The 
intermediate is then stereospecifically hydrolysed back to free glycine. 
Thus when dideuterated glycine is incubated with glutamic pyruvic 
transaminase and water o f normal isotopic composition, stereospecific 
reprotonation of the intermediate (193) leads, after hydrolysis of the 
SchifPs base (194), to stereospecifically labelled (S-2H | )glycine (188b) 
(Scheme 5.6)142.
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As the reagent is for use with proton nmr it is essential that the 
presence of the diprotiated species should be avoided. The presence of 
the diprotiated species would interfere with, and greatly complicate the 
estimation of the enantiomeric excess. To eliminate this possibility the 
enzyme was incubated with didcuteratcd glycine. As the didcuterated 
species is invisible to proton nmr complete "washing out" of the pro-R 
deuterium is not required though of course as much as possible should be 
removed to ensure maximum sensitivity.
The method of Upson and Hruby143 for preparing a -d e u te ra te d  
amino acids, by boiling glycine under reflux with acetic anhydride and 
d i -acetic acid, gave very poor results with 9% of residual proton 
remaining in the acetylglycine after two treatments. The most 
convenient and reliable method of preparing d2 -glycine is the acid 
hydrolysis of deuterium exchanged diethyl acctamidomalonate (Scheme 
5 .7 )* 4 4 . The use of twice deuterium exchanged diethyl acetamido 
malonate gave much better deuterium content in the product than the 
reported use of unexchangcd diethyl acetamidomalonate. The acidic 
solution of deuterium chloride in deuterium oxide was prepared by 
adding thionyl chloride to ice cold deuterium oxide. The didcuterated 
product was isolated by concentrating to dryness and passing over a 
Dowex 50W-8X(H+) ion exchange resin as before. The proton nmr of the 
B o c-d 2 -glycine derivative showed only the r-butyl protons.
D O
C O j C H jC H j
(146)
Conditions : DCI /  D2O
Scheme 5.7
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The incubation of d2 -glycine with the glutam ic pyruvic 
transaminase leads to the formation of (2S)-12-2H j 1-glycine (starting 
from 2H 2 -glycinc in H2 O) with 2-pro-R protonation. Arigoni and Bcsmer 
reported that the incubation proceeded at pH 6.6*4 2. However, on 
repetition of their procedure at this pH. no proton incorporation was
seen. Proton incorporation occurred at the pH near the optimum for the 
transaminase namely pH 7.1. The reaction mixture was stirred for two
days in the dark at 37°C. For the enzymatic reaction to succeed it was also
essential that the pH of the solution was corrected to pH 7.1 after the
addition of the pyridyl-phosphate before the addition of the enzyme. The 
mixture was worked up by passing the solution directly over a column of
Dowex 50W-8X (H+) and eluting the product with 4% aqueous pyridine.
The proton nmr spectrum of the B oc-(S)-(2-2 H 1 1-glycine derivative 
showed signals corresponding to a single C-2 proton and nine r-buty l
p ro to n s .
5.3.2 : Preparation of Methyl (2 S )-I2 -2Hi]brom oacetate (190).
In order to introduce the electron-dcnating p -m e th o x y p h e n y I  
ring into the glycine it was necessary to replace the amino group by 
bromine which in tum could be displaced with p-anisidine. The reaction 
of sodium nitrite with a-amino acid in an acid solution is reported as 
proceeding with retention o f configuration14*. This retention is 
attributable to interaction with the carboxylate group rather than to the 
formation of an a-lactone. The carboxylatc group shields one side of the 
carbocation from nucleophilic attack, forcing the incoming nucleophile 
to attack from the same side as the leaving group (Scheme S.8).
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(189)
Conditions : sodium nitrite, hydrobromic acid. 0°C 
Scheme 5.8
When this procedure was carried out on the monodeuterated 
glycine the chiral bromoacctic acid thus derived was isolated by repeated 
extraction with diethyl ether. Bromoacctic acid (189) was methylated by 
the use of diazomelhane. The ether was then carefully distilled from the 
low boiling monodeutcrated methyl bromoacctate (190) which was itself 
purified by bulb-to-bulb distillation.
Methyl N - p -m cthoxyphenylglycinate (both stereospecifically  
monodcutcratcd and unlabcllcd) was prepared by refluxing methyl 
bromoacetate. p-anisidine and 1.2 equivalents of trielhylamine in dry 
THF for two hours. The product was purified by flash chromatography 
eluting with ethyl acetate /  petroleum ether 5 : 1. The product was 
expected to be methyl N -p-m cthoxyphcnyl(21?)-|2-2H \ l-glycinate. given 
that the displacement of the bromine should proceed by an Sn 2 
mechanism with inversion.
Examination of the mass spectrum of the methyl AT-p-methoxy 
p h e n y l(2 /f)- |2 -2H i l-glycinate revealed the isotopic composition of the
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product thereby indicating the percentage of di-protiated. mono, and 
dideuterated species present (Table 5.1).
Table 5.1 : Isotopic composition of chiral reagent 187.
187 ' h 2 2h , 2” 2
ratio 6.9 79.1 14.0
5.4 : Preparation of diastereomers of m ethyl A / -p -m e th o x yp h e n yl 
(2 H )-[2 -2H i ] glycinate with chiral acids.
Methyl N -p-methoxyphenylglycinate (187) was coupled with a 
range of racemic carboxylic acids using 2-ethoxy- 1-ethoxycarbonyl- 
1,2-dihydroquinolinc (EEDQ) to give the amides in high yields. The 
products were purified by flash chromatography with ethyl acetate / 
petroleum ether 10 : 1 (Scheme S.9).
I l l
Conditions : EEDQ, THF, rt, 8hr.
OCOCHj
JUO
OCOCHj
(195) (196)
O
Br
JUO
Br
(198) (199)
(■) : R - H  
(b) : R -  D
Scheme 5.9
The proton nmr spectra of the diprotiated amides (195-9a) showed 
the expected  AB quartet for the signal corresponding to the 
diastereotopic glycinate C-2 protons (Table 5.2). The glycinate protons 
showed a large difference in their chemical shifts and had a large 
geminal coupling constant of 17 Hz. Reacting racemic carboxylic acids 
with the monodeuterated glycine derivative likewise gave the expected 
signals in the proton nmr. In place of the AB quartet two triplets were 
observed corresponding to a single glycinate proton in the two 
diastereomers formed (Figure 3).
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Figure 3
a : 250 MHz proion nmr o f methyl AM 4-m ethoxyphenyl)-A T-(0-acetyl- 
m andclate)[2-2H \ Iglycinate (196).
b 250 MHz proton nmr of methylene protons o f methyl
tf-(4-m ethoxyphenyl)-A r-(0-acetyl-m andelate)glycinate (196)
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Table 5.2 : chemical shift and J  values of dlastereomers 195-199.
amide a b
H® HP J (Hz) H® HP
195 4.71 3.95 17 4.68 3.98
196 4.41 4.01 17.1 4.50 4.1
197 4.41 4.13 17 4.40 4.15
198 4.51 4.17 17.1 4.49 4.16
199 4.46 4.25 17.1 4.42 4.26
To conclusively prove (hat these signals were indeed from the 
g lycinate  proton of the m onodeuterated  diastereom ers. the 
monodcuterated reagent was coupled with enantiomerically pure O •(■*■)- 
acetylmandelic acid. This should give a single triplet corresponding to 
either the 'downfield' Ha  or the 'upfield' HP signal. However the proton 
nmr spectrum of this product was identical to the racemic material. This 
unexpected result could only be be due to two possibilities :
1. The EEDQ coupling reagent racemised the 0-(+)-acetylmandelic acid.
2. The monodcuterated glycine reagent was racemised at some stage in its 
synthetic pathway.
The use of DCC as the coupling reagent in the preparation of the 
pure diastcreomer gave a similar proton nmr spectrum with two triplets. 
This indicated that the second possibility o f the glycine moiety being 
racemised in its preparation was more likely. The enantiospecificity of 
the transaminase protonation of glycine ia well established140*141' 142. 
Of all the steps in the chemical synthesis of the reagent, the bromination
114
of (he chiral glycine was thought to be the most likely cause of 
racem isation .
To test this p ossib ility  the approach o f  preparing
d iastereoiso topom eric  derivatives was again used. Coupling
1H 2 -bromoacetic acid with a-methylbenzylamine gave the amide (200a) 
which also displayed an AB quartet although with strong second order 
distortion (coupling constant J = 13.8 Hz).
Conditions : EEDQ. THF, rt. 8hr. 1 '
(a) : R = H
(b) : R ■ D
Scheme 5.10
The presumed optically active bromoacetic acid was initially 
coupled with racemic a-m ethylbenzylam ine to give a m ixture of 
diastereomers of amides (200b). The proton nmr of this product showed 
the expected two triplets corresponding to a single proton. The reaction 
with (S)>(-)-a-methylbcnylaminc gave the amide (200b) the proton nmr 
spectrum of which also displayed a pair of triplets (Table 5.3).
I I S
Table 5.3 : Chemical shift of C-2 protons of amide 200.
Amide H“ (ratio) hP (ratio)
(2 0 0 a) 3.91 3.90
(2 0 0 b) 3.89 (5) 3.86 (4)
( 2 0 0 b)* 3.89 _____1 2 ____ 3.86 _____ i i l _
* using ( /? ,S )- a-m e thyl be n7 .y la min c .
(The intensities of the triplets for the monodeuterated amides (200b) 
were not equal but had a ratio of 5 : 4. This was a result of a small amount 
of diprotiated amide present which, as a result of isotopic shift, 
overlapped with the downfield H° proton. The presence of this 
unexpected species was revealed by nmr relaxation experiments and by 
mass spectra of the amide (200b). This problem was not observed in the 
amides 195-199 because of the proton nmr spectrum was first order. Thus 
the signal for the C-2 proton in the mono-protiated species was between 
the signals for the residual diprotiated species.)
This indicated that the monodeuterated bromoacelic acid 
recovered from the diazotisation of the optically pure monodeuterated 
glycine had racemised. This had not been expected as in all previous 
applications of this method for the halogénation of amino acid 
derivatives the reaction had proceeded with retention. All these cases 
however used secondary amino acids which reacted via secondary 
c a rb o ca tio n s14*’' 4®*14^**4*. ^  possible explanation is that when glycine 
is treated in this way the primary carbocation which forms is too
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reactive for it to be effectively stabilised by the carboxylate group, so 
that the configurational integrity of the glycine is not maintained.
In order to overcome this problem of racémisation in the 
bromination step the direct formation of the W -p-m cthoxyphenyIglycinc 
(2 0 1 ) from glycine by the use of benzynes was investigated 
( S c h e m e 5 . i l ) 149. 1.4-Dimethoxy-2-chlorobenzene was used as the 
benzyne precursor. This would give a single, highly activated product 
compared with l-chloro-4-methoxybcnzene which would favour the 
formation of the less activating mcta methoxy isomer over the desired 
more activating ortho or para derivatives.
Conditions : Potassium, liquid ammonia, iron (III) nitrate, 2hr. 
Scheme S .ll
The desired product could not be isolated from the reaction mixture.
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5.4 : Summary.
It is clear that the principle of using diastereoisotopomeric 
derivatives for chiral analysis is a valid one. In the present case, the 
practical application of the method was vitiated by the unexpected 
racémisation of the (S )- |2 -2H \ l-glycine in the diazolisation step.
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CHAPTER SIX.
EXPERIMENTAL DETAILS.
6.1 : Introduction.
Chemicals used in the following syntheses were either purified 
according to the literature methods or were purchased as the highest 
available grade.
Nuclear magnetic resonance (nmr) spectra were recorded using the 
following instruments
Broker WH-400 (operating frequency *H nmr « 400 MHz. ■ 100 MHz). 
Broker ACF-250 (operating frequency *H nmr « 250 MHz, ,3C ■ 63 MHz). 
Perkin-Elmer R-34 (operating frequency * H nmr -  220 MHz).
Chemical shifts are given in 5 relative to TMS ( 6  ■ O.Oppm).
Multiplicities of the proton nmr are abbriviated as follows:
s. singlet; br. s. broad single; d. doublet; br. d. broad doublet; t. triplet; q.
quartet; m. multiple!.
Thin layer chromatography was routinely used to follow the course of 
reactions on glass precoatcd with 0.2mm Merck silica gel 60p2$4- 
Methods of detection involved one or more of the following methods :
U.V. fluorescence quenching.
Potassium permanganate (0.5% in water).
Phosphomolybdic acid (7% in ethanol) and heating.
Ninhydrin (0.2% in n-butanol) and heating.
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Flash chromatography involved columns of 15-20cm of Kieselgel 60 (230- 
400 mesh ASTM). The solvents used were either glass distilled or of high 
g rad e .
Optical rotation were measured on an Optical Activity Limited Model 
AA-1000 polarimetcr. Wavelength ■ 589nm. Cell length = 2dm. 
Concentration of samples are given in g /  100cm-*.
Infra red (IR) spectra were recorded on either Pcrkin-Elmer 580-B or 
Perkin-Elmer 1720X instruments.
Mass spectra (MS) were recorded on a Kratos MS 80. X-ray crystal 
structure on a Nicolet P2 j .
6.2 : EXPERIMENTAL DETAILS FOR CHAPTER THREE.
Preparation of (/7)-2-(A/-benzyloxycarbonyl)aminoadipic acid (138)92
A solution of benzyl chloroformate (0.63g, 2.35mmol) in toluene (2cm3) 
was added over two hours to a vigorously stirring solution of 
(/?)-2-aminoadipic acid (0.25g. l.Smmol) in water (1.0cm3), 2 M sodium 
hydroxide (1.3cm3) and acetone (1.3cm3) at 0°C. After the addition was 
completed the solution was stirred for an extra 30 minutes at room 
temperature. The pH of the solution was maintained in the region of 
8.0-8.7 throughout the reaction by the addition of further 2 M NaOH. 
W ater (10cm3 ) was added to the mixture and the organic phase removed. 
The aqueous phase was washed with diethyl ether (2x10cm3) to remove 
residual benzylchloroformate. The aqueous layer was acidifed to congo 
red with 3 M HCI and extracted with diethyl ether (2x10cm3 ). The
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combined ethereal layers were washed with water ( 1 0 cm3 ), saturated 
brine ( 1 0 cm3), dried over magnesium sulphate and evaporated under 
reduced pressure. The white solid product was recrystallised from ethyl 
acetate /  petroleum ether to give the title compound (138) (0 .37g. 83%). 
M. p. I34-135°C. [a lp  -  -9.29° (CH3 OH. 22.4°C. c-1.07). 8 h (220 MHz; CDCI3 ) 
7.45 (5H. br. Ph-//). 5.15 (2H. s. Ph-C«2 ). 4.2 (1H. m. CH). 2.35 (2H. t. J 7 
Hz. OCCH2). 18 (4H, m. C« 2 ). m/z (El) 295 (M+. 32%). 284 (10). 264 (11). 250 
(38). 236 (26). 206 (100). 185 (15.5). m/z (Cl) 296 (M+I+. 21%). 252 (38). 234 
(11). 205 (100). 187 (3). Vm ajiCH Clsl/cm -' 2928. 1712. 1496. Agrees with 
literature data9 2 .
Preparation of a -b e n z y l A /-benzylo xycarbonyl-L -2 -am inoadip ic acid 
(139)92.
In a citrate / phosphate buffer solution (1 M. pH 4.2, 3cm3). papain 
(ex-Sigm a, type 2 crude. 0.13g). L -cystcinc (18m g) and
cthylcncdiaminctctraacctic acid tetra sodium salt (1 M. 3 On L) were 
allowed to stir for 10 minutes. N -benzy loxycarbony  1 -L -2 -am in o ad ip ic  
acid (0.14g, 0.5mmol) in dichloromcthane (50cm3) and benzyl alcohol 
(1 .5cm 3) were added and the solution was stirred at 37°C for 2 days. The 
reaction mix was filtered through a bed of eelite and the cake washed 
with dichloromcthanc (15cm3) and water (15cm3). The organic layer was 
separated off and the aqueous phase extracted with ethyl acetate 
(2x25cm 3) and acidified with 1 M potassium bisulphatc solution to pH 2.0. 
The combined organic phase was washed with water (10cm3) and 
saturated brine (10cm 3). The solution was dried over magnesium 
sulphate and concentrated under reduced pressure to give an oil which 
was flash chromatographed with ethyl acetate /  petroleum ether 1 : 2 0  
solvent system to remove the benzyl alcohol. The product was eluted with
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ethyl acetate / petroleum ether 2  : 1 to give an oil which solidified and 
was recrystalliscd from ethyl acetate /  petroleum ether to give the title 
compound (139) (0.1 Ig. 60%). M. p. 89.5-90°C. (o )d  -  13 8 °  (H2 O. 24.6°C. 
c-1.01). 6H (400 MHz; CDCI3 ) 9.8 (1H. br. s. COOH). 7.45 (10H. br. s. Ph//). 
5.54 (1H. br. d. J 8.3 Hz. NH). 5.15 (2H. br. s. PhCH2). 5.10 (2H. s. PtiC//2 ). 
4.45 (1H. m. CH), 2.35 (2H. m. OCCH2). 18  (4H. m. CH2). «c 00 0  MHz; CDCI3 )
178.1 (Cl). 172.0 (C6 ), 155.9 (C -0  Z). 136 (Cl Ph). 135.1 (Cl Ph). 128.5 (Ph). 
128.4 (Ph). 128.3 (Ph). 128.0 (Ph). 127.9 (Ph). 77.2 (C-Ph). 76.9 (C-Ph). 53.6 
(C2). 33.0 (C3). 31.6 (C4). 20.2 (C5). m/z (Cl) 385 (M+l*. 21%). 342 (18). 295 
((M-Bz)+, 7). 250 (16). 234 (4). 206 (20). 144 (3.5). vm„  (C H C ^l/cnr1 2928. 
1712. 1496. Agrees with literature data9 2 .
Preparation of a-benzyl /V-benzyloxycarbonyl-L-2-aminoadipyl-S-benzyl- 
cysteine (140)98.
A solution of a-benzyl Af-bcnzyloxycarbonyl-L-2-aminoadipic acid (139) 
(0.248g, 0.64mmol) and tricthylaminc (204pl, 0.64mmol) in THF (dry. 
7 c m 3) under nitrogen and was stirred for 5 minutes at -15°C. /so b u ty l 
chloroform atc (95pl, 0.62mmol) was added and the reaction mixture 
allowed to stir for a further 30 minutes. A solution of 5 -bcnzy l-cysteine 
(0.132g. 0.62mmol). tricthylaminc (120pl. 0.34mmol) in water (6 cm3), 
precoolcd to 0°C. was added in one portion. It was then stirred for 1 hour 
at room temperature when it was diluted with water (10cm3). The 
resulting solution was washed with diethyl ether ( 1 0 cm3), then layered 
with ethyl acetate (15cm3) and acidified to congo red with 1 M HCI. The 
organic phase was separated off and washed with water ( 10cm3) and 
saturated brine ( 10cm3). dried over magnesium sulphate and evaporated 
under reduced pressure to give the title compound (140) which was used 
without further purification (0.3 lg. 82%). 8 h (400 MHz; CDCI3 ) 9.0 (1H, br.
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s. COOH),  7.45 (15H, br. s. PhH). 6.7 (1H. br. d. J 7.3 Hz. NH).  5.54 (1H. br. d. J
8.1 Hz. NH). 5.15 (4H, m. PhCH2). 4.7 (1H. m. CH). 4.4 (1H. m. CH), 3.67 (2H. s. 
SC«2Ph). 2.81 (2H. m. CHC//2 ). 2.2 (2H. m. OCC//2 ). 18  (4H. m. 2xCH2). 
8 c  (100 MHz; CDCI3 ) 173.2, 173.0. 172.1. 155.9 . 137.6 (Cl Ph). 135.1 (Cl Ph).
128.8 (Ph). 128.5 (Ph). 128.4 (Ph). 128.3 (Ph). 128.1 (Ph). 127.9 (Ph). 127.1 
(Ph). 67.1, 53.4 (C2). 51.4 (C2). 36.4, 34.9. 33.0. 31.4. 20.2. m/z (El) 385 (M+. 
28.5%). 488 (10.7), 297 (20.9), 255 (12.3). 221 (11.4), 171 (10.1). 148 (100). 
vmix (CHCI3 )/cm-> 3200b. 1714. 1510. Agrees with literature data98 .
Preparation of benzyl (/?)-2 -(A/-f-butyloxycarbonyl)am ino-3-butenoate
(145)100.
A solution of sodium hydroxide (0.215g, 5.3mmol), water (0.5cm3) and
m ethanol (2 .8cm 3) was added to a solution of azibenzil (O.I5g,
0 .6 7 m m o l) ,0 ° in diethyl ether (3.4cm3) in a loosely stoppered conical 
flask (25cm 3) and allowed to stand for 8 hours with periodic shaking. The 
reaction was filtered and the filter cake was washed with diethyl ether 
(5 cm 3). The solution was treated with 10% sodium hydroxide (5cm3)
which caused it to separate into two layers. The upper organic phase was 
removed and treated with 10% NaOH (4x3cm3) and dried over magnesium 
sulphate. This solution was added to a stirred  m ixture of 
(ff)-2-(Ar-r-butyloxycarbonyl)amino-3-butcnoic acid (7 Smg. 0 .4 mmol) in
diethyl ether (15cm3). A drop of ethereal hydrogen chloride was added to 
catalyse the reaction which proceeded with the concomitant evolution of 
gas. The solution was washed with sodium bicarbonate (5%. 10cm3) and
saturated  brine ( 1 0 cm3 ), dried over magnesium sulphate and 
concentrated under reduced pressure to give an oily residue which was 
purified by flash chromatography eluted with ethyl acetate /  petroleum 
ether 1 : 3 to give the title compound (145) (97mg, 8 8 %). 6 h  (400 MHz;
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CDCI3 ) 7.33 (5H, m. Ph-//). 5.90 (1H. ddd. I 16.5. 10.3. 5.3 Hz. C //-C H 2 ). 5.33 
(1H. dd. 17.1. 1.6 Hz. CH=C//H irans). 5.21 (IH. dd. J 10.3. 1.5 Hz. CH=CH// cis). 
5.22, 5.19. 5.17. 5.14 (2H. AB q. J 12.3 Hz. C//2 -Ph). 4.91 (1H. unres. I. CH), 
1.44 (9H, s. r-Bu). 6c  (100 MHz. CDCI3 ) 170.4 (Cl). 154.8 (C-O Boc). 135.1 (Ph- 
1). 132.5 (C3), 128.3 (Ph-2). 128.3 (Ph-4). 128.0 (Ph-3), 117.4 (C4). 80.0 (C- 
M e3 Boc). 67.2 (CH2 PI1). 55.8 (C2). 28.1 (CH3 Boc). m/z (Cl) 292 ((M+l)+. 
51.7%). 254 (17.1). 253 (73.0), 236 ((M +l-Q H s)*. 75.0). 192 ((M+I-C4 H8 - 
C 0 2 ) * .  80.0). 156 (52.9). 108 (36.9). m/z (El) 292 ((M +l)+. 0.2%).
156(72.1). 100 (88.9), 91 (C 7 H7+. 36.9). vmax (C H C ^ /c m ' 1 1713, 1680, 
1455.
Preparation of benzyl (/?)-2 -(N -f-butylo xycarbo nyl)am ino-3-butenoate  
p-toluene sulphonic acid (1 4 2 )101.
Benzyl (/?)-2-(A /-r-butyloxycarbonyl)am ino-3-butenoate (97mg.
0.33 mmol) was dissolved in diethyl ether (20cm3) and stirred at 0°C 
while p-lolucnesulphonic acid (leq.. 63.6mg. O.33mmol) in ethanol 
(15cm 3) was added over 2 hours. The mixture was stirred overnight. The 
solvent was removed under reduced pressure to give the title compound 
(142) that was used without further purification (124.4mg, 100%). 6 h  (220 
MHz; CDCI3 ) 7.8 (2H. d. J 8  Hz. a-H plsa). 7.3 (5H. m. Ph-//). 7.1 (2H. d. J 8  Hz. 
p- / / 2 ptsa), 5.82 (1H. m (ddd). C //-C H 2 ). 5.4 (1H. d. 16 Hz. CH-C//H trans). 5.25 
(1H. d. J 12 Hz. CH-CH// cis). 5.05 (2H. AB q. J 10 Hz. C //2 *Ph). 4.91 (IH. m. 
CH), 2.3 (3H, s. CH3  plsa).
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Preparation of a -b e n z y l-N -b e n z y lo x y c a r b o n y l-L -2 -a m in o a d ip o y l- 
S-benzyl-L-cysteinyl-D-2-am ino-3-butenoic acid benzyl ester (141)98.
A solution of benzyl (/?)-2-amino-3-butcnoatc p-toluene sulphonic acid 
(142) (127mg, O.33mmol) in dichloromcthane (dry, 5cm3) was added to a 
solution of a-benzyl A /-bcnzyloxycarbonyl-L -2-am inoadipoyl-S-benzyl- 
cysteine (140) (0.188g, O.33mmol). triethylamine (45pl. O.33mmol) and 
EEDQ (1.2eq.. 0.097g. 0.4mmol) in dichloromethane (dry. 10cm3) and the 
solution allowed to stir overnight at room temperature. The solvent was 
removed under reduced pressure and the residue taken up in ethyl 
acetate (13cm3). The organic layer was washed with sodium bicarbonate 
(3%. 10cm3) and saturated brine (10cm3). dried and concentrated under 
reduced pressure. The solid product was recrystallised from ethyl acetate 
/ petroleum ether. The product was finally purified on C-18 column with 
a Waters model 440 HPLC (eluent w ater 6 6 %, acetonitrile 33%, 
trifluoroacetic acid 1%) (25mg, 10%). 6 h (400 MHz; CDCI3 ) 7.33 (20H, m, 
Ph-tf), 6.93 (1H. d. I 7.7 Hz. NH cys). 6.2 (IH . d. J 7.6 Hz. NH vg). 5.90 (1H. 
ddd. J 17.1. 10.4. 5.4 Hz. C //-C H 2  vg). 5.55 (IH . d. J 8.0 Hz. NH aa). 5.31 (1H. 
dd. 17.1. 1.5 Hz. CH-C//H trans vg). 5.21 (IH. dd, J 10.4. 1.4 Hz. CH -CH//cis 
vg). 5.1 (6 H, m. CW2 Ph). 4.52 (1H. m. CH).  4.4 (2H. m. CH). 3.73 (2H. s. 
S C « 2 Ph). 2.88. 2.86. 2.85. 2.83, 2.70. 2.69. 2.67. 2.65 (2H. 2xAB q. J 14 Hz. 
CHC«2S cys). 2.2-1.6 (6 H. m. CH2 aa). 6c  (100 MHz. CDCI3 ) 171.9. 169.7. 169.7.
137.9. 136.1. 135.1. 134.9. 131.1. 130.2. 129.0. 128.9. 128.6. 128.5. 128.4. 128.2. 
128.04. 128.01. 127.2, 118.23. 77.1, 67.5, 67.1. 67.0. 54.6, 53.5. 51.9. 36.5. 35.2.
32.9. 32.9. 31.6. 31.8. 21.2
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Preparation of diethyl acetamido[Z- and E-2-(phenylsu lphonyl)-e thenyl) 
malonate (147a. b and c )62.
An anhydrous solution of diethyl acetamidomalonate (146) (3.96g,
!8 mmol) and potassium r-buloxide (freshly sublimed, 0.3g, l.Kmmol) in 
THF (12cm3) was stirred for 30 minutes at room temperature under 
nitrogen. The tem perature was lowered to -10°C  and phenyl
2-(trimethylsilylethynyl) sulphone (3.0g, !2mmol) in THF (dry. 12cm3) 
was added and stirred for one hour at this temperature. After a further 
hour water (3cm3) was added and the reaction allowed to stir overnight. 
The reaction was extracted with diethyl ether (15cm3). The ethereal
layer was washed with dilute NaOH (1 M. 5cm3) to remove excess diethyl
acetamidomalonate. The organic layer was dried first over magnesium 
sulphate and finally over 3A molecular sieves before being evaporated 
under reduced pressure to give an oily residue. Flash chromatography 
using chloroform /  diethyl ether /  petroleum ether 1 : 1 : 3  separated the 
Z- and £-isomers. Z -acctam ido|2-(phcnyl sulphonyl)-ethenyI]m alonate 
(Z-147a) (3.19g. 60%). M. p. 94-96°C. 8 «  (220 MHz; CDCI3 ) 7.45 (6 H. m.. 
•CHPhH).  5.54 (1H. d. J 12 Hz. C//■). 4.26 (4H. q. 7 Hz. CH2  El). 2.1 (3H. s. 
COCH3 ). 1.25 (6 H, t. J 7 Hz. CA/j Et). 8 c  (100 MHz. CDCI3 ) 168.9 (C-O). 165.5 
(C-O). 140.2 (Cl Ph). 133.8 (C4 Ph). 129.3 (Ph). 127 (Ph). 64.1 (t e n  C). 63.6 
<CH2). 22.1 (Ac CHj). 13.8 (CH3 ). vmax (C H C ^ /c n r 1 3418 . 2234, 1748, 1678. 
1271. £ -ac e lam id o [2 -(p h en y lsu lp h o n y l)-e lh cn y l)m a lo n a le  (E -1 4 7 .)  
(0.92g. 20%). M. p. IO5-107OC. 6 h (220 MHz: CDCI3 ) 7.45 (6 H. m.. -CHPhH),
7.1 (IH. br. i. NH). 6.4 (IH. d. 1 16 Hz, C//«), 4.26 (2H. q. 7 Hz, C H j El), 2.0 
(3H. >. C O C H j), 1.25 (3H, I, J 7 Hz, C H j  El). Z - z c e l « n i l d o - |2 -  
(p h cn y lsu lp h o n y l)-(3 ,4 -2H 2 l-clhcnyl]malonalc (Z-147b) (3 .19g, 60%).
M. p. 94-96°C. Sh  (220 MHz; CDCI3 ) 7.45 <6 H. m.. NH, PtiH), 4,26 (4H, q, 7 Hz, 
C H j El), 2.1 (3H, z. COCHj). 1.23 (6 H, I. J 7 Hz. CHs El). £ .zccl«m ido[2-
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(p h eny lsu lphony l)-I3 ,4 -2 H 2 l-ethcnyl)malonaie (E-147c) 8 h  (220 MHz; 
CDCI3 ) 7.45 (5H. m.. Ph//). 7.05 (1H. br. s. NH), 4.26 (4H. q. 7 Hz. CH2  El). 2.05 
(3H, 1. COC//j). 1.25 (6 H. I. J 7 Hz. C //j  El). Agrees wilh literature data62.
Preparation of diethyl acetamidoethenylmalonate (148)62.
Aluminium foil (1.36g, l.S6 mmol). cut into small pieces, was agitated in 
an aqueous mercury (II) chloride solution (0.5%. 20cm3) for several 
minutes. The mercury chloride solution was decanted off and the shiny 
aluminium amalgam patted dry on filter paper. The amalgam was added 
to a solution of diethyl acetamido[2 -(phenylsulphonyl)ethenyl]malonate 
(0.5g, 1.3mmol) in 1,4-dioxane (wet. 20cm3) and stirred at room 
temperature for 2 days. The solution was filtered to remove a grey 
precipitate and concentrated under reduced pressure to give an oil 
which was distilled bulb to bulb under reduced pressure to give the title 
compound (148) (0.25g, 80%). B. p. 135°C 0.1 mm Hg. 8 h  (220 MHz; CDCI3 ) 
7.0 (1H. br. s. N« ) . 6.58 (1H. dd. I 16 Hz. C//«). 5.35 (1H. d. J 12Hz. «CH//). 5.3 
(1H. d. J 16Hz, -C//H). 4.26 (4H. q. 7 Hz. CH2 El). 2.1 (3H. s. COCH3 ), 1.29 (6 H. 
I. J 7 Hz. CH3  El). 8 c  (100 MHz. CDCI3 ) 168.5 (O O ). 166.9 (C«0). 116.2 (»C).
115.9 (-C ). 66.9 (tert C). 62.8 (CH2). 22.7 (Ac CH3 ). 13.8 (CH3 ). vm a * 
(C H C l 3 ) /c m  • ' 3418. 1738, 1683. 1271. £ -d ic th y l acctam ido(2-
(phenylsulphonyl)-(3 ,4 -2 H2 l-ethenyl)malonate. 8 h (220 MHz; CDCI3 ) 7.0 
(1H. br. s. NH).  5.3 (1H. br. s. -C //D ). 4.26 (4H. q. 7 Hz. CH2 El). 2.1 (3H. s. 
C O C t f j ) ,  1.29 (6 H. t. i 7 Hz. CH 3  El). Z -d ic th y l acetam ido[2- 
(phcnylsulphonyl)-|3 ,4 -2 H2 l-cthenyl) malonate. 8 h (220 MHz; CDCI3 ) 7.0 
(1H. br. s. NH). 5.35 (1H. br. s. «CDH),  4.26 (4H. q. 7 Hz. CH2  Et). 2.1 (3H. s. 
COCH3 ), 1.29 (6 H, t. J 7 Hz. CH3  Et). Agrees with literature data62.
127
Preparation of 2-amino*3-butenoic acid (71).
D iethyl a c e ta m id o [2 -(p h en y lsu lp h o n y l)e th en y l Im alonate  (0 .41g. 
1.69mmol) was refluxed in HCI ( 6  M, IScm^) for 1 hour. The ¿olution was 
treated as for 2-amino-3-butcnoic acid (in chapter 6.3) to give the title 
compound (71) (0.18g. 77%). SH (220 MHz; D2 O) 5.9 (1H. m. C //*C H 2 ). 5.45 
(1H. d. J 15.7 Hz. CH=CH// trans). 5.43 (1H. d. J 12.5 Hz. CH=C//H cis). 4.3ppm 
(1H. d. J 9 Hz. C //-C H -C H 2 ). Z-(3 .4 -2 H2 l-2 -amino-3 -butenoic acid (220 MHz; 
D2O) 8 h 3.5 (1H. br. s. CD=CDH cis). 4.3ppm (1H. br. s. CH-CD«). £ -(3 .4 -2 H2 )- 
2-amino-3-butenoic acid (220 MHz; D2 O) Sh 5.4 (1H. br. s. CD=C//D trans), 
4.3ppm (1H. br. s. CH-CD-). Agrees with literature data62.
Preparation of 2-(N-(f-butyloxycarbonyl)amino)-3-butenoic acid (1 4 3 )" .
As for (175) using di-r-butyl-dicarbonate and 2-amino-3-butenoic acid 
(O.lOlg, l.Ommol) to give the title compound (0.193g, 96%). Sh (220 MHz; 
CDCI3 ) 7.1 (1H. m. NH). 6.0 (1H. m. C //*C H 2). 5.45 (1H. d. 19 Hz. CH=CH// 
trans). 5.30 (1H. d. J 10 Hz. CH=C//H cis). 4.87 (1H. m. CH). 1.41 (9H. s. r-Bu). 
£ - (3 ,4 - 2 H 2 l-2 -(Af-(r-butyloxycarbonyl)amino)-3 -butenoic acid Sh (250  
MHz; CDCI3 ) 7.1 (1H. m. NH), 5.37 (0.72H. unres. t. CD=C//D trans). 5.30 
(0.28H, br. s. CD=CDH cis). 4.87 (1H. m. CH). 1.41 (9H. s. r-Bu). Z-(3 .4 -2 H2 J-2 - 
Af-(r-bulyloxycarbonyl)amino)-3*butcnoic acid Sh (220 MHz; CDCl3 ) 7 .1  
(1H. m. NH), 5.37 (0.6H. br. s. CD*C//D trans). 5.30 (0.3H. br. s. CD=CDH cis). 
4.87 (IH. m. CH), 1.41 (9H. s. r-Bu).
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6 .2  : E X P E R IM E N T A L  D E T A IL S  F O R  C H A P T E R  F O U R .
Preparation of methyl-3-butenylimidate hydrochloride (153)107.
Gaseous hydrogen chloride (dry) was bubbled through the solution of 
3-propenenitrile (freshly distilled , 3.5g, 52mmol) and methanol 
(superdry. 3.5cm3) and was stirred under a nitrogen atmosphere at 0°C 
for one hour. The vessel was tightly sealed and allowed to stir overnight 
at 4°C. Cold diethyl ether (dry, 200cm3) was added causing the product to 
precipitate from solution which was removed by filtration. The cake was 
washed with further ether (2 x 50cm3). The white hygroscopic solid was 
dried under high vacuum to give the title compound (153) (6 .8 6 g, 97%). 
SH (220 MHz; D2 0 )  5.9 (1H. m. C //*CH2). 5.25 (1H. br. d. J 16 Hz. CH-C//H 
trans), 5.25 (1H. br. d. J 12 Hz. CH-CH// cis). 3.7 (3H. s. OCH3 ). 3.17ppm (2H. 
d. J 12 Hz. CH2). vm,*  (nujol mulIVcm*1 1669 (C-N). m/z (Cl) 136 ((M+l)+. 
10.1%). 122 (5.4). 100 ((M-HCI)+. 100). 8 6  ((M-HCI-CH3)+. 47.1). 6 8  (2.0). 
m/z (El) 235((2M-HCI)'f , 2.5%). 202 ((2 M4-2 -2 HCI)*. 7.1). 185 ((2M+1-HCI- 
CH3)+. 16.9). 136 ((M+l)«\ 28.7). 110 (39.7). 100 ((M-HCI)+. 100). 93 ((2M+1- 
2HCI-CH3)+. 63.7). 8 6  ((M+1-HCI-CH3)+. 1.2).
Preparation of methyl N-chloro 3-butenylimidate (154).
Imidate hydrochloride (153) (3.0g. 22mmol) was added directly to a 
vigorously stirred solution o f sodium hypochlorite solution (fresh. 
12-14% available chlorine. 130cm3) at 0°C under a nitrogen atmosphere. 
After stirring at this temperature for one hour the solution was 
extracted with petroleum ether (40-60° fraction. 2 x 50cm3). The organic 
phase was dried with magnesium sulphate and evaporated under reduced 
pressure to give the title compound (154) as a colourless oil which was
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used without further purification. (2.98g. 100%). &h (220 MHz; CDCI3 )
5.9 (1H. m. C //-C H 2 ). 5.28 (1H. d. J 17 Hz. CH-C//H trans). 5.25 (2H. d. J 11 Hz. 
CH -C H // cis). 3.85 (3H. s. OCH3 ). 3.4ppm (2H. d. J 12 Hz. CH2). m/z (El) 134 
((M +l)+, 6.9%). 98 ((M-HCI)+, 20.6). 92 (17). 83 (0.7). 69 (100).
Preparation of (fl,S)-2-am inobut-3-enoic a dd  (71).
A solution of methyl A(-chloro-3-butenylimidate (154) (0.882g. 6 .6  mmol) 
and sodium hydroxide (3 equivalents. I.303g. 33 mmol) in water (150cm3) 
was stirred overnight at 2°C. The solution was passed over a column of 
Dowex 50W-8X (H) and washed with water (250cm3). The product was 
eluted with 5% aqueous pyridine solution to give the amino acid (0.3542g. 
53%) pure by 1H nmr which was rccrystallised from water /  ethanol to 
give the title product (71) (0.2l86g, 33%). M. p. 175°C(d). #h (220 MHz; 
D20 ) 8 h 5.9 (1H. m. C//-CH 2), 5.45 (1H. d. J 15.7 Hz. CH-C//H trans). 5.43 (1H. 
d. J 12.5 Hz. CH*CH// cis). 4.3ppm (1H. d. J 9 Hz. C //-CH -CH2). *C 0 0 0  MHz. 
D2 0 )  173.7 (Cl). 131.0 (C3), 122.1 (C4). 57.8 (C2). m/z (Cl) 102. ((M+l)+. 
20.1%). 58 ((M +1-C02)+, 1.1). 56 (9.1) (Found M+l+ : 102.0555. C4 H gN 0 2 
requires 102.0555). Agrees with literature data3®®.
Preparation of (f t ,S )-2 -(N -f -b u ty lo x y c a rb o n y l-a m in o )b u t-3 -e n o ic  acid 
(143).
A solution of methyl N -chloro-3-butcnylimidate (154) ( l . lg ,  8.9mmol) 
and sodium hydroxide (3 cq.. I.079g. 27mmol) in water (50cm3) was 
stirred overnight at 2°C. 1,4-dioxane (50cm3) was added followed by 
di-r-butyl dicarbonate (1.2 eq.. 2.136g. 9.79mmol) and allowed to stir for 8 
hours at 2°C. The 1,4-dioxane was removed in vacuo and the resultant 
aqueous solution washed with ethyl acetate (10cm3). The aqueous phase
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was layered with ethyl acetate (25cm3) and acidified to pH 2 with cold I M 
potassium bisulphate solution The aqueous layer was washed with 
further ethyl acetate (2 x 25cm3). The combined organic phases were 
washed with water ( 1 0 cm3) and saturated brine ( 10cm3), dried with 
magnesium sulphate and concentrated under reduced pressure to give 
the product as a straw coloured oil (143) (l.lOSg, 67%). 8 h (220 MHz; 
CDCI3 ) 7.1 (1H. m. NH). 6.0 (1H. m. C //-C H 2 ). 5.45 (1H. d. 19 Hz. CH=C//H 
trans). 5.30 (1H. d. J 10 Hz. m. CH=CH// cis). 4.87 (1H. m. CH), 1.41 (9H. s. l- 
Bu). 8 c  (100 MHz. CDCI3 ) 174.5. 173.6 (Cl). 156.7. 155.2 (C-O Boc). 132.6. 132.2 
(C3), 117.5 (C4), 81.6. 80.3 (C-Mc3 Boc). 57.0. 55.6 (C2). 28.1 (CH3 Boc). m/z 
(C l) 202 ((M+l)+. 2.4%), 163 (20). 146 ((M-C4 H g)+. 6.5). 102 ((2M- 
C 0 2 C4 Hg)+, 4.9). 8 6  (0.6). (Found M+1+ : 202.1067. C9 H 1 6 NO4  requires 
202.1079). m/z (El) 202 ((M+l)+. 20.1%). 58 ((M+l-C0 2 )+. 1.1). 56 (9.1). vm„  
(CHCl3 )/cm*> 1720. 1510, 1465.
Preparation of e th y l-(S )-2 -(N -f-b u ty lo x y c a rb o n y l)a m in o b u t-3 -e n o a te
(144)96.
A mixture of citratc/phosphatc buffer solution (IM. pH 4.2. 15ml). papain 
(ex-Sigma. type 2 crude. 0.3g), L-cysteine (45mg) and ethylenediamine 
tctraacctic acid tetra sodium salt (1 M, 7SpL) were allowed to stir for 10 
minutes. ft.S-acid (143) (O.Sg, 2.5mmol) in dichloromethane (3cm3) and 
ethanol (2cm3) were added and the solution was stirred at 37°C for 2 days. 
The reaction mix was filtered through a bed of Celite and the cake 
washed with ethyl acetate (15cm3) and water (15cm3). The organic layer 
was separated off and the aqueous phase extracted with ethyl acetate 
(2 5 c m 3) and acidified with I M potassium bisulphate solution until blue 
to Congo red. The combined organic phase was washed with water 
(1 0 cm 3) and saturated brine (10cm3). The crude (/?)-acid was removed by
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washing the organic layer with I M sodium bicarbonate solution 
(2 x 5 cm 3) and after acidification was subjected to a further incubation 
with papain as above. The combined organic phases of both runs were 
washed with saturated brine (lOcm^), and dried with magnesium 
sulphate and concentrated under reduced pressure to give an residue 
which was flash chromatographed with ethyl acetate /  petroleum ether 
I : 9 solvent system to give an oil (144) (0.2g, 80%). 8 h (400 MHz; CDCI3 ) 
5.83 (1H. ddd. J 17.1. 10.4. 5.4 Hz. C//»CH2). 5.35 (1H. dd. 17.1. 1.8 Hz. CH=C//H 
trans). 5.30 (1H. dd. J 10.3. 1.7 Hz. CH=CH// cis). 4.8 (1H. m. CH), 4.17 (2H. q. J 
7.1 Hz. C //2 CH 3 ). 1.41 (9H. s. i-Bu). 1.23 (3H. t. J 7.1 Hz. CH2 C //j ). 8 c  (100 
MHz. CDCI3 ) 170.6 (C l). 154.7. 155.2 (C=0 Boc). 132.7 (C3). 117.0 (C4). 79.9 
(C-Me3 B o c ) .  61.6 (C2). 55.7 (CH2 Et). 28.1 (CH3 Boc). 14.0 (CH3 Et). m/z (Cl) 
230 ((M+l)+. 0.8%). 174 ((M+l-C4 Hg)+, 18.2). 156 (13.8). 130 ((M+l-C4 Hg- 
C 0 2)*. 9.2). 1 0 0 ((M-fl-C4 Hg-C0 2 -C2 H5 )+. 23.1). 56(2.8%). (Found M+1+: 
230.1394. C |iH 2 0 NO 4  requires 230.1392). vmax (C H C ^ /c m * 1 1770. 1712. 
1495 cm '1.
The optical purities o f  the resolved amino acid derivatives was examined 
by the optical rotation of the free amino acid prepared by the usual 
method of acid hydrolysis and ion exchange with Dowcx 50W-8X (H+). 
(S)-2-amino-3-butcnoic acid : (a |o  * +94.7° (H2 0 , 25.8°C. c*0.25).
(R)-2-amino-3-bulcnoic acid ; |o |d * +96.3° (H2 0 , 22.9°C. c*0.46).
Preparation of methyl /V-chloro-3-pentenylimidate (156).
As for (153) using freshly distilled 3-pentenenitrile (155) (5.0g. 
6l.7mmol) to give the title compound (156) (8.03g, 87%). 8 h (400 MHz; 
CDCI3) 5.75 (2H, m. C //-C //). 3.77 (3H. s. OCH3 ). 3.04 (2H. d. J 7 Hz. C//2). 175 
(3H, d. J 5 Hz. CHj).  m/z (El) 263 ((2M+1-HCI)*. 1.8%). 149 ((M)+. 0.6). 
114((M -C I)+ . 100). 99(7.5). 93 (15). 75 (7.4). 55 (13.9) (Found M+l+ :
132
150.0658. C6 H i3 CINO requires 150.0677). vmax ( C H C ^ /c m 1 3176, 1660. 
1475.
Preparation of methyl A/-chloro-3-pentenylimidate (157).
As for (154) using fresh methyl-3-pentenylimidate hydrochloride (156) 
(2.0g, 13.4mmol) lo give the title compound (157) (1.91g. 97%). (400 MHz; 
CDCI3) 6 h (400 MHz; CDCI3 ) 5.6 (1H. m. C//-CH). 5.45 (1H. m. CH«C//). 3.76 
(3H, s. OCH3 ). 3.25 (2H. ddd. J 6.7. 1.3. 1.3 Hz. CH2), 167 (3H. q. ddt. J 6.4. 1.3, 
1.3 Hz. CH3). 5C (100 MHz. CDCI3 ) 174.6 (C-l). 129.6(C-3). 121.7 (C-4). 
54.7 (C-2). 35.2 (OCH3 ). 17.8 (C5-H). m/z (El) 147 ((M)+. 3.24%), 132 ((M- 
C H 3)+. 2.99). 112 ((M-HCI)+, 4.85). 97 (1.27) (Found M+ : 147.0441. 
CfiHioCINO requires 147.045). m/z (Cl) 148((M+1)+. 21.63%). 132 ((M- 
CH3)*. 1.06). 112-((M-HCI)+, 2.43). vm„  (C H C ^ /c n r 1 2950, 1605. 1443.
Preparation of 2-amino-3-pentenoic acid (158).
As for (85) using methyl N -ch lo ro -3 -pen teny lim idite  (157) (0.8g.
5.4mmol) to give the title compound (158) (0.084g, 14%). M. p. 178°C (d). 
«H (250 MHz; D20) 5.9 (1H. ddq. J 6.5. 15.3. 0.8 Hz. C//*CH). 5.35 (1H. ddq. 8.5. 
1.7, 15.3 Hz. CH-CH). 4.1 (1H. d. J 8.5 Hz. CH2). 16 (3H. dd. J 6.5. 1.7 Hz. C//j). 
6 C (63 MHz. CDCI3 ) 174.5 (Cl). 135.9 (C3). 123.4 (C4). 57.9 (C2). 18.0 (C5). 
m/z (El) 116 ((M+l)+. 10.6%), 70 ((M -C02)+. 2.4). 35 (10.5) (Found M+1+: 
116.0713. C5 H j0 NO2 requires 116.071).
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As for (143) using methyl N -chloro-3-pcntcnylim idatc (157) (0.6g,
4.5mmol) to give the title compound (159) (0.35g. 29%). 5h (250 MHz; 
CDCI3 ) 5.8 (1H. dqd. 15.26. 6.32. 1.11 Hz. C//CH3 ). 5.51 (1H. m. N//) . 5.45. 5.30 
(1H. unres. dd. J 15. 5 Hz. C //-CH CH 3 ). 4.75. 4.54 (1H. 2xm. CH). 1.67 (3H. d. 
6.7, CH3 ), 1.39 (9H. s. f-Bu). 5C (100 MHz. CDCI3 ) 177.5, 175.2 (C l). 156.6.
155.1 (C-O Boc), 130.0. 129.7 (C3). 125.0 (C4). 81.5. 80.1 (C-Me3 Boc). 56.6.
55.1 (C-2), 28.1 (CH3 Boc). 17.6 (C-5).
P r e p a r a t i o n  o f  2 - ( W - f - b u t y l o x y c a r b o n y l ) a m i n o - 3 - p e n t e n o i c  a c i d  ( 1 5 9 ) .
Preparation of ethyl (S )-2 -(/V -/-butyloxycarbo nyl)am ino )-3 -penteno ate  
(160).
As for (144) using (/? .S )-2-(A /-f-buty loxycarbonyl)am ino-3-pcntenoate  
(0.3g. 1.4mmol) to give the (/? ) -2 -(A (-r-buty  I o x y c a rb o n y  I ) am i no - 
3-pcntcnoatc (0.84g, 56%) and the title compound ethyl (S ) - 2 - (N  -
f-butyloxycarbonyl)amino-3-pentcnoate (160) (O.I3g, 76%). 8 h  (250 MHz; 
CDCI3 ) 5.71 (1H. dqd. J 14.3. 6.56. 1.4 Hz. CH=C//CH3 ). 5.35 (1H. unres. dd.
15.5. 4.8 Hz. C//»CHCH3). 5.1 (1H. m. NH). 4.67 (1H. m. CH), 4.17 (2H. q. J 7.0 
Hz. CH2  Et). 1.65 (3H. d. J 5.1Hz. Ctfj). 1.41 (9H. s. f-Bu). 1.23 (3H. t. J 7.0 Hz. 
CH 3  El). 5c (63 MHz. solvent CDCI3 ) 129.2 (C3). 125.5 (C4). 79.9 (C-Me3 Boc). 
61.4 (C2). 55.7 (CH2 Et). 28.2 (CH3 Boc). 17.6 (C5). 14.0 (CH3 El), m/z (Cl) 244 
( (M + l)+. 0.8%). 205 (30.6). 188 ((M -C ^g)* , 8 6 .8 ). 170 ((M-C4 H g-C 02)+.
48.3). 144((M -C4Hg-C02-C2H5)+. 87.7). 127 (20.3), 114 ((M-C4 H g -C 0 2- 
C 2 H 5)+. 29). 99 (6.3). 70 ((M-C4 Hg-C 0 2 -C 2 H 5 .C 0 2)+. 25.5). m/z (El) 
170 ((M -C 4 H g -C 0 2)+, 38.4%). 134 (15.1). 127 (27). 114 ((M-C4 H g -C 0 2- 
C 2 H 5)+. 93.6). 83 (100). 70 ((M-C4 H g -C 0 2 -C 2 H 5 . C 0 2)+ , 25.5). vm t„ 
(CHCI3 )/cn*1 1760. 1708. 1493.
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The optical purities o f the resolved amino acid derivatives were
examined by the optical rotation of the free amino acid prepared by the
usual method of acid hydrolysis and ion exchange with Dowex 50W-8X
(H+).
(S)-2-amino-3-pcntcnoic acid : [a |o  * +111.9° (H2O, 25.6°C, c=0.2).
(/?)-2-amino-3-pcntcnoic acid : (alo  ■ +114.2° (H2O, 29.5°C. c=0.2).
Preparation of 2-m ethyl-2-butene-1-ol (162).
Methyl tiglate (161) (3.8g, Slmmol) was added to a stirred ethereal 
(6 0 cm 3) solution of lithium aluminium hydride (1.87g. Slmmol) at 0°C 
and stirred for two hours. The excess lithium aluminium hydride was
destroyed by the careful addition of ethyl acetate ( 1 0 cm3) and the
suspension was filtered and washed with saturated brine to give the title
compound (162) which was used without further purification. (3.65g, 
85%). 8 h (220 MHz; CDCI3 ) 5.54 (1H. q. J 7 Hz. C-CW). 4.02 (2H. s. CH2), 169 
(3H. a. C-CH3), 1.69 (3H. d. J 7 Hz. CH-C//j).
Preparation of 1-bromo-2-methyl-2-butene (163).
Phosphorous tribromide (0.33eq.. 2.97cm3. 28mmol) was added carefully 
to a solution of 2-mcthyl-2-bulene-l-ol (162) (7.39g, 8 6 mmol) in diethyl 
ether (200cm3 ) at 0°C  the solution was allowed to stir overnight at room 
temperature. The mixture was washed with water (30cm3) and saturated 
brine (30cm3), dried over magnesium sulphate and reduced in vacuo. 
The residue was distilled to give the title compound (163) (8.3g. 67%). 
B. p. 74°C 18 mm Hg. 6 H (220 MHz; CDCI3 ) 5.74 (1H. q. J 8  Hz. CW-CH3 ). 4.01 
(2H. a. CH2), 1.78 (3H. a. CHj). 1.64 (3H. d. J 8  Hz. CH-C//j). Agrees with 
literature data150.
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P r e p a r a t i o n  o f  3 - m e t h y l - 3 - p e n t e n e n i t r i l e  ( 1 6 4 ) .
l-Bromo-2-melhyl-2-buicne (163) (5.3g. 36mmol) was added to a solution 
of sodium cyanide (l.leq ., 2.1g, 43mmol) in DMSO (30cm3) at 30°C. and the 
solution allowed to stir until it reached room temperature. The mixture 
was diluted with water (230cm3) and extracted with petroleum ether (4 x 
23cm 3). The organic phase was washed with water (30cm3) and saturated 
brine (30cm3). dried over magnesium sulphate and concentrated under 
reduced pressure. The residue was distilled to give the title compound
(164) (2.5g. 73%). B. p. 54°C 18 mm Hg. 5H (220 MHz; CDCI3 ) 3.6 (1H. q. 
J7  Hz. C //-C H 3 ). 3.04 (2H, s. CH2), 173 (3H. s. CHj).  1.64 (3H. d. i  7 Hz. 
C H -C //j). Agrees with literature data130.
Preparation of methyl 3-methyl-3-pentenylimidate hydrochloride (165).
As for (133) using 3-mcthyl-3-pcntenenitrile (164) (l.63g, 17mmol) to 
give the title compound (163) (2.75g. 100%). 6 H (220 MHz; D2 0 ) 3.13 (1H. q. 
J 2.8 Hz. C//-CH3 ). 4.21 (3H. s. OCH3 ). 3.33 (2H. s. CH2). 1.7 (3H. s. CH3), 1.68 
(3H. d. J 2.8Hz. CH-C//J). m/z (El FAB) 291 ((2M-HCI)*. 0.9%). 236 ((2M-2CI).
1.1). 220 (2.6). 183 (8.9). 164 ((M+l)+. 26.3). 149 ((M-CH3)+. 0.9). 128 ((M- 
Cl)+, 100). 110(3.1). vmax (nujol mulD/cm 1 1656. 1465. 1448 c m 1.
Preparation of methyl /V-chloro-3-methyl-3-pentenylimidate (166).
As for (154) using methyl 3-mcthyl-3-pcntenylimidate hydrochloride
(165) (l.Og. 6 .lmmol) to give the title compound (166) (l.Og. 100%). 5 h 
(400 MHz; CDCI3) 5.28 (1H. qq. J 6.7. 1.3 Hz. C//-CH3 ). 3.76, 3.74 (1H. a. OCH3 ). 
3.22 (2H. br. s. CH2). 1.6 (3H. br. a. C //j) . 1.38 (3H. d. J 6.7 Hz. CH-Ctfj). 5C 
(100 MHz. CDCI3 ) 174 (Cl). 128.5. 128.1 (C3). 122.9. 128.1 (C4). 56.8. 54.4
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(C2). 41.1. 40.4 (OCH3 ). 15.7 (C5). 13.3 (C6 ). m/z (Cl) 178 ((M+NH3)*. 1.3%), 
162 ((M+l)+. 56.6). 146 ((M-CH3)+, 1.1), 126((M-CI)+. 12.4). 111((M-CH3- 
Cl)*. 0.8). 85 ((M-CH3 -CI-CN)+. 0.8). m/z (El) 162((M+1)+, 39.5%). 146 ((M- 
CH3)+, 54.2). 126 ((M-CI)+, 100). I l l  ((M-CH3 -CI)+. 32.2). 94 ((M-C1-0CH3).
54.3) . 85 ((M-CH3 -CI-CN)+. 54.3). vm„  (nujol mulD/cm 1 1608. 1445.
Preparation of 2-amino-3-methyl-3-pentenoic acid (167).
As for (85) using methyl A /-chloro-3-m cthyl-3-pcntcnylim idate (166) 
(0.46g, 2.9mmol) to give the title compound (167) (0.22g, 100%). 6 h (400 
MHz; D2 0 ) 5.71 (1H. qq. J 6.7. 1.3 Hz. C//-CH3). 4.11 (1H. s. CH). 1.6 (3H. dq. J 
1.0. 6.7Hz. CH-O/j). 1.56 (3H. dq. J 1.2. 1.0Hz. CH3 ). Bq  (100 MHz. CDCI3) 174.1 
(Cl). 130.7 (C4). 128.8 (C3). 62.9 (C2). 13.7 (C5). 11.8 (C6 ). m/z (El FAB) 259 
((2M>1)+, 10.6%). 222 (11.0). 185 (7.2). 130 ((M+l)+. 100). 113 ((M-OH)+.
14.4) , 93 ((M-OH-CO)+, 10).
Preparation of 2-(W -f-butyloxycarbonyl)am ino-3-m ethyl-3-pentenoic acid 
(1 6 8)107.
Methyl ^-chloro-3-mcthyl-3-pcntenylimidate (167) (0.79g, 4.8mmol) in 
petroleum ether 40-60° (3cm^) was added to sodium (3eq.. 0.34g. 
l4.6mmol) in methanol (6 cm3) and stirred at room temperature for 24 
hours. The solution was diluted with water (20cm3) and 1.4-dioxane 
(20cm 3) and di-r-butyl-dicarbonalc (1.2 eq., 1.27g. 5.8mmol) and worked 
up as usual to give the title compound (168) (2.75g. 100%). ¿ h (250 MHz; 
CDCI3) 5.63 (IH. m. C//-CH3). 5.26 (1H. m. NH), 4.7. 4.51 (1H. m. CH), 1.64 
(3H. a. CH3 ), 1.63 (3H.d. J 6  Hz. CH-C//j). 1.42 (9H. a. /-Bu). 6 c  (63 MHz. 
CDCI3 ) 175.2, 174.0 (Cl). 155.4 (C -0  Boc), 130.6 (C4). 125.2, 125.1 (C3). 80.2 
(C-Me3 Boc). 61.69. 60.31 (C2). 28.3 (CH3 Boc). 13.5 (C5). 12.9 (C6 ). m/z (Cl)
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230 ((M +l)+, 5.6%), 191 (48.2), 174 ((M-C4 Hg)+. 51.3), 146 ((M-C4 Hg-CO)+,
5.2). 130((M-C4Hg-CO2)+. 17.4). 112 (8.4). 84 ((M-C02C4 H9 -C02)+. 43.8). 79 
(5.9). m/z (El) 173 ((M-C4 Hg)+, 5.7%), 128 ((M-CC>2 C4 H9.)+. 53). 112 (6 .6 ). 
84 ((M-C0 2 C4 H9 -C0 2)+. 35.8). v,,** (CHCI3 )/cm-» 1715s. 1655s. ¡456.
Preparation of ethyl (S )* 2 * (N -f-b u ty lo x y c a rb o n y l)a m in o -3 -m e th y l-3 - 
pentenoate (169).
As for (144) with 2-(A /-f-butyloxycarbonyl)am ino-3-m ethyl-3-pentenoic 
acid (168) (0.23g, l.Ommol) to give the title compound (169) as a straw 
coloured oil (69mg. 53%). 8 H (400 MHz.; CDCI3 ) 5.57 (1H. br. q. J 5.9 Hz. CH- 
CH3 ), 5.27 (1H. br s. NH). 4.65 (1H. br. d. J 7.3 Hz. CH). 4.17 (2H. q. J 7.1 Hz. 
C« 2  El). 1.62 (3H, d. J 6.0 Hz. CH-Cftj). 1.6 (3H. s. C //j). 1.42 (9H. s. f-Bu). 1.23 
(3H. t. J 7.1 Hz. CWj Et). 8 c  (100 MHz. CDCI3 ) 171.3 (Cl). 154.8 (C*0 Boc). 
131.0 (C3). 124.3 (C4), 79.7 (C-Me3 Boc). 61.3 (C2). 60.4 (CH2 Et). 30.8 (CH3 
Boc). 14.0 (CH3 El). 13.4 (C5). 12.7 (C6 ). m/z (Cl) 258 ((M+l)+. 11.6). 219 
(31.4). 202 ((M-C4 H g )* . 52.8). 158 ((M-C4 H g - C O j ) 4 , 85.3).
157 ((M -C02C 4 Hg)+. 3.6). 110 (1.1). 84 ((M-C4 Hg-C02-C2H5 .C 0 2 )+. 39.7). 
v™« (CHCI 3 )/cm‘' 2928. 1712. 1496.
The optical purity of the resolved amino acid derivative was examined by 
the optical rotation of the free amino acid prepared by the usual method 
of acid hydrolysis and ion exchange with Dowex 50W-8X (H+). 
(S)-2-aminopcntcnoic acid ; |a lo  * +65.4° (H2 O, 24.1°C, c=0.26).
Preparation of 3-methyl-propenenitrile (171 ) 111.
Copper (I) cyanide (8.96g. 0.1 mol) was added slowly to a solution of 
3-chloro-2-mcthyl-l-propene (9.1 g. O.lmol) in nitrobenzene (freshly 
distilled, 40cm3) at 125°C for two hours. The title compound (171) was
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purified by fractional distillation (6.26g, 77%). B. p. 84-86°C 18 mm Hg. 
fill (220 MHz; CDCI3 ) 5.14 (1H. br. s. O C //H ). 5.05 (1H. br. s. C«CHtf). 3.11 
(2H, s, CH2 ). 1-87 (3H, s. C //j). Agrees with literature data1**.
Preparation of methyl 3-methyl-3-propenylimidate hydrochloride (172).
As for (153) using 3-methyl-3-propenenilrilc (171) (2.0g, 2Smmol) to 
give the title compound (172) (3.6g. 100%). fin (220 MHz; D2 O) 5.18 (1H. br 
s. C-CWH). 5.03 (IH .br s. C-CHW). 4.2 (3H. s. OCH3 ). 3.42 (2H. s. C« 2 ). 1-8 (3H. 
a. CH3). m/z (El FAB) 263 ((2M-HCI), 1.7%). 227 ((2M-2HCI)*. 1.48). 136 
(1.39). 114 ((M-HCI)+ . 100). 89(1.22). 73 (4.37). vmax (nujol mulD/cm' > 
1806. 1660. 1466.
Preparation of methyl A/-chloro-3-methyl-3-propenylimidate (173).
As for (154) using methyl N - c h I o r o - 3 - me t hy I - p ro p e n y  I i m id a te  
hydrochloride (172) (1.0. 6 .8 mmol) to give the title compound (173) (l.Og, 
87%). fiH (220 MHz; CDCI3 ) 5.02. 4.93 (1H. br s. C-CWH). 4.87. 4.8 (1H. br s. 
C-CHW). 3.94. 3.8 (3H. s. OCH3 ), 3.24. 3.0 (2H. s. CH2 ). 1.79.1.76 (3H. s. CH3 ). 8 c  
(100 MHz. CDCI3 ) 174.1 (Cl). 138.3. 137.8 (C4), 114.1. 113.7 (C3). 57.0. 54.7 
(C2). 39.8. 39.1 (C5). 22.4, 22.0 (OCH3 ). m/z (Cl) 148 ((M+l)+. 17.2%), 112 
((M -HCI)+. 65.0). 97 ((M-HCI-CH3 )*. 3.7). 84 (9.3). 72 (12.5). m/z (El) 148 
((M+1)*, 17.2%). 112 ((M-HCI)+, 65.0), 92 (12.2). 81 ((M-HCl-OCHs)*. 16.0). 
77 (12.5%). vmax (CHCljVcm*1 1608. 1446. 1379.
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Methyl Af-chloro-3-mcthyl-3-propcnylmidate (173) (0.4g, 2.7mmol) was 
dissolved in petroleum ether 40-60° (Scm^) and added to » solution of 
sodium (3 cq., I .8 6 g, 8 1 mmol) in methanol (6 cm^). The solution was 
stirred overnight at room temperature. Water (I0cm ^) was added to the 
mixture and the solution acidified with M HCI. The organic layer was 
removed and the solution passed down a Dowex SOW 8 X (H+) ion exchange 
column and the product eluted with 4% aqueous pyridine to give the title 
compound (174) which was recrystallised from ethanol /  water (0.24g, 
76%). M. p. 186°C (d). 5h (400 MHz; D20 ) 5.51 (1H. dq. J 1.2 Hz. C-C//H). 5.25 
(1H. d. J 1 Hz. O C H //), 4.19 (1H. s. C-Ctf). 1.72 (1H. dd. J 2,1Hz. C//j). 8 c  (100 
MHz. solvent D2 0 )  173.4 (Cl). 148.6 (C3). 129.5 (C4). 60.9 (C2). 55.7 (C5). 
m/z (El FAB) 116 ((M+l)+. 67%). 93 (100). 75 (47.6). 70 (39.2). 58 (40.7). 
Agrees with literature data107.
Preparation of 2-(M -f-butyloxycarbonyl)am ino-3-methyl-3-propenoic acid 
(175).
P r e p a r a t i o n  o f  2 - a m i n o - 3 - m e t h y l - 3 - p r o p e n o i c  a c i d  ( 1 7 4 ) 1 0 7 .
As for (143) using di-r-butyl-dicarbonate and 2-amino-3-propenoic acid 
(0.282g, 2.5mmol) to give the title compound (175) (0.53g, 100%). 5h (220 
MHz; CDCI3) 5.41 (1H. m. NH), 5.1 (1H. br s. C-C//H). 5.02 ( lH .b r s. C-CHH). 
4.74. 4.58 (1H. m. CH). 1.7 (3H. s. CH3). 1.31 (9H. s. r-Bu). 8 c  (100 MHz. CDCI3 ) 
174.4. 173.3 (Cl). 155.0 (C -0  Boc). 140.0 (C4). 114.9 (C3). 80.2 (C-Me3 Boc). 
60.1. 58.8 (C2). 28.1 (CH3 Boc). 19.2 (C5). m/z (Cl) 216 ((M+l)+, 1.4%). 177 
(9.8). 160 ((M-C4 Hg)+. 4.7). 116 ((M-C4 H g -C 0 2)+, 6.7). 97 (1.3), 70 ((M- 
C0 2 C4 H9 -C 0 2)+. 39.1). m/z (El) 159 ((M-C4 H f)+ . 21.9%). 114 (80.1). 96 
(12.4). 83 (23.4). 83(100). 70 ((M-C02 C4 H9 -C 0 2)+. 72.3). vm„  (CHCl3 )/cm-> 
1718, 1455.
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P r e p a r a t i o n  o f  1 - b r o m o - 3 - m e t h y l - 2 - b u t e n e  ( 1 7 7 ) .
As for (163) using 3-methyl-2-butcne-l-ol (176) (4.3g, SOmmol) to give 
the title compound (177) (5.68g. 76%). B. p. 6 6 °C 18 mm Hg. 8 H (220 MHz; 
CDCI3 ) 5.55 (1H. t. J 8 Hz. C//«C), 4.04 (2H. d. J 8 Hz. CH2). 1.79 (3H. s. C*Ctfj). 
1.74 (3H, s. C«C//j).
Preparation of 4-methyl-3-pentenenitrile (178).
As for (164) using l-bromo-3-mclhyl-2-butene (177) (3.78g, 25mmol) to 
give the title compound (178) (2.0g. 83%). B. p. 130°C 18 mm Hg. 6 h 
(220 MHz; CDCI3) 5.21 (1H. t. J 7 Hz. C//-C). 3.08 (2H. d. J 7 Hz. CH2). 179 (3H. 
s. C*C//j), 1.64 (3H, s. C=C//j). Agrees with literature d a t a ' l l .
Preparation of 5.5'-dimethyl-2-methoxy-1-pyrrolinium hydrochloride (180).
As for (153) with 4-mcthyl-3-pcntcncnitrile (178) (3.0g. 31.5mmol) to 
give the title compound (180) as a white solid (S.lg, 100%). 6 h (400 MHz; 
CD CI3 ) 3.64 (3H. s. OCHj). 2.42 (2H. q. AA'BB', CH2), 1.94 (2H. q. AA'BB', 
C H 2). 152 (6 H. s. C(CH3 )2 ) . 6 C (100 MHz. CDCI3 ) 172.2 (Cl). 69.2 (C4). 52.6 
(C3). 41.8 (C2). 32.1 (2xCH3). 31.5 (OCH3 ). m/z (Cl) 164 ((M+l)+. 17.1%). 150 
(0.8). 128 ((M-HC0+, 9.8). 114 ((M-HCI-CH3)+. 1.6). 96 ((M-HCI-OCH3 )+.
1.3). 73 (2.3%). m/z (El) 128 ((M-HC1)+. 24%). 112 (5). 96 ((M-HCI-OCH3 )*. 
14). 86(4), 77 (3.5). v,,,«* (chorofomD/cm 1 1643. 1435. 1090 cm '1.
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A solution of m-chloropcrbcnzoic acid (purified, 1.6 eq.. 0.23g. 1.3mmol) 
was added to ethyl (S )-2 -(A f-r-b u ty lo x y ca rb o n y l)-am in o -3 -b u tcn o a tc  
(0.19g, O.82mmol) in carbon tetrachloride (3cm3) at 0°C  under nitrogen 
and stirred for two hours. The mixture was concentrated under reduced 
pressure and purified by flash chromatography ethyl acetate /  
petroleum ether I : 10 to give the title compound as an oil (181) (0.123g, 
60%). 6 H (250 MHz.; CDCI3 ) 5.0 (IH, br d. J 8.5 Hz. NH). 4.60 (1H. dd. I 8.9, 1.7 
Hz. O2 CC«). 4.23 (2H. q. J 7.1 Hz. CH2 Et). 3.42 (IH. m. CHC//). 2.75 (IH. dd. J
4.5. 4.3 Hz. CHH). 2.64 (1H. dd. J 4.5, 2.5 Hz. CH//). 1.42. 1.41 (9H. s. l-Bu), 1.28 
(3H, t. J 7.1Hz, CH3  Et). 6 c  (100 MHz. CDCI3 ) 169.8 (Cl). 155.3 (C-O). 80.1 (C- 
Me3 B o c ). 61.7 (C2). 52.7 (CH2 Et). 51.1 (C3). 43.6 (C4). 28.2 (CH3 Boc). 13.9 
(CH 3 Et). m/z (Cl) 246 ((M+l)+. 17.7%). 190 ((M-C4 Hg)+, 99.1). 172 ((M- 
C02C2H5)+. 22.2), 146 ((M ^ H g -C O i)* . 8.9). 128 (3.9). 116 ((M-C4 Hg-C02- 
C2 H5 V*. 14.2). 72 ((M-C4 Hg-C0 2 -C2 H5 .C0 2 )+. 79.9). (Found M+ : 246.1333. 
C 1 1 H2 0 NO3 requires 246.1341). vmax (nujol mulD/cm' 1 3430, 1770, 1705.
Preparation of ethyl (S )-2 -(W -f -b u ty lo x y c a rb o n y l) -a m in o -3 -h y d ro x y  
butanoate (182)115.
A solution o f e thyl-(S  ) -( N  - t - bu  ty  lo  x y c a r bo n y I ) - a m i n o - 3 .4  - 
epoxybutanoate (0 .1 Ig. O.45mmol), fresh Raney nickel (lem 3 slurry) in 
ethanol (50cm3) was shaken at 100°C and 10 atmospheres of pressure for 
1 hour and allowed to cool overnight. The reaction mixture was filtered 
through a bed of celite and washed with ethanol (10cm3). The solution 
was evaporated under reduced pressure. The residue was purified by 
flash chromatography with ethyl acetate /  petroleum ether 3 : 1 to give
P r e p a r a t i o n  o f  2 - ( N - f - b u t y l o x y c a r b o n y l ) a m i n o - 3 , 4 - e p o x y - b u t a n o a t e
( i s i ) 11*.
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the title compound (182) as a diastcreomeric mixture (0.066g, 60%). 8 h 
(220 MHz; CDCI3 ) : 8 H 3.46 (1H. m. NH). 4.34 (1H. m. CH). 4.23 (2H. q. J 7.1 Hz. 
CH2 El). 3.86 (1H. overlapping q. J 8  Hz. C//OH). 1.47 (9H. s. i-Bu). 1.29 (6 H. 
m. CH3 A CH3  Et). vmax (CHClsM nr1 3439. 3012. 1713. 1456. 1439.
Preparation of ethyl 2 -(N -f -b u ty lo x y c a rb o n y la m in o )-3 ,4 -d ih y d ro x y  
butanoate (183).
A solution of ethyl (S )-2 -(\- f-b u ty lo x y c a rb o n y l)-a m in o -3 -b u te n o a tc  
(0. lg. 0.4m m ol). 4-methylmorpholine N  -oxide (O.lg. O.Smmol) and 
osmium tetraoxide (O.lcq.. I4.6pl. 0.04mmol) in /-butanol /  water ( 8  : 1. 
5cm ^) was stirred for 24 hours at room temperature. Sodium sulphite 
(0.9g) was added to destroy the OSO4 . The mixture was partitioned between 
ethyl acetate (10cm 3) and water (I Ocm3). The organic layer was washed 
with water ( 1 0 cm 3) and saturated brine ( 1 0 cm3). dried over magnesium 
sulphate and concentrated under reduced pressure to give the crude 
mixture of diols which were separable by careful flash chromatography 
with ethyl acetate /  petroleum ether 2 : 1 to give ethyl (25, 3/f ) -2 - (N -/- 
butyloxycarbonyl)amino-3,4-dihydroxybutanoalc (I9mg, 17%). M. p. 77- 
78°C. Rf * 0.23 (ethyl acetate / petroleum ether 2 : 1). 8 h (400 MHz; CDCI3 ) 
5.46 (1H. br. d. J 7.7 Hz. NH). 4.34 (1H. br. t. J 7.02 Hz. CH). 4.23 (2H. q. J 7.2 
Hz. CH2 Et). 3.86 (1H. m. C//OH). 3.68 (2H. m. CH2 OH). 1.43 (9H. s. /-Bu). 1.29 
(3H. t. J 7.2 Hz. CH 3 El). 6 c  (100 MHz. solvent CDCI3 ) 170.7 (Cl). 156.3 (C -0  
Boc). 80.8 (C-MC3  B o c ) .  73.0 (C3). 62.7 (C2). 61.9 (C4). 55.7 (CH2 El). 28.1 
(CH3 B o c ) .  14.0 (CH3 El), m/z (Cl) 264 ((M+l)+, 11%). 235 ((M-C2 H5)+. 30.6). 
225 ((M-C4 Hg+N H 3 )4 , 40.8). 208 ((M-C4 Hg)«\ 38.4). 188 (6.0). 179 ((M- 
C4 Hg-C2 H5 )*. 34.6). 164 ((M-C4Hg-C02)+. 87.7), 144 (9). 118 (3.8). 90 ((M- 
C4 Hg-C02 -C2 H5 -C 0 2)+. 2.8). (CHCl3 )/cm-> 1792. 1713.
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and an oil elhyl (25, 35)-2-(A /-f-buty loxycarbonyl)am ino-3 .4-d ihydroxy 
butanoate (45mg, 40%). Rf = 0.26 (elhyl acetate / petroleum ether 2 : 1 ) .  
8 h (400 MHz; CDCI3 ) 5.56 (1H. br. d. J 8.2 Hz. NH). 4.44 (1H, dd. 8.2, 1.5 Hz. 
CH). 4.2 (3H. m+2xq. J 7.2 Hz. C//OH and CH2 Et). 3.5 (2H. m. C//2 OH). 1.42 
(9H. s. I-Bu). 1.27 (3H. t. J 7.1 Hz. CH3  Et). 5c <100 MHz. CDCI3 ) 170.8 (Cl). 
156.8 (C -0  Boc). 80.7 (C-Me3 Boc). 72.0 (C3). 62.7 (C2). 61.9 (C4), 55.0 (CH2 
Et). 28.1 (CH3 B o c ) .  14.0 (CH3 Et). m/z (Cl) 264 ((M+l)+. 9.4%). 235 
((M -C2 H5)+. 6.3). 225 ((M-C4 H8 +N H 3)+. 29.1). 208 ((M-C4 H8)+. 25.1). 190 
((M -C 0 2 C 2 H5)+, 2.4). 179((M-C4 H8-C 2H5)+, 36.2). 164 ((M-C4 H g -C 0 2)+.
43.5). 147 (4.3). 118 (1.9). 90 ((M-C4 H8 -C 0 2 -C2 H5 .C 0 2)+, 3.2). m/z (El) 147 
(8 %). 116 (2.9). 101 (9.3). 90 ((M-C4 H8 -C 0 2 -C2 H5 .C 0 2)+. 7.5). 74 (5.4). vmax 
((CHCl3)/cm-'l738. 1697.
The optical purities of the resolved amino acid derivatives were 
examined by the optical rotation o f the free amino acid prepared by the 
usual method of acid hydrolysis and ion exchange with Dowex 50W-8X 
(H+).
8 h (400 MHz: D20) 4.1 (1H. m. C//OH). 3.7 (1H. d. 3.9Hz. CH). 3.67 (2H. C//OH). 
8 c  (100 MHz. CDCI3 ) : 8c  69.9 (C2). 70.0 (C3). 57.3 (C4).
(25. J/?)-2-amino-3.4-dihydroxybutanoic acid : (o ]d  = +7.0° (H2 0 . 25.8°C, 
c*0.25).
(25. 35)-2-amino-3.4-dihydroxybutanoic acid : [ a |o  = -7.3° (H2 0 , 22.9°C, 
c-0.46).
Preparation of ethyl (2 S )-2 -(^ * f-b u ty lo x y c a rb o n y l)a m in o c y c lo p ro p y l 
ethanoate (184).
Ethereal diazomethane (estimated 2 eq .) was added carefully to a solution 
ethyl (5 )-2 -(A/ -(/-buly loxycarbonyl)am ino)-3-butcnoaie  (0 .23g. 1.0
mmol) in diethyl ether (10cm3). Palladium (II) acetate (5mg) was added
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with an immediate evolution of gas. The excess dia/omcthanc was blown 
off under a stream of nitrogen and the organic layer was filtered, 
washed with water ( 1 0 cm3), saturated brine ( 1 0 cm3 ), dried over 
magnesium sulphate and concentrated under reduced pressure. The 
residue was purified by flash chromatography with ethyl acetate /  
petroleum ether I : 10 and distillation to give the title compound (184) as 
an oil (O.lg. 80%). B. p. 220°C (0.6 mm Hg. bulb to bulb). «h (400 MHz; 
CDCI3 ) 5.05. 4.8 (1H. d. J 6 .8  Hz. NH), 4.2 (2H. m. CH2  Et). 3.75. 3.45 (1H. br. t. 
J 7.8 Hz. CH). 1.41 (9H. s. i-Bu). 1.27 (3H. t. J 7.1 Hz. CH 3  Et). 1.02 (1H. m. 
C //(C H 2 )2 ). 0.5 (4H, m. CH2) «H 000 MHz. CDCI3 ) 172.1 (Cl). 151.6 (C -0  
Boc). 79.7 (C-Me3 Boc), 61.0 (C2). 56.5 (CH2 Et). 28.2 (CH3 Boc), 14.1 (CH3 
Et). 13.7 (C3), 2.62 (C4. 5). m/z (Cl) 244 ((M+1)+. 4%). 205 (9.6). 188 ((M- 
C 2 H5)+, 25). 170 ((M-C02C2 H5)*. 4.4). 144 ((M-C4 H g-C02)+. 22.9). 109(1.2). 
84 (3.1). 70 ((M-C4 Hg-C0 2 -C2 H5 .C0 2)+. 15.2). m/z (El) 170 ((M-C02 C2 H5)«\ 
4.8%), 114 ((M-C02 C 2 H5-C4 H8)+. 2.9). 84 (6.2). 70 ((M-C4 H g-C 0 2 -C2 H5. 
C 0 2)«\ 51.7).
Preparation of 2-(S)-amino-2-cyclopropylethanoic acid (1 8 5)122.
Ethyl (25)-2*(A /-/-butyloxycarbonyl)am inocyclopropylethanoate (184) 
(0.97g, 0.4mmol) was refluxed in 6  M HC1 (5cm3) for 1 hour and treated as 
before to give the title compound (185) (30mg. 6 6 %). M. p. 189°C(d). 
[o | d  ■ +58.7° (H20 , 24.7°C, c-0 .2 3 ). 5h (400 MHz; D20 )  2.99 (1H. d. J 9.8 Hz. 
CH),  1.06 (1H. m. C//(CH 2)2). 0.5 (3H. m. CH2), 0.36 (1H. m. CH2). 6 C 00 0  
MHz. CDCI3 ) 173.5 (Cl). 60.0 (C2). 12.5 (C3). 3.60 (C4. 5). m/z (El FAB) 115 
(M+-. 13.6%). 93 (100). 75 ((M-C3 H5)+. 34.6). 58 (31.9).
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A solution o f  ethyl (R ) - 2 - ( \ - r - b u t y  lo x y c a r b o n y  l ) - a m i n o - 3 .4 -  
epoxybutanoate (181) (0.23g. 1.0 mmol) and potassium fluoride (1.2 eq., 
0.08g, 1.1 mmol) in methanol ( 10cm3) was stirred at room temperature for 
24 hours. The solution was partitioned between ethyl acetate (20cm3) and 
water (20cm3). The organic layer was washed with water (10cm3 ) and 
saturated brine ( 10cm3), dried over magnesium sulphate and evaporated 
under reduced pressure to give a residue which after flash 
chromatography with ethyl acetate / petroleum ether 1 : 10  gave the title 
compound (186) as a colourless oil (O.lg, 75%). 5h (400 MHz; CDCI3 ) 6.64 
(1H. br. t. J 7.4 Hz. O C H), 6.42 (1H. br. s. NH). 4.24 (2H. q, J 7.1 Hz, C/ / 2  Et). 
4.18 (2H. br. d. I  7.4 Hz. C //2 OH), 1.46 (9H. s. r-Bu). 1.31 (3H. t. J 7.1Hz. CH3  
Et). «c (100 MHz. CDCI3 ) 164.5 (Cl), 154.0 (C»0 Boc). 129.4 (C2), 126.2 (C3). 
81.3 (C-Mc3 Boc). 61.8 (C4), 58.4 (CH2 Et). 29.6 (CH3 Boc). 14.0 (CH3 Et). rn/z 
(Cl ) 246 ((M +l)+. 10.9%). 190 ((M-C2 H5)«\ 40.7). 172 (30). 146((M.C4 H8> 
C 0 2)+. 7.7). 128 (85.2). 100 (1.9). m/z (El) 126 (0.7%). 116 (0.7). 85 (1.8). 83 
(2.7). vmax (CHCl3 )/cm-1 3408. 3011. 1708. 1495.
P r e p a r a t i o n  o f  e t h y l  2 - ( W - f - b u t y l o x y c a r b o n y l ) a m i n o - 4 - h y d r o x y -
2 - b u t e n o a t e  ( 1 8 6 ) .
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6.4  : EXPERIMENTAL DETAILS FOR CHAPTER FIVE.
Preparation of [2 -2H2)-fllycine (1 8 8a )144.
The exchangable protons of diethyl acetoamidomalonate (146) 
were removed by dissolving it in a solution of deuterium oxide /
d i -methanol with a catalytic amount of pyridine and evaporating the 
resultant solution. The d2 -diethyl acetomalonate so prepared was then 
added to a solution of 6  M DCI /  D2 O (prepared by adding thionyl chloride 
to D2 O) and refluxed for 30 minutes. The solution was concentrated under 
reduced pressure and passed down a Dowex 30W-8X (H+) ion exchange 
column. The free amino acid was eluted with 4% aqueous pyridine
concentrated under reduced pressure to give the title compound (188a).
No signal was seen in the proton nmr in D2 O. A sample was converted to 
its /-butyloxycarbonyl derivative 6 h (250 MHz; CDCI3 ) 1.47 (9H. s. f-Bu).
Preparation of (2 S )-[2 -2Hi]glycine (1 88b)142.
(2 -2 h  2  IGlycine (0.35g. 4.5mmol) and pyridoxal-5-phosphate 
(0.03g) was added to 0.3mmol potassium phosphate buffer and the pH was 
readjusted to pH 7.1 with 6  M NaOH (45 cm3). Glutamine pyruvate 
transaminase (ex Sigma Chemical Co. Ltd., from porcine heart,
suspension in ammonium sulphate solution, pH 6.0, 320u) was added and 
the solution was stirred for 3 days at 37°C in the dark. The solution was 
directly passed over a Dowex 50W-8X (H+) ion exchange column and the 
(2 S )-(2 -2H 1 jglycine was eluted with 4% aqueous pyridine which was 
concentrated under reduced pressure to give the title compound (188). A 
sample was convened to its r-bulyloxycarbonyl derivative 8 h (250 MHz; 
CDCI3 ) 3.98 (0.8H, m. CD//). 1.47 (9H. s. I-Bu).
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Preparation of methyl (S )-[2 -2Hi]bromoacetate (189).
(2S)-(2-2H i (glycine (0.25g, 3.3mmol) was added in small portions over 2 
hours to a vigorously stirred solution of sodium nitrite (0.3Ig, 4.35mmol) 
in hydrobromic acid (2.3 M, 20cm3) at 0°C. The solution was allowed to 
stir overnight at room temperature. The solution was exhaustively 
extracted with diethyl ether ( 6  x 13cm3), dried over magnesium sulphate 
and concentrated under reduced pressure. The liquid residue was taken 
up in further diethyl ether (23cm3 ) and treated with ethereal 
diazomethane (1.3 eq.) with immediate evolution of gas. The excess 
diazomethane was driven off under a stream of nitrogen. The ether was 
fractionally distilled off and the product distilled bulb-to-bulb to give the 
title compound (189) (0.422g, 83%). B. p. 30°C 18 mm Hg. The distillate was 
used immediately in the next stage of the synthesis.
Preparation of methyl N-(4-methoxyphenyl)glycinate (187).
An anhydrous solution of p-anisidine (freshly distilled, 0.246g, 2mmol), 
methyl bromoacctate (Q.305g. 2mmol), triethylamine (0.222g, 2.2mmol) in 
THF (13cm3) was refluxed under a nitrogen atmosphere for two hours. 
The solution was filtered to remove the triethylamine hydrobromide 
which was washed with THF (2x13cm3). The filtrate was concentrated 
under reduced pressure. The oily residue was purified by flash 
chromatography with ethyl acetate /  petroleum ether 1 : 8 to give the 
title compound (187) (0.34g, 8 8 %). 8 H (250 MHz; CDCI3 ) 6.71, 6.67, 6.5, 6.46 
(4H, AB q. J 8.9 Hz. Ph-//). 3.95 (1H, br. s. NH), 3.76 (1H. s. CHj), 3.67 (3H. s. 
OC//j). 3.64 (3H. s. OCH3 ). 6q  (100 MHz. CDCI3 ) 171.8 (Cl). 152.5 ((Ph). 141.1 
(Ph). 114.8 (Ph). 114.3 (Ph). 55.6 (C2). 52.1 (CO2C) 46.5 (PhOC). m/z (El) 195 
((M)*, 1.7%). 136 (9.7). 120 (1.1). 99 (1.2) (Found M* : 195.0894. C 10H13O3 N
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requires 195.0895). vmaK(CH C l3 ) /c m - 1 3212. 1743. 1465. Methyl N -(4- 
m cthoxyphcnyl)-|2-2H i ]-glycinatc Sh  (250 MHz; CDCI3 ) 6.83, 6.79, 6.65, 
6.62 (4H. AB q. J 8.9 Hz. Ph-//), 3.95 (1H. br. s. CD//). 3.78 (3H. s. OCWj). 3.76 
(3H, s. OCH3 ). m/z (El) 196 ((M)+. 19.3%), 137 (100), 121 (11.2). 100 (7.9) 
(Found M+ : 196.0951. C 10H 12DO3 N requires 196.0958).
Preparation of methyl N -(4 -m e th o x y p h e n y l)-A / -(0 -a c e ty l* 3 -h y d ro x y - 
4-methylbutanoate)glycinate (195).
An anhydrous solution of methyl A(-(4-methoxyphenyl)glycinate (0.39g, 
2mmol). 0-acctyl-3-hydroxy-4-mcthylbutanoic acid (0.3Sg, 2.2mmol), and 
EEDQ (1.1 eq., 0.544g. 2.2mmol) in THF (10cm3) was allowed to stir 
overnight. The solution was evaporated under reduced pressure and the 
residue taken up in ethyl acetate (10cm3). The organic solution was 
washed with hydrochloric acid (1 M, 10cm3), sodium bicarbonate (5%. 
10cm 3) and finally with saturated brine (10cm3). The solution was dried 
over magnesium sulphate and evaporated under reduced pressure. The 
product was purified by flash chromatography eluting with ethyl 
acetate /  petroleum ether I : 8 to give the title compound as an oil (195) 
(0.6g, 80%). &h (250 MHz; CDCI3 ) 7.43 (2H. AB q. J 9.0 Hz. a-Ph-H), 6.91 (2H. 
AB q. J 9.0 Hz. p-Ph-//). 4.85 (1H. d. J 5.0 Hz. COO/OAc). 4.75. 4.68. 3.98. 3.92 
(2H. AB q. J 17.1 Hz. CH2). 3.83 (3H. s. OCH3 ), 3.74 (3H. s. OCH3 ). 2.10 (3H. s. 
COCH3 ). 2.03 (1H. m. C//(CH3 )2 ). 0.93 (3H. d. J 6 .8  Hz. CHC//j). 0.83 (3H. d. 
J 6.9 Hz. CHC//j). 5C (100 MHz. CDCI3 ) 170.8. 169.9. 169.5, 159.2. 134.3, 129.3.
114.5, 74.9, 55.3. 52.0. 51.8. 29.5. 20.5. 19.1. 16.6. m/z (El) 337 (M «\ 9.4%). 
241 (4.5). 195 (100). 136 (67.9) (Found M+ : 337.1539. C 1 7 H2 3 O6 N requires 
337.1525). vm i,  ( C H C lj l / c n r 1 3496. 3026. 1736. 1672. 1511. Methyl 
N -(4-mcthoxy phenyl )-AT-(0-acety l-3-hydroxy-4-m ethy Ib u tan o a tcH  2- 
2H | |-glycinate SH (400 MHz; CDCI3 ) 7.43 (2H. AB q. J 9.0 Hz. o-Ph H). 6.91
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(2H. AB q. J 9.0 Hz. P-Ph-//). 4.85 (1H. d. J 5.0 Hz. COCWOAc). 4.71 (0.3H. br. s. 
//«), 3.94 (0.3H. br. s. HP), 3.83 (3H. s. OCH3), 3.74 (3H. s, OCH3 ), 2.10 (3H. s. 
COCH3 ). 2.03 (1H. m. C//(CH3)2). 0.93 (3H. d. J 6 .8  Hz. CHC//j). 0.83 (3H. d. J 
6.9 Hz. CHC//j).
Preparation of methyl N -(4 -m e th o x y p h e n y l)-A / -(0 -a c e ty l-m a n d e la te ) 
glycinate (196).
As for (195) using 0-acetylmandclic acid (0.43g, 2.2mmol) to give the title 
compound as an oil (196) (0.53g, 75%). 6 h (250 MHz; CDCI3 ) 7.43 (9H. m. 
Ph-//). 5.80 (1H. s. C//Ph), 4.41 (IH. d. J 17.1 Hz. / / “ ). 4.01 (1H. AB q. J 17.1 
Hz. HP), 3.69 (3H, s. OCH3 ). 3.57 (3H. s. OCH3 ), 2.01 (3H. s. COCH3 ). Sq  (100 
MHz. CDCI3 ) 170.4. 169.0. 168.7. 159.5. 133.43. 133.4. 129.8. 129.0, 128.7. 128.6. 
128.3. 114.4. 73.5. 55.3. 51.5. 20.5. m/z (El) 371 (M+-. 38.7%). 340 (4.0). 241 
(4.1). 195 (100). 149 (18.8), 136 (45.3) (Found M+ : 371.1373. C2 0 H2 1 O 6 N 
requires 371.1368). v max (C H C l3 )/cm*l 3487. 3026. 1738. 1677, 1511. 
Methyl Ar>(4-m ethoxyphcnyl)-A('-(0-acetyl-m andclate)-[2-^H 1 1-glycinate 
5h (250 MHz; CDCI3 ) 7.43 (9H. m. Ph-//). 5.89 (IH. s. C//Ph). 4.50 (0.35H. br. 
s. / / “ ). 4.01 (0.35H. br. s. HP). 3.81 (3H. s. OCH3 ), 3.70 (3H. s. OCH3 ). 2.13 (3H. 
$. COCtfj).
Preparation of methyl N-(4-methoxyphenyl)-A/'-(2-(A/-f-butyloxycarbonyl) 
amino-3-butenoate) glycinate (197).
As Tor (195) using 2-(Af-f-butyloxycarbonyl)amino-3-butenoic acid (143) 
(0.2g. 2.2mmol) to give the title compound as an oil (197) (0.3g. 40%). <h 
(250 MHz; CDCI3 ) 7.31 (2H. AB q. J 8 .8  Hz. o-Ph-//). 6.93 (2H. AB q. J 9.0 Hz. 
P-Ph-//). 5.62 (IH. m. C //-C H 2). 5.43 (IH. br. d. J 7.5 Hz. NH), 5.14 (2H. m. 
C H -C H i) ,  4.8 (IH. unres. t. J 7.5 Hz. CH), 4.57. 4.48. 4.16, 4.07 (2H. AB q.
I S O
J 17.1 Hz. CH 2). 3.82 (3H, s. OCH3), 3.74 (3H. s. OCH3 ). 1.41 (9H. s. I-Bu). 8 c  
(100 MHz, CDCI3 ) 171.0. 169.2. 159.5. 132.7. 129.5. 129.2. 118.1. 114.8. 79.5. 
55.4. 53.2. 52.1. 38.6. 29.6. 28.3. Methyl /V-(4-melhoxyphenyl)-yV*-(2-(tf- 
/-buty loxycarbonyl)am ino-3-butcnoate)-|2 -2H 1 1-glycinatc 8 h (400 MHz; 
CDCI3 ) 7.24 (2H. AB q. J 8 .6  Hz. a-Ph-//). 6.83 (2H. AB q. J 8.9 Hz. ß-Ph-H). 
5.57 (1H. ddd. J 16.8. 10.4. 6.1 Hz. C //-C H 2 ). 5.36 (1H. br. d. J 8.3 Hz. NH), 5.14 
(2H. m. CH=CH2 ). 4.8 (1H. unrcs. t. J 6 .8  Hz. CH), 4.41 (0.3H. br. s. Ha ), 4.01 
(0.3H, br. «. Hß), 3.74 (3H. 8. OCH3 ). 3.67 (3H. s. OCH3 ), 1.34 (9H. s. l-Bu).
Preparation of methyl N -(4 -m e th o x yp h en yl)-A / '-(2 -b ro m o p ro p a no a te ) 
glycinate (198).
As for (195) using 2-bromopropanoic acid (0.35g, 2.2mmol) to give the 
title compound as an oil (198) (0.55g. 83%). 8 H (250 MHz; CDCI3 ) 7.37 (2H. 
AB q. J 8.3 Hz. a-P h-//). 6.91 (2H. AB q. J 9.0 Hz. ß-Ph-//). 4.55, 4.48, 4.23. 
4.16 (2H, AB q. J 17.0 Hz. CH2), 4.32 (1H. q. J 6.7 Hz. C//Br). 4.19 (1H. AB q. J 
17.0 Hz. Hß), 3.84 (3H. s. OCH3 ), 3.75 (3H. s. OCH3 ), 1.74 (3H. d. I 6.7 Hz. 
CHC//j). 8c(100 MHz. CDCI3 ) 170.3. 169.1. 159.6. 134.1. 129.0. 114.8, 55.4. 52.1. 
51.7, 38.2. 21.5. m/z (El) 331 (M+8 1 Br+. 14.6%). 329 (M+7 9 Br+, 15.2). 208 
(5.9). 195 (43.4). 162 (12.6), 136 (100). 120 (49.2) (Found M+ ; 329.0261. 
C i 3 H i6 0 479BrN requires 329.0345). vmax (CHCl3 )/cm-> 3026. 1752, 1669. 
1511. 1219. Methyl A M 4-m ethoxyphcnyl)-A f'-(2-brom opropanoate)-(2- 
2 H 1 I glycinatc 8 H (250 MHz; CDCI3 ) 7.37 (2H. AB q. J 8.3 Hz. a-P h-//). 6.91 
(2H. AB q. J 9.0 Hz. ß-Ph-//). 4.49 (0.3H. br. s. Ha), 4.32 (1H. q. J 6.7 Hz. 
C//Br), 4.16 (0.3H. AB q. J 17.0 Hz. Hß), 3.84 (3H. s. OCH3). 3.75 (3H. s. OCH3). 
1.74 (3H. d. J 6.7 Hz. CHCH3 ).
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Preparation of methyl N -(4 -m e th o x y p h e n y l)-A / '-(2 -b ro m o -2 -p h e n y l 
ethanoate) glycinate (199).
As for (195) using 2-bromopropanoic acid (0.47g. 2.2mmol) to give the 
title compound as an oil (199) (0.59g. 76%). 8 h (250 MHz; CDCI3 ) 7.37 (7H. 
m. Ph-//). 6 .8 8  (2H. unrcs d. J 6 .6  Hz. o-McOPh-//), 5.43 (1H. s. CHPh). 4.48. 
4.41. 4.29, 4.22 (2H. AB q. J 17.1 Hz. CH 2 ). 3.82 (3H. s. OCH3 ). 3.70 (3H. s. 
O C //j). 8 c  (100 MHz. CDCI3 ) 168.9. 168.1. 159.7. 136.2. 134.0. 129.2. 128.9. 
128.7. 128.5. 114.9. 55.5. 52.1. 51.9. 45.6. m/z (El) 393 (M+8 , Br+. 37%). 391 
(M + 7 9 Br+. 37.6). 311 (60). 252 (44.6). 195 (72). 136 (96). 120 (67.6) (Found 
M* : 391.0428. CigH|gC>4 79BrN requires 391.050). vmax (C H C ^ /c n T 1 3029. 
1752. 1674, 1511. 1219. Methyl /V -(4-m ethoxyphenyl)-A T -(2-brom o- 
2-phenylcthanoate)-12-2H 1 )-glycinaie. 8 h (250 MHz; CDCI3 ) 7.37 (7H. m. 
P h-//). 6 .8 8  (2H, unrcs d. J 6 .6  Hz. a-M cO Ph-//). 5.43 (1H. s. C//Ph). 4.42 
(0.3H. br. s. / / “ ). 4.24 (0.3H. br. s. HP). 3.82 (3H. s. OCH3 ). 3.70 (3H. s. OCH3 ).
Preparation of 2-bromo-A/-(1-phenylethyl)ethanamide (200).
As for 196 using bromoacetic acid (0.47g, 2.2mmol) to give the title 
compound 199 which was recrystalliscd from ethanol /  water (0.59g. 
76%). M. p. 110.5-112°C. 8h  (250 MHz; CDCI3 ) 7.25 (5H. m. Ph-//). 6.71 (1H. 
br. s. N//). 5.12 (1H. m. C//Ph). 3.96. 3.91. 3.90. 3.85 (2H. AB q. J 13.8 Hz. 
CH 2). 1.54 (3H. d. J 6.9 Hz. CH 3 ). m/z (El) 245 (M+8 I Br+. 15.9%). 243 
(M +7 9 Br+, 16.1). 241 (M +'H 2 ^ 8 , B r+ l+. 1.2%). 199 (1.5). 163 (9.9). 120 (3.3). 
8 h (250 MHz; CDCI3 ) 7.25 (5H. m. Ph-//). 6.61 (1H. br. s. NH). 5.03 (1H. m. 
C//Ph), 3.89 (0.5H. I. J 1.86 Hz. D//«). 3.86 (0.5H. I. J 1.86 Hz. DHP), 1.54 (3H. d. 
J 6.9 Hz. C//j). 8 c  (100 MHz. CDCI3 ) 140.1. 128.7. 127.1. 125.9. 62.1. 48.4. 21.6. 
14.4. vma*/cnr* 3415. 1675. 1525.
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TABLE 1. A ton coordinates (xlO«) ant' isotropic thermal parameters (A*xlO^
Atom X y z U
O ( i ) 1155(9) 428(5) 207(2) 57(2)
0 ( 2 ) 2408(9) - 3 7 1 ( 5 ) 1632(2) 50(2)
0 ( 3 ) - 2982( 12) - 3 53 4( 6 ) 610(3) 69( 2)
0 ( 4 ) - 3444( 10) - 106 8( 6 ) 36(2) 66( 2)
0 ( S ) - 9 0 9 ( 9 ) 1620(5) 831(2) 52(2)
0 ( 6 ) - 4 9 2 ( 8 ) 127(4) 2271(2) 41( 1)
N ( i ) - 1657( 11) - 5 4 1 ( 6 ) 1452(2) 39(2)
C ( 1 ) - 2 15 ( 1 4) 479(7) 602(3) 43( 2)
C ( 2 ) - 1298( 12) - 7 3 9 ( 6 ) 866(2) 35(2)
C ( 3 ) - 3754( 14) - 113 6( 8 ) 604(3) 46(2)
C ( 4 ) - 4590( 15) - 251 6( 8 ) 791(3) 57(3)
0 ( 5 ) 291(14) - 2 5 5 ( 7 ) 1778(3) 37( 2)
C ( 6 ) 1231(12) 521(7) 2703(3) 37( 2)
0 ( 7 ) 2729(15) - 6 9 4 ( 7 ) 2887(3) 57( 3)
0 ( 8 ) - 4 87 ( 1 4) 966(8) 3156(3) 50( 3)
0 ( 9 ) 2905(14) 1651(7) 2519(3) 51(3)
0 ( 10 ) 206(17) 2859(8) 623(3) 66( 3)
0 ( 11 ) 2645(19) 3077(8) 883(3) 69( 3)
E q ui v a l e n t  i s o t r o p i c  U def i ned as one t h i r d  of the 
t r ace of the or t h o go na l i se d  U i j  tensor
o m - c m
0 ( 3 ) - C ( 4 )
0 ( 5 ) - C (1)
0 ( 6 ) - C (5) 
M ( l ) - C ( 2 )  
C ( l ) - C ( 2 )  
C ( 3 ) - C ( 4 )
C ( 6 ) - C (8 )
C ( 1 0 ) - C ( 11)
TABLE 2. Bond lengths (A)
221(9) 0 ( 2 )
409(10) 0 ( 4 )
320(9) 0 ( 5 )
331(8) 0 ( 6 )
460(8) H< 1)
493(10) C ( 2 )
516(11) C (6)
514(10) C (6)
485(14)
- C ( 5 ) 1. 210( 9)
- C ( 3 ) 1 . 400( 8)
- C ( 10 ) 1. 465( 10)
- c  (6 ) 1. 465( 8)
- C ( 5 ) 1. 355( 10)
- C ( 3 ) 1 . 531( 10)
- C ( 7 ) 1. 525( 10)
- C ( 9 ) 1 . 514( 10)
TABLE 3. Bond anglesi ( d e g . )
C ( 1 ) - 0 ( 5 ) - C ( 10) 117 . 3 ( 6 ) C ( 5 ) - 0 ( 6 ) - C ( 6 ) 121 . 6 ( 5 )
C ( 2 ) “M( 1 ) - C ( 5 ) 120 . 1 ( 6 ) 0 ( 1 ) - C ( 1) - 0 ( 5 ) 123 . 0 ( 7 )
0 ( 1 ) - C ( 1 ) - C ( 2 ) 123 . 2 ( 7 ) 0 ( 5 ) - C ( 1 ) - C (2 ) 113 . 7 ( 6 )
N ( 1 ) - C ( 2 ) - C (1 ) 111 . 5 ( 5 ) N ( l ) - C ( 2 ) - C < 3 ) 109 . 2 ( 5 )
C ( l ) - C ( 2 ) - C ( 3 ) 111 . 9 ( 6 ) 0 ( 4 ) - C ( 3 ) - C (2 ) 107 . 2 ( 6 )
0 ( 4 ) - C ( 3 ) - C ( 4  ) 112 . 3 ( 6 ) C ( 2 ) - C ( 3 ) - C ( 4 ) 1 1 1 . 6 ( 6 )
0 ( 3 ) - C ( 4 ) - C ( 3 ) 111 . 8 ( 6 ) 0 ( 2 ) “C ( 5 ) - 0 ( 6 ) 126 . 7 ( 6 )
0 < 2 ) - C ( 5 ) - N ( l ) 123 . 3 ( 6 ) 0 ( 6 ) - C ( 5 ) - N (1) 110 . 0 ( 6 )
0 ( 4 ) - C ( 6 ) - C ( 7) 109. 9( 5) 0 ( 6 ) - C ( 6 ) - C ( 8 ) 102 . 3 ( 5 )
C ( 7 ) - C ( 6 ) - C { 8 ) 110 . 2 ( 6 ) 0 ( 6 ) - C (6 ) - C (9) 111. 6( 5)
C ( 7 ) - C ( 6 ) - C (9 ) 
0 < 5 ) - C ( 1 0 ) - C (  11)
110 . 8 ( 6 )
110 . 1 ( 6 )
C ( 8 ) - C ( 6 ) - C (9) 111 . 7 ( 6 )
TABLE 4. A n i s ot r op i c thermal parameters ( A 2 x 10 3 )
Atom U n Uaa Uia U a a Uii
0 ( 1 ) 60( 3) 59(3) 54( 3) - 7 ( 3 ) 10(3)
0 ( 2 ) 34(3) 67(4) 48( 3) - 1 6 ( 3 ) 3( 2)
0 ( 3 ) 67(4) 55(3) 86( 4) - 2 6 ( 3 ) - 1 5 ( 4 )
0 ( 4 ) 54(3) 96(4) 49( 3) - 1 6 ( 3 ) - 3 ( 3 )
0 ( 5 ) 52(3) 42(3) 62( 3) - 2 ( 3 ) 12(3)
0 ( 6 ) 32(2) 52(3) 40( 2) - 1 1 ( 2 ) 2( 2)
N ( 1) 30(4) 51(4) 35( 3) - 1 0 ( 3 ) 1( 3)
C ( 1 ) 40(4) 46(5) 42( 4) - 6 ( 4 ) 3( 4)
C ( 2 ) 28(4) 41(4) 35( 4) - 9 ( 3 ) 2( 4)
C ( 3) 41( 4) 56(5) 41( 4) - 1 1 ( 4 ) - 2 ( 4 )
C (4 ) 41(5) 67(6) 6/ ' S) - 1 9 ( 5 ) 0( 4)
C ( 5 ) 42(4) 37(4) 33, 4 ) - 3 ( 3 ) - 0 ( 4 )
C ( 6 ) 31(4) 41(4) 39( 3) - 6 ( 3 ) - 1 1 ( 4 )
C ( 7 ) 47( 5) 56(5) 67( 5) 2 ( 4 ) - 1 0 ( 4 )
C ( 8 ) 47(4) 65(5) 38( 4) - 7 ( 4 ) - 1 ( 4 )
C ( 9 ) 46(5) 46(5) 60( 5) - 1 3 ( 4 ) - 3 ( 4 )
C ( 1 0 ) 71(7) 57(5) 71( 5) 1 ( 5 ) 6( 6)
C ( l l ) 85( 7) 51(5) 73( 6 ) 1 ( 5 ) 9( 6)
The a n i s o t r o p i c  thermal  parameter  exponent  takes the form:
- 2 m * ( h 2a**Ui i  ♦k*b**Un ♦ . . .  ♦2hka*b*U,a)
Uia
- 1 2 ( 3 )
- 4 ( 3 )
1(4)
- 6 ( 4 )
4( 3)
- 0 ( 2 )
2( 4)
6 ( 4)
- 3 ( 4 )
- 8 ( 4 )
- 1 0 ( 5 )
- 1 2 ( 4 )
- 5 ( 4 )
2( 5)
- 1 4 ( 5 )
- 6 ( 5 )
1(5)
- 1 6 ( 5 )
TABLE 5. H-atoa coordinate» (»10«I and tharaal paraaatari <A»«10>)
At o» X y Z U
H ( 2 ) -138 -1446 797 80
H( 3) -5044 -550 728 80
H ( 4* ) -6196 -2684 642 80
H ( 4b ) -4671 -2535 1183 80
H ( 7»  ) 3 6 8 S ( 15) - 485( 7 ) 3206(3) 80
H ( 7b ) 3796( 15) - 1019( 7) 2603(3) 80
H ( 7c ) 1537( 15) - 1372( 7) 2976(3) 80
H ( 8* ) 4 30 ( 1 4 ) 1227(8) 34*»5(3) 80
H (8b) - 1 7 5 5 ( 1 4 ) 343(8) 3267(3) 80
H ( 8c) - 1 2 2 1 ( 1 4 ) 1746(8) 2993(3) 80
H ( 9a ) 3760( 14) 2123(7) 2804(3) 80
H ( 9b ) 1942( 14) 2276(7) 2310(3) 80
H ( 9c ) 4078( 14) 1218(7) 2284(3) 80
H( 10a) 352 2822 232 80
H(10b) -833 3600 724 80
H ( l i a ) 3383( 19) 3936(8) 811(3) 80
H ( l l b ) 3715( 19) 2377(8) 755(3) 80
H ( l l c ) 2390( 19) 2977(8) 1270(3) 80
H ( 1 ) - 2 9 4 6 ( 1 0 5 ) - 265( 58) 1561(21) 11(17)
M O I ) - 3 8 8 5 ( 227) -4153( 108) 525(46) 158(57)
H ( 4 ) - 5 1 8 1 ( 2 0 9 ) -862(102) - 141 ( 3 7) 128(36)
